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GENERAL INTRODUCTION 
During the rodent estrous cycle, a period of sexual behavior of 
limited duration is exhibited by the female around the time of ovulation 
(12, 93, 182-184). The occurrence of this period of sexual behavior is 
most often characterized by the presence of the lordosis posture in 
response to genital stimulation by the male. Although this posture 
varies slightly among species, it consists of a general immobilization 
and a pronounced dorsiflexion of the spine. By assuming this posture, 
the female greatly increases the chance of successful copulation 
occurring. In addition to lordosis, or receptive behavior, proceptive 
behaviors are displayed during this period. These behaviors, in the 
rat, include darting and hopping, rapid ear vibration, and approach to 
and withdrawal from the male (48, 97). The exhibition of these 
behaviors is thought to increase the attractiveness of the female to the 
male, thereby increasing the likelihood that mounting will be attempted 
(7, 89). 
Hormonal Control of Sexual Behavior 
The occurrence of the period of sexual behavior (heat) in many 
rodent species, including rats and guinea pigs, is regulated by the 
sequential secretion of the ovarian hormones, estradiol and 
progesterone. Surgical removal of the ovaries prevents the appearance 
of the behavior while treatment with estradiol and progesterone restores 
it (24, 34, 33, 45, 47). Although estradiol treatment alone can 
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activate sexual receptivity in ovariectomized (OVX) animals, 
progesterone given 18 - 60 hours after estradiol has a facilitory effect 
(63, 143). This facilitation may be manifest as a decrease in latency 
from estradiol administration to the onset of lordosis, as an increase 
in the intensity of lordosis, as an increase in the appearance of 
proceptive behaviors, and as a reduction in the amount of estradiol 
required to induce lordosis (24, 63, 143, 175). Progesterone 
administered in the absence of prior estrogen treatment has no effect on 
sexual behavior (11, 63). 
The importance of progesterone in the regulation of sexual 
behavior is well-established. Myers et al. (125) first demonstrated in 
the mid-1930s that the onset of sexual behavior in estrous-cycling 
female guinea pigs coincided with the beginning of the preovulatory 
growth phase of the ripening ovarian follicle. Prior to this study, it 
was thought that sexual behavior resulted from the actions of estrogens 
alone (3); however, because preovulatory growth of the ovarian follicle 
was known to be triggered by luteinizing hormone (LH) (66), this study 
raised the possibility that a second factor was involved. 
Dempsey et al. (45), were the first to suggest that this second 
factor was progesterone. This was based on their finding that LH 
activated lordosis only when injected during the stages of the cycle 
when ripening ovarian follicles capable of ovulation were present. In 
comparison, progesterone was effective even when injected at earlier 
stages of the cycle. In addition, progesterone administered to 
estrogen-pretreated OVX guinea pigs facilitated lordosis, whereas no 
effect was observed with LH injection. Dempsey and coworkers concluded 
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that sexual behavior required the action of progesterone which -is 
released from the preovulatory follicle following stimulation by LH. 
However, because progesterone was thought at that time to be released 
only by the corpus luteum, this conclusion was at first largely ignored 
by some workers in the field (8). Later studies in which progesterone 
concentrations were measured in serum obtained from general circulation 
(30, 39, 62, 64, 163) and in serum obtained from the ovarian vein (31), 
confirmed the preovulatory release of progesterone. Furthermore, this 
release of progesterone has been shown to just precede the onset of 
sexual receptivity in both rats (62, 163) and guinea pigs (64). The 
source of this preovulatory progesterone is most likely not corpora 
lutea from preceding ovulations. Feder and Boy (61) have recently 
reported that in prepubertal guinea pigs, administration of estradiol 
followed by injection of either LH or follicle-stimulating hormone 
resulted in the activation of lordosis. This treatment also resulted in 
increased circulating progesterone levels just prior to lordosis onset, 
with no luteinization of unruptured follicles. 
Further evidence that progesterone is involved in the activation 
of sexual behavior is provided by the finding that female guinea pigs 
(33) and rats (5, 140) do not become sexually receptive when deprived of 
preovulatory progesterone by ovariectomy just prior to the onset of 
sexual receptivity. Progesterone, exogenously administered to these 
animals, restored the period of receptivity. Injecton of supplemental 
estradiol, however, had no effect; therefore, acute ovariectomy in these 
studies prevented the onset of sexual receptivity by acting to limit 
progesterone and not estradiol. 
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In addition to its facilitory effects, progesterone has also been 
shown to have an inhibitory effect on sexual receptivity (63, 71, 99, 
114). Following the termination of the period of sexual receptivity in 
intact estrous-cycling guinea pigs, injection of progesterone or 
sequential injection of estradiol and progesterone does not result in 
the activation of a second receptive period (45, 185, 187). Soy et al. 
(71) were the first to suggest that this refractoriness was the result 
of progesterone action. They found that sequential injection of 
estradiol and progesterone in guinea pigs during various stages of the 
estrous cycle was less effective in activating sexual receptivity when a 
functional corpus luteum was present. 
Similar inhibitory effects have been obtained in OVX animals. 
Following the termination of sexual receptivity in hormonal 1y-treated 
OVX guinea pigs, a second injection of progesterone does not result in 
the activation of a second receptive period (63, 114). Similar findings 
have been reported for mice (47), hamsters (34), and rats (22, 92, 99, 
126, 186). This inhibition has been termed sequential inhibition (142), 
because it occurs subsequent to the period of estrogen priming, in a 
similar fashion, progesterone treatment initiated at the time of 
estradiol treatment inhibits the ability of a subsequent progesterone 
stimulus to facilitate a period of sexual behavior (11, 21, 75, 174). 
This type of inhibition has been termed concurrent inhibition because 
the inhibitory effects occur during the estrogen priming period (142). 
The sequential inhibitory effects of progesterone are largely 
determined by the initial dose of progesterone (26, 27). In rats, a 
greater dose of progesterone is required to cause sequential inhibition 
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than is required to facilitate sexual receptivity (49). The opposite 
relationship occurs in guinea pigs (119). In both species, sequential 
inhibition, as well as concurrent inhibition, can be overcome with a 
greater dose of progesterone (14, 75). In addition, supplemental 
injection of estradiol at the time of the initial injection of 
progesterone restores the ability of a subsequent progesterone injection 
to facilitate sexual behavior (22, 82, 126, 160, 185). These findings 
suggest that the inhibition is actually the result of a decreased 
sensitivity to progesterone. 
Neural Site of Hormonal Control 
of Sexual Receptivty 
The identification of the principal neural sites for the 
activation of lordosis by estradiol and progesterone was highly 
controversial until fairly recently. The methods used to elucidate 
these sites were primarily steroid autoradiography, used to identify 
regions capable of sequestering hormone, and hormone implantation, used 
to identify groups of cells capable of responding to ths hormone (6) 
Results of estradiol benzoate implantation into rat brain 
implicate both the anterior hypothalamus-preoptic area (AH-POA) and 
ventromedial nucleus of the hypothalamus (VMN) as the primary sites for 
estrogens effects on lordosis (91, 181). A similar finding has been 
reported in guinea pigs (118). 
Davis et al. (41, 42), and Rubin and Barfield (155), reported 
that estradiol implants are most effective in priming OVX rats to 
exhibit lordosis when placed into the VMN. These studies were conducted 
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with estradiol diluted 1:250 with cholesterol in order to minimize the 
spread of estradiol, and thereby achieve a more concise localization. 
In addition, this manipulation allowed for the specific identification 
of sites where estadiol had a griming effect on lordosis (ij.e. required 
subsequent progesterone treatment), rather than an activational effect. 
The results obtained in these studies indicated that such implants 
placed in the VMN, but not the AH-POA, permitted a sufficient priming 
effect to allow progesterone-facilitated lordosis to occur. 
In support of the VMN as the the site of estrogen action, steroid 
autoradiography (136, 168) and immunohistochemistry (121) have shown 
that the VMN contains neurons capable of accumulating estradiol. In 
addition, biochemical assay of microdissected VMN has confirmed that the 
VMN contains high-affinity estrogen binding sites (147). 
A variety of neural sites for progesterone actions on lordosis 
has been implicated by progesterone implant studies in the rat and 
guinea pig brain. These include the mediobasal hypothalamus (116, 141), 
caudate putamen (131), interpeduncular nucleus (94), ventral tegmental 
area (94), arcuate nucleus (116), and the midbrain reticular formation 
(181). The discrepancy among these studies may be due to the use of 
high priming doses of estradiol, or to diffusion of progesterone to 
sites distant from that of the implant. In a carefully controlled 
study, Rubin and Barfield (156) found that only implants placed 
bilaterally into the VMN of estradiol-primed OVX rats were able to 
facilitate lordosis. Cannulae placements in the preoptic area, midbrain 
reticular formation-interpeduncular nucleus, or midbrain central gray 
were ineffective. In addition, the facilitation was independent of the 
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adrenal gland, and therefore, not the result of an effect on the 
adrenal-pituitary axis to increase adrenal secretion of progesterone. 
Autoradiography of progestin uptake in estrogen-pretreated rat 
(177) and hamster brain (124) demonstrates that the VMM contains cells 
capable of accumulating progestins. In addition, biochemical assay of 
(liicrodissected VMN has confirmed that the VMN contains a high 
concentration of high-affinity estrogen-dependent progestin binding 
sites (332). 
In further support of the importance of the VMN in the hormonal 
activation of sexual receptivity, Mathews and Edwards (102, 103) have 
shown that electrolytic lesions of the VMN block the hormonal activation 
of lordosis. In addition, Pfeifle et al. (138) reported that bilateral 
parasaggital knife cuts lateral to the VMN prevent progesterone-
facilitated sexual receptivity. Furthermore, electrical stimulation of 
the VMN facilitates lordosis in estrogen-pretreated animals (137). 
Nevertheless, the VMN may not be the only site where progesterone's 
effects on receptivity are manifest, although it appears to be the 
principal site. 
Neural sites within the MBH have also been identified as the site 
for the inhibitory effect of progesterone on sexual behavior (19, 100, 
157), Rubin and Barfield (157) reported that bilateral progesterone 
implants placed in the rat VMN first facilitate sexual receptivity and 
subsequently result in the animal becoming refractory to a systemic 
injection of progesterone. Progesterone implants placed in the preoptic 
area or in various parts of the midbrain neither facilitated lordosis 
nor caused refractoriness to further progesterone stimulation, 
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indicating that VMN stimulation is necessary tor the inhibitory effect 
of progesterone to occur. Furthermore, these studies demonstrate a 
common neural site in the rat for progesterone's dual effects on 
lordosis. 
In contrast, the neural site for the inhibitory effect of 
progesterone in guinea pigs is thought to be neuroanatomical 1 y distinct 
from the facilitory site (116, 117). Morin and Feder (117) reported 
that progesterone implants placed bilaterally near the zona compacta of 
the midbrain substantia nigra failed to facilitate sexual receptivity in 
estradiol-pretreated OVX guinea pigs, yet prevented subsequent 
systemically-injected progesterone from facilitating the behavior. 
Furthermore, implants in the MBH which facilitated lordosis failed to 
inhibit the actions of subsequent progesterone (116). However, closer 
examination of the data presented in this study has yielded opposite 
conclusions (16). 
In their study, Morin and Feder (116) injected progesterone 
systemically 8 hours after intrahypothalamic placement of progesterone 
implants. No difference in heat duration was noted as compared to 
animals that did not receive the progesterone injection. This was taken 
as evidence that the progesterone implant did not inhibit the effect of 
the systemically-injected progesterone. However, in the absence of the 
progesterone implant, the progesterone injection would have been 
expected to result in prolonged heat duration. Because the full 
expected effects of the systemic progesterone injection did not occur, 
these results could be interpreted as evidence that progesterone placed 
in the MBH exerts an inhibitory influence on lordosis. 
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In a second experiment, Morin and Feder (116) injected 
progesterone into animals that had not responded by 8 hours after 
intrahypothalamic placement of progesterone or cholesterol. Although 
91% of the cholesterol-implanted animals responded to this injection, 
only 65% of the progesterone-implanted animals responded. The 
progesterone-implanted animals also showed a trend toward shorter heat 
durations as compared to cholesterol-implanted animals. When the scores 
of the non-responsive animals (heat duration = 0 hours) were factored 
into the analysis, a statistically significant decrease in heat duration 
by progesterone implants was found (16). 
From a third experiment, Morin and Feder (116) concluded that 
progesterone implants placed in the MBH failed to inhibit responsiveness 
to a progesterone injection administered 24 hours after implantation. 
This was based on the finding that a similar percentage of 
cholesterol-implanted and progesterone-implanted guinea pigs responded 
to the progesterone injection (337. and 38% respectively). However, when 
compared with 100% of non-implanted animals that responded to the 
injection, the inhibitory effect of the cannulation is apparent. The 
problem lies in the fact that either cannulation alone or cholesterol 
exposure had an inhibitory effect which may have masked the effect of 
the implanted progesterone. Therefore, based on this experiment, it can 
not be concluded that implants placed in the MBH fail to inhibit 
responsiveness to additional progesterone. 
Taken together, the reanalysis of the work of Morin and Feder 
(116) agrees with work done in the rat, showing that both the facilitory 
and inhibitory effects of progesterone occur within the MBH. It has not 
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yet been possible to determine if these effects are due to actions 
within the same cell. 
Cellular Mechanisms of Hormonal 
Control of Sexual Receptivity 
The activation of sexual receptivity by estradiol and 
progesterone is thought to be mediated by intracellular, 
steroid-specific hormone receptors. High-affinity, estrogen-specific 
intracellular estrogen binding sites have been demonstrated in several 
brain regions, including the MBH (68, 121, 147). Following injection of 
estradiol, the concentration of these binding sites, or receptors, 
decreases as the concentration in the cell nuclear compartment increases 
(90, 154). Based primarily on studies of estrogen action in peripheral 
tissues, it is thought that as a result of increased nuclear binding of 
estradiol-estrogen receptor complexes, specific RNA-dependent 
alterations in protein synthesis occurs (73, 104). In support of this, 
Rainbow et al. (144) reported that administration of a protein synthesis 
inhibitor, anisomycin, near the time of estradiol treatment, inhibited 
the activation of sexual receptivity in response to a progesterone 
injection 24 hours later. In addition, antiestrogens, which act to 
decrease nuclear estrogen accumulation and retention (55, 87, 170), 
block estradiol's effects on sexual receptivity (55, 87, 88, 153, 170, 
171). 
One result of the action of estradiol in the brain is the 
induction of intracellular progestin binding sites. These binding sites 
are of high affinity (Kd = 0.3 nti) and high specificity, and are 
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susceptible to degradation by pronase (19, 95, 96, 111, 132). 
Estradiol-induced increases in these binding sites, or receptors, have 
been demonstrated in the hypothalamus, pituitary gland, preoptic area, 
and midbrain, but not in the cortical amygdala, hippocampus, or cerebral 
cortex (19, 95, 111, 132), This increase in progestin receptor levels 
can be blocked by antiestrogen treatment (55, 153), or by administration 
of the protein synthesis inhibitor, anisomycin (144), suggesting the 
involvement of a genomic mechanism. 
The induction of progestin receptors by estradiol is dose 
dependent. Doses of estradiol that are sufficient to prime OVX rats 
(112, 133) or guinea pigs (19) to respond to progesterone are sufficient 
to increase hypothalamic intracellular progestin receptor levels. 
Furthermore, progestin receptor induction is temporally linked to the 
estrogen priming period (19, 60, 112, 131, 133). Depending on the dose 
of estradiol, an interval of 18 to 60 hours between estradiol and 
progesterone treatment results in maximal activation of lordosis (63, 
143). An interval of less than IB h is insufficient to allow 
progesterone facilitation to occur. In agreement with this, Blaustein 
and Feder (19), and Parsons et al. (131, 133), have shown that estradiol 
induction of progestin receptors is not detectable before 12 to 18 h 
after estradiol injection. 
Blaustein and Feder (20), found that subcutaneous injection of 
progesterone in OVX estradiol-pretreated guinea pigs, resulted in a 
transient increase in progestin receptor levels in hypothalamic nuclear 
fraction as measured by an in vitro exchange assay. Concurrent with 
this increase, cytosol progestin receptor levels decreased. The 
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transient increase in nuclear progestin receptor levels paralleled the 
concentration of progesterone measured in serum, and temporally 
correlated with the display of sexual receptivity. Nuclear receptor 
levels increased prior to the initiation of sexual receptivity, and 
decreased as the behavior dissipated (12 - 24 hours after progesterone 
injection), A similar finding has been reported by McGinnis et al. 
(106), following intravenous injection of progesterone to 
estradiol-pretreated rats. 
Hypothalamic estrogen and progestin receptor levels have been 
measured during the estrous cycle of the rat (107, 146). Changes in 
nuclear estrogen receptor concentrations during the cycle parallel 
changes in serum estradiol levels; receptor concentrations are low 
during estrus and diestrus I, but begin to increase on diestrus II 
(metestrus). Peak levels of nuclear estrogen receptors are observed at 
proestrus. In a similar pattern, the concentration of cytosol progestin 
receptors are at their lowest level during diestrus I. These levels 
begin to increase on diestrus 11, and attain peak levels on the morning 
of proestrus, just prior to the preovulatory release of progesterone 
(107). Nuclear progestin receptor concentrations, which are low during 
other stages of the cycle, increase dramatically on the afternoon of 
proestrus, just prior to the onset of sexual behavior (146). These 
patterns of receptor concentration fluctuations provide further support 
that intracellular steroid hormone receptors are involved in the 
activation of sexual behavior. 
In support of the contention that progesterone acts through a 
genomic mechanism to facilitate the onset of sexual receptivity, Rainbow 
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et al. (144) reported that injection of anisomycin around the time of 
progesterone injection prevented the initiation of sexual receptivity. 
This effect was most likely not due to debilitation of the animals since 
injection of anisomycin to animals in estrogen-induced heat had no 
effect on lordosis. In a later study, Rainbow et §1. (145) found that 
anisomycin applied directly to the VMN prevented progesterone's 
facilitory effects on lordosis. A similar finding was reported by 
Glaser and Barfield (69), who also demonstrated that this effect was 
specific for the VMN. Anisomycin placed in the preoptic area or in the 
midbrain in the region of the interpeduncular nucleus had no effect on 
sexual behavior. In addition to demonstrating that progesterone 
facilitation of lordosis is protein synthesis-dependent, these studies 
provide further evidence that the VMN is the principal site for 
progesterone's effects on lordosis. 
Following the injection of progesterone, cytosol progestin 
receptor levels decrease and are not replenished as the concentration of 
nuclear progestin receptors decreases (13, 19, 112). This has led to 
the hypothesis that progesterone inhibition is, in effect, a 
hyposensitivity to progesterone caused by a progesterone-induced 
decrease in the availability of progestin receptors (19, 112, 159). In 
support of this hypothesis, Moguilewsky and Raynaud (112), and Blaustein 
and Feder (19), have reported that progesterone administered at the time 
of estradiol (concurrent inhibition), almost completely blocked the 
induction of cytosol progestin receptors by estradiol. In addition, in 
the sequential inhibition paradigm, a second behaviorally-ineffective 
injection of progesterone 24 hours after the initial injection only 
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slightly increased the concentration of nuclear progestin receptors (14, 
20). A larger dose of. progesterone, one that is capable of overcoming 
the inhibition, increased nuclear progestin receptor levels by 41% over 
what was measured following the lower progesterone dose (14). Likewise, 
injection of supplemental estradiol at the time of the initial 
progesterone injection, a treatment that restores sensitivity to 
subsequent progesterone, allowed a 1077. greater increase in nuclear 
progestin receptor accumulation in response to a second injection of 
progesterone 24 hours later (13). These studies suggest that 
progesterone decreases sensitivity to itself by decreasing the 
availability of progestin receptors, and that supplemental estradiol 
restores sensitivity by increasing intracellular progestin receptor 
levels. 
Although the studies discussed above support the hypothesis that 
a downregulation in the concentration of intracellular progestin 
receptors is involved in mediating the effects of progesterone on sexual 
behavior, a report by Parsons and McEwen (129), contradicts this 
evidence. In this study, Parsons and McEwen extended the findings of an 
earlier report by Wallen et al. (176), showing that a protein synthesis 
inhibitor can prevent the occurrence of the refractory period in guinea 
pigs. Parsons and McEwen (129) reported that injection of anisomycin, 3 
to 9 hours after injection of progesterone blocked the occurrence of a 
refractory period to progesterone in OVX estradiol-pretreated rats. 
Twenty-four hours after the initial injection of progesterone, cytosol 
progestin receptor levels were decreased; however, a second injection of 
progesterone at this time appeared to have facilitated sexual 
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receptivity. Unfortunately, animals were not tested prior to the second 
injection of progesterone to verify that they were not still responsive 
from the initial progesterone exposure. Blaustein et ai.. (17) found no 
effect of protein synthesis inhibition on the refractory period to 
progesterone; however, with a procedure similar to that used by Parsons 
and McEwen (129), they found that anisomycin delayed the termination of 
the period of sexual receptivity induced by the first progesterone 
injection. It is possible that in the study by Parsons and McEwen, rats 
were still receptive at the time of behavioral testing from the first 
progesterone treatment, rather than receptive from the second 
progesterone treatment. Therefore, the results obtained by Parsons and 
McEwen (129), do not necessarily contradict the hypothesis that 
intracellular progestin receptors are involved in mediating progesterone 
action on sexual behavior. 
It should be noted that in the earlier study by Wallen et al. 
(176), a slightly different treatment sequence was used. DVX 
estradiol-pretreated guinea pigs were treated with cycloheximi de, a 
protein synthesis inhibitor, one hour before or one hour after r e c e i v i n g  
progesterone. Animals were tested for lordosis, and S hours after 
progesterone injection, a second sequence of estradiol followed 36 hours 
later by progesterone was initiated. Animals were tested again for 
lordosis following the second progesterone injection. Based on the 
finding that more animals that had received cycloheximide were receptive 
during the second test, as compared to non-cycloheximide treated 
animals, the authors concluded that progesterone-induced inhibition was 
protein synthesis-dependent. However, the results of this experiment 
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are difficult to interpret because latency to lordosis following the 
second injection of progesterone was not reported. It is possible that 
prior cycloheximide treatment increased the sensitivity to estradiol, or 
in some other progesterone-independent manner activated sexual 
receptivity. As in the case of the study by Parsons and McEwen (129), 
animals must be tested prior to progesterone in order to verify that 
they are, in fact, responding to that injection of progesterone. 
Furthermore, Shivers et al. (160) reported that in rats, the RNA 
synthesis inhibitor, actinomycin D, infused into the third ventricle had 
no effect on the refractoriness to progesterone induced by the 
sequential inhibition paradigm. 
The mechanism by which progesterone induces down regulation of 
its own receptors is not fully understood. Zucker (185, 187) first 
hypothesized, based on behavioral data alone, that progesterone acted to 
prevent estradiol "from acting at the neural sites that mediate 
receptivity." It is conceivable that by preventing estradiol action i n  
the hypothalamus, progesterone could prevent further induction of 
intracellular progestin receptors. However, a number of studies have 
shown that progesterone does not affect accumulation or retention of 
CH)estradiol (21, 43, 98, 172), depletion or repletion of cytosol 
estrogen receptors following estradiol treatment (43, 134), or the 
binding of estradiol to hypothalamic estrogen receptors (50). A recent 
report, however, indicates that progesterone under certain conditions, 
has an inhibitory influence on hypothalamic estrogen receptor levels 
(15). In OVX rats treated chronically with estradiol, progesterone 
administration resulted in a decreased level of nuclear estrogen 
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receptors as measured 24 hours after progesterone injection. At an 
earlier time after injection (6 hours), a decrease in cytosol estrogen 
receptors was observed; therefore, this decrease in nuclear receptor 
levels was most likely the result of a decreased availability of cytosol 
receptors. It seems unlikely that such a mechanism is responsible for 
progesterone's inhibitory effect, since a high dose of progesterone 
overcomes the inhibition rather than exacerbates it. Furthermore, it is 
uncertain if nuclear estrogen receptor occupation at the time of 
progesterone injection is required for sexual behavior to occur. 
In a study examining the time course of retention of 
(3H)estradiol in hypothalamic cell nuclei following subcutaneous 
estradiol injection, Walker and Feder (172), found that nuclear 
accumulation of estradiol peaked at 11 hours following injection, and 
remained elevated at this level until 43 hours after injection. 
Progesterone injecton 39 hours after estradiol injection did not alter 
this retention. In a later study, Walker and Feder (173) found that 
injection of an antiestrogen 40 or 47 hours after estradiol treatment 
inhibited sexual behavior in response to progesterone injected 60 hours 
after estradiol treatment. These experiments raised the possibility 
that estradiol had a maintenance effect on the activation of sexual 
behavior. That is, estradiol had to be present in hypothalamic cell 
nuclei at the time of onset of sexual receptivity. 
Blaustein et al. (IS) measured the retention of (®H)estradiol in 
rat hypothalamic cell nuclei following a single intravenous injection of 
0.3 ug of estradiol. This dose of estradiol can provide sufficient 
priming action to allow an injection of progesterone 18 hours later to 
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facilitate sexual receptivity. Twenty-four hours after the injection, a 
small but statistically significant amount of (=H)estradiol was still 
present in hypothalamic cell nuclei. This small amount could be 
displaced by antiestrogen treatment, indicating that it was 
specifically-bound estradiol. Furthermore, injection of either CI-623 
or nafoxidine, both antiestrogens, along with progesterone, inhibited 
the onset of sexual receptivity. Taken together, these studies provide 
good evidence that estradiol must be present in the cell nucleus at the 
time of onset of sexual behavior. 
In contrast, McEwen et al. (105) reported no reliably detectable 
amount of ('H)estradiol present in hypothalamic cell nuclei 24 hours 
following intraperitoneal injection of 10 yg estradiol to OVX rats. In 
their study, nuclear-bound radioactivity declined substantially between 
12 and 24 hours after injection. At 24 hours after injection, levels of 
radioactivity that were only twice background levels Were present. 
Because, by definition, these levels are at the limit of the sensitivity 
of their assay, the authors concluded that little, if any, estradiol is 
retained by cell nuclei, and that the behavioral effects of estradiol on 
sexual receptivity do not require occupation of nuclear binding sites by 
estradiol. In support of their conclusions, florin et al. (120) reported 
that the antiestrogen MER-25 injected 2 to 12 hours before progesterone 
did not prevent the onset of sexual receptivity. 
Recent studies indicating that short, discrete exposure to 
estradiol is sufficient to provide sufficient priming action for the 
activation of lordosis by progesterone (35, 112, 130, 164, 180), and to 
increase the concentration of cytosol progestin receptors (84, 169), may 
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also suggest that long term estradiol retention may not be necessary for 
the activation of lordosis. However, the question of nuclear estradiol 
retention following these treatments has not yet been addressed. 
Unfortunately, the question of the role of long-term retention of 
nuclear estradiol on sexual receptivity, and on the refractory period to 
progesterone, remains unresolved. 
In addition to inducing the formation of intracellular progestin 
receptors, estrogen action in the hypothalamus also results in a number 
of changes in neuronal ultrastructure. Carrer and Aoki (33) found that 
following ovariectomy in the rat, many cells of the VMN contained a 
large, globular, oval nucleus, and a scarcity of cytoplasm. Other cells 
appeared unaffected by hormonal depletion. Following estrogen 
treatment, significant changes were noted in many of the cells affected 
by ovariectomy. Cell nuclei had become larger, more irregular in 
contour, and had acquired indentations in the nuclear envelope. The 
endoplasmic reticulum had greatly hypertrophied in these cells, with an 
increase in the number of attached ribosomes and polysomes. Other 
changes were also noted in the Qolgi apparatus and mitochondria. 
Similar findings have also been reported fay Cohen and Pfaff (37). Ifc is 
possible that these described changes in ultrastructure, along with an 
increased level of intracellular progestin receptor levels, are 
necessary during the estrogen priming period for sexual receptivity to 
occur. 
In the absence of estrogen stimulation, a low, but significant, 
concentration of estrogen-independent progestin receptors is present in 
the hypothalamus (19, 95, 111). Etgen (56, 57), has proposed that 
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estradiol-induced increases in intracellular progestin receptor levels 
are not a necessary part of the estrogen priming process for sexual 
receptivity to occur. This is based on the finding that when rats were 
primed with g,B'-DDT, a polychlorinated pesticide with estrogenic 
properties, rather than estradiol, progesterone was able to activate 
sexual behavior despite there being no apparent induction of 
hypothalamic progestin receptors. These data were interpreted to 
indicate that the low level of estrogen-independent progestin receptors 
could mediate progesterone's effects, or that progesterone was acting 
through a membrane-bound receptor system. Because these findings 
question the hypothesis that estrogen-induced progestin receptors are 
necessary for the activation of sexual receptivity by progesterone, they 
were reexamined in the second study presented in this dissertation. 
Other researchers have also questioned the role of intracellular 
progestin receptors in mediating progesterone's effect on sexual 
behavior. This is based partly on reports that progesterone 
administered intravenously can facilitate lordosis by 30 minutes after 
injection (86, 109). This is considered by some to be too short a time 
period to allow for a genomic mechanism; however, steroid hormones have 
been shown to exert genomic effects within 20 minutes in peripheral 
tissues (122). Furthermore, as mentioned earlier, McGinnis et al. (98) 
have demonstrated that nuclear progestin receptor levels following 
intravenous progesterone injection increase prior to the onset of sexual 
receptivity. In addition, protein synthesis inhibition blocks 
progesterone's facilitory effect on sexual behavior (69, 144, 145). 
Beyer and coworkers (9, 10, 65) have proposed that progesterone 
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acts at the membrane level to facilitate sexual receptivity. According 
to their hypothesis, progesterone acts to increase the concentration of 
cyclic nucleotides, thereby resulting in the activation of previously 
inactive, lordosis-relevant, cellular proteins. As a result of the 
activation and subsequent actions of these proteins, a period of sexual 
behavior occurs. These proteins, they suggest, may be synthesized in an 
inactive form in response to estrogen treatment. The evidence to 
support this hypothesis is scant. Dibutyryl cAMP administered to 
estrogen-primed OVX rats facilitated the display of sexual receptivity 
(10). In the absence of estrogen priming, cAMP had no effect. The 
degree and duration of facilitation by cAMP could be increased by 
administration of theophylline, a phosphodiesterase inhibitor. In 
addition, theophylline had the same effect on progesterone-facilitated 
sexual receptivity (9). In further support of this hypothesis, Towle 
and Sze (169) have recently demonstrated the existence of 
steroid-specific progestin binding sites in synaptosomes isolated from 
whole rat brain. However, the findings reported by Beyer and coworkers 
merely suggest that cyclic nucleotides play a role in the activation of 
sexual receptivity. They do not provide evidence.that progesterone acts 
directly to affect these levels. It seems more likely that as a result 
of progesterone action, neurotransmitters are released, which in turn 
act through a cyclic nucleotide mechanism to activate lordosis. In 
support of this, catecholamines, thought to be involved in the 
activation of lordosis, have been shown to act by increasing cAMP levels 
(128). Furthermore, more research is required on the membrane-bound 
steroid hormone binding sites described by Towle and Sze before 
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biological events can be attributed to them. 
In the -first study of this dissertation, evidence is provided to 
support the hypothesis that intracellular progestin receptors are 
involved in the activation of sexual receptivity by estradiol and 
progesterone. The use of a recently developed antiprogesterone, RU 486, 
is employed. This synthetic steroid has been found to antagonize 
progesterone's action on the maintenance of the uterine endometrium (72, 
78, SO), on the maintenance of pregnancy (80, 05), on the growth of 
progesterone-sensitive breast cancer cells (4), and on release of 
pituitary hormones (79). These effects are thought to be the result of 
RU 406 acting to prevent progesterone interaction with the intracellular 
progestin receptor (4, 70, 80, 139). 
Mechanism Responsible for the Termination 
of Sexual Receptivity 
Little is known of the mechanism by which the period of sexual 
receptivity terminates; however, in OVX animals, both estradiol and 
progesterone have been shown to influence the length of the receptive 
period. Moreines and Feder (113), found that shortening the exposure 
time of OVX guinea pigs to estradiol capsules decreased the duration of 
the receptive period induced by a progesterone injection. Similarly, 
administration of supplemental estradiol at the time of progesterone 
injection has been shown to result in increased heat duration (13, 38, 
82). florin and Feder (115) have shown that injections of progesterone 
every three hours to OVX hormonally-treated guinea pigs prolonged the 
period of sexual receptivity by more than two hours. Interestingly, 
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heat termination occurred despite the continued administration of 
progesterone. Similarly, Hansen and Sodersten (74) reported that heat 
duration in rats is dependent upon the dose of both estradiol and 
progesterone, but heat termination occurred despite the continued 
administration of both hormones. 
As discussed earlier, the transient increase in hypothalamic 
nuclear progestin receptor concentration following the injection of 
progesterone to OVX, estradiol-pretreated guinea pigs correlates 
temporally with the expression of sexual receptivity (20). This 
correlation suggests that heat termination may result from the loss of 
progestin receptors from the cell nucleus. Perhaps as the concentration 
of progesterone-progestin receptor complexes in cell nuclei decreases, 
the cellular effects of progesterone diminish, resulting in the loss of 
sexual responsiveness. Based on this hypothesis, hormonal manipulations 
that delay the loss of progestin receptors from hypothalamic cell nuclei 
should also delay the termination of the period of sexual receptivity. 
In support of this hypothesis, Blaustein (13) has reported that 
injection of supplemental estradiol at the time of progesterone 
injection to estradiol-pretreated OVX guinea pigs delayed heat 
termination and the loss of hypothalamic nuclear progestin receptors. 
In the last three studies included in this dissertation, further 
hormonal manipulations were conducted in order to test the relationship 
between heat termination and the loss of progestin receptors from 
hypothalamic cell nuclei. 
In the studies included in this dissertation, progestin receptor 
levels were measured in MBH-PQA or in MBH, rather than in the VMN alone. 
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"This is because assay techniques to measure nuclear progestin receptor 
levels exclusively in the VMN have not yet been perfected. In addition, 
it was not until the studies of Rubin and Barfield (155 - 157) that it 
was demonstrated that the VMN was the principal site for the hormonal 
activation of sexual behavior. Prior to these studies, it was thought 
that the POA, which contains estrogen-dependent progestin binding sites, 
also is involved in the hormonal regulation of sexual behavior. In 
light of the studies by Rubin and Barfield, receptor levels measured in 
the last study were measured in the MBH rather than the MBH-POA. 
It should be noted that recent studies have questioned the 
intracellular location of unoccupied steroid hormone receptors. Studies 
by King and Greene (84), and Welshons et al. (178) suggest that steroid 
hormone receptors, both occupied and unoccupied, reside primarily in the 
cell nucleus. According to the proposed model of steroid action 
resulting from these studies (36, 70), steroid hormone receptors are in 
loose association with nuclear components in the absence of bound 
ligand. Upon binding steroid hormone, the receptor complex becomes 
tightly associated with specific nuclear components. An alternative 
model has been proposed from the findings of Martin and Sheridan (101). 
They propose that unoccupied intracellular steroid hormone receptors are 
present in both the cytoplasm and the nucleus of the cell in a state of 
equilibrium. As receptors bind ligand, they become associated with 
chromatin, and equilibrium between the remaining unoccupied receptors is 
reestablished. These models suggest that all or much of the apparent 
localization of unoccupied receptors in the cytoplasm is an artifact of 
tissue homogenization. However, consistent with the classical model of 
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steroid hormone action, these models hold that hormone binding of the 
receptor results in a greater or tighter association with cell nuclear 
components. Therefore, receptors measured in the cytosol fraction by 
routine techniques such as those used in the following studies, may 
represent loosely associated, unoccupied receptors released from cell 
nuclei during tissue homogenization, whereas receptors measured in the 
nuclear fraction may represent primarily tightly associated, occupied 
receptors. In the following studies, the classical terminology (cytosol 
and nuclear receptors) was used as a matter of convenience rather than 
as an indication of where receptors are located in vivo. 
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Explanation of Dissertation Format 
The dissertation is composed of five sections corresponding to 
five papers that have been published, submitted for publication, or are 
currently in press (25-29). All of the research presented in these 
studies was conducted by the degree candidate, with guidance provided by 
the major professor, Dr. Jeffrey D. Blaustein. Because some of the 
research presented in this dissertation was conducted following the 
relocation of Dr. Blaustein's laboratory from the Department of Zoology 
at Iowa State University, to the Division of Neuroscience and Behavior, 
Department of Psychology, University of Massachusetts, Amherst, MA, the 
name of that institution appears on the title page of some of the 
papers. Each section or paper is in a form similar to that as submitted 
for publication, and as such includes its own set of references. A 
general discussion of these five papers is included at the end of the 
dissertation. The references for the General Introduction and Summary 
and Discussion are located at the end of the dissertation under the 
heading Literature Cited. 
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SECTION I. INHIBITION OF SEXUAL BEHAVIOR IN FEMALE GUINEA PIGS BY A 
PROGESTIN RECEPTOR ANTAGONIST 
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ABSTRACT 
The new steroidal progestin receptor antagonist, RU 38486, was 
used to determine if progesterone-facilitation of sexual behavior in 
female guinea pigs requires interaction of the hormone with neural 
progestin receptors. Five rag but not 0.5 mg RU 38486 inhibits the 
expression of sexual behavior in ovariectomized, estrogen-primed guinea 
pigs treated with 0.1 mg progesterone. This inhibition can be overcome 
by administration of a large dose of progesterone, suggesting that the 
drug effect is specific to the progestin receptor system. RU 38486 
binds, i.n vitro, to progestin receptors and decreases the availability 
of hypothalamic progestin receptors in estrogen-treated guinea pigs. 
These studies provide strong evidence that progesterone interaction with 
intracellular neural progestin receptors mediates the facilitation of 
sexual behavior by progesterone in female guinea pigs. 
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INTRODUCTION 
D u r i n g  the estrous cycle of some female rodents, including guinea 
pigs, the sequential secretion of estradiol and progesterone from the 
ovaries activates a period of sexual behavior (heat) which is 
characterized, in part, by the elicitation of the lordosis posture in 
response to mating stimulation (20). Progesterone has a dual effect on 
female sexual behavior in guinea pigs. In estrogen-pretreated animals, 
it first facilitates the expression of the behavior, and then causes a 
hyposensitivity to itself (1, 2, 22). The result is that guinea pigs 
are refractory to additional progesterone a day after receiving 
progesterone. 
Results from a variety of studies suggest that some of 
progesterone's effects in the brain may be mediated by interaction with 
intracellular progestin receptors, as are some of its effects in 
peripheral reproductive tissues (4, 6, 10, 13, 16). Evidence in support 
of this hypothesis comes from a variety of studies. Estradiol treatment 
in ovariectomized (OVX) guinea pigs increases the level of cytosol 
progestin receptors in some regions of the guinea pig brain, primarily 
the mediobasal hypothalamus and preoptic area <4, 19). These regions 
are thought to be the primary site for the hormonal induction of female 
sexual behavior by estradiol and progesterone (15), Administration of 
progesterone causes a transient increase in the level of progestin 
receptors in the cell nuclear fraction, while concurrently decreasing 
the level of progestin receptors in the cytosol (5). This accumulation 
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of nuclear progestin receptors precedes the initiation of sexual 
behavior. As the period of sexual behavior terminates, by about 14 h 
after progesterone injection, the level of nuclear progestin receptors 
returns to baseline, while cytosol progestin receptor levels remain 
depressed (5, unpublished observations). This down-regulation by 
progesterone of its own cytosol receptors may explain why animals are 
refractory to a second injection of progesterone one day after the first 
injection. 
A recently developed steroidal progesterone antagonist, RU 38486, 
has been shown to antagonize a variety of progesterone's effects in the 
mammalian uterus (11, 17). This drug also binds, i.n vitro, with high 
affinity to uterine cytosol progestin receptors, suggesting that it may 
antagonize progesterone's action by inhibiting binding of progesterone 
to intracellular progestin receptors (17). In the present study, we 
provide evidence, using RU 38486, that at least one of progesterone's 
behavioral effects is mediated by intracellular neural progestin 
receptors. 
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MATERIALS AND METHODS 
Animals 
Adult, Hartley strain female guinea pigs (Camm Research 
Institute, Wayne, NJ) were group housed in 38 X 48 X 20 cm cages with 
lights on from 0600 - 2000 h. Guinea pig chow (Teklad Mills) and water 
were freely available. All animals were treated with tetracycline-HCl 
(American Cyanamid, Wayne, NJ) in their drinking water (6 g/1) for 2 
days prior to and 5 days following ovariectomy. Ovariectomies were 
performed three weeks prior to use under a combination of Innovar-Vet 
(Pitman-Moore, Washington Crossing, NJ, 0.04 ml/animal, i.m.) and 
Chloropent (Fort Dodge Laboratories, Fort Dodge, lA, 1.7 ml/kg, i.p.) 
anesthesia. All hormonal injections were subcutaneous. Estradiol 
benzoate (EB) was dissolved in sesame oil; progesterone and RU 38486 
(17B-hydroxy-116-{4-di methyl ami nophenyl)-17a-(l-propynl)-estra-4,9,-
diene-3-one; Roussel-Uclaf, Romainville, France) were dissolved in 
sesame oil containing 157. benzyl benzoate and 5% benzyl alcohol. 
Injection volumes were 0.1 ml for EB and progesterone, and 0.2 or 0.4 ml 
for RU 38486 (0.5 mg and 5.0 mg, respectively). In all experiments, 
10 pg EB was injected 40 h prior to progesterone. 
Behavioral Testing 
Animals were tested hourly for lordosis by manually stimulating 
the flanks and perineal area and measuring the length of time the 
lordosis posture was held (21). An animal was considered sexually 
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receptive if she held the lordosis posture for 1 sec or longer during 
two consecutive tests. Testing continued until all animals were 
nonresponsive or for a minimum of 14 h. An animal was considered no 
longer sexually receptive when she failed to respond during two 
consecutive tests. Latency to lordosis, heat duration, and maximum 
lordosis duration were calculated as described previously (3, 9). 
Brain Dissection 
Guinea pigs were decapitated and their brains rapidly removed. 
The mediobasal hypothalamus (MBH) and preoptic area (PDA) were dissected 
on a chilled block. The wedge-shaped MBH sample was bounded rostrally 
by the caudal edge of the optic chiasm and caudally by the caudal edge 
of the mammillary bodies. Cuts were made extending from the lateral 
hypothalamic fissure to the midpoint of the corpus callosum to form the 
lateral boundaries, and a cut through the level of the fornix formed the 
dorsal boundary. The PDA sample extended 3 mm rostrally from the 
hypothalamic section and included the anterior hypothalamus and preoptic 
area. A line continuous with the lateral ventricles formed the lateral 
boundaries and the anterior commissure formed the dorsal boundary. The 
MBH and POA from each animal were pooled. 
Combined Cytosol and Nuclear Progestin Receptor Assay 
Cytosol and nuclear progestin receptor levels were measured as 
described previously (1, 2) with minor modifications. All procedures 
were at 0-4 =C. Tissues were placed in a glass tissue grinder 
containing 1.0 ml buffer AT (0.32 M sucrose, 1 mM KHgPO*, 1 mM MgClz, 
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10% glycerol, 12 mM monothioglycerol, pH 7.2) and were homogenized with 
a Teflon pestle with appropriate clearance for cell nuclear isolation. 
Homogenates were then transferred to 12 X 75 polycarbonate tubes and the 
tissue grinders rinsed with 0.5 ml buffer AT. The homogenates were 
centrifuged at 1000 X g for 5 min. Cytosol extract was obtained by 
centrifuging the supernatant at 48,000 X g for 30 min. The pellet from 
the first centrifugation was washed twice.with 2.0 ml buffer Ay and the 
nuclei sedimented in 0.3 ml buffer AT + 1.0 ml buffer B (2.15 M sucrose, 
1 mM KH2PO4, 1 mM MgCl2, 10% glycerol, pH 7.2) by centrifuging at 25,000 
X g for 20 min. The pellicle and supernatant were removed and the walls 
of the tube dried, leaving only purified cell nuclei. 
For the cytosol receptor assay, 300 pi samples of cytosoi were 
applied to 4.5 X 68 mm columns of Sephadex LH-20 (equilibrated with 
buffer AT) to remove potentially competing steroids. Immediately after 
runnning into the column, the sample was washed in with 100 ul buffer 
AT and the macromolecular fraction eluted with 700 yl buffer AT. 
Two-hundred-fifty pi aliquots of filtered cytosol were incubated with 
50 yl buffer AT containing 17. ethanol (final concentration) and 
(17o!-methyl-'H)R 5020 (New England Nuclear, Boston, MA; Specific 
activity = 87 Ci/mmol) +/- 250-fold concentration of unlabeled 
progesterone. A final concentration (in 300 yl) of 0.4 nM (®H)R 5020 
was used because this concentration results in binding almost 
exclusively to the progestin receptor with almost no specific binding to 
blood contaminants or low affinity binders (4). 
Following a 16-20 h incubation at 0-4 °C, bound (^H)R 5020 was 
separated from free by gel filtration using Sephadex LH-20 columns 
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(Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated with buffer AT. 
Two-hundred-fifty yl samples of incubate were applied to the column and 
washed in with 150 yl buffer AT. Thirty min after applying the sample, 
the protein peak was eluted into scintillation vials with 700 yl buffer 
AT. Five ml scintillation fluid (0,17 g Bis MSB + 5,5 g PPD / liter 
Scintillation grade toluene (Fisher Scientific) containing 337. Triton 
X-100) were added and radioactivity was counted on a Packard Tri-Carb 
Model 300C spectrophotometer at an efficiency of 41%. Specific binding 
was calculated by subtracting nonspecific binding (with unlabeled 
progesterone) from total binding (without unlabeled progesterone). 
Protein concentration was determined using the dye-binding method of 
Bradford (7). Results are expressed as femtomoles {^H)R 5020 
specifically bound per mg cytosol protein. 
For the nuclear receptor assay, the cell nuclear pellet was 
dispersed with 280 yl buffer TEST (10 mM Tris-HCl, 1,5 mM NagEDTA, 10% 
glycerol, 12 mM monothioglycerol, pH 7.4). After 15 min. an equal 
volume of buffer TEGTK 1.0 (TEST + 1.0 mM KCl, pH 7.4) was added. The 
tube contents were vortexed and incubated for 15 min. The nuclei were 
centrifuged at 48,000 X g for 5 min. Two-hundredrfifty yl samples of 
the supernatant (nuclear extract) were incubated with 50 yl buffer TEGTK 
0.5 (TEST + 0.5 mM KCl, pH 7.4) containing 1% ethanol (final 
concentration) and ('H)R 5020 +/- 250-fold concentration of unlabeled 
progesterone. A final concentration of 4.0 nfl (=H)R 5020 was used (5). 
Following a 16-20 h incubation, bound {'H)R 5020 was separated from free 
as described above except that buffer TEGTK 0.5 was used. The DNA 
content of the nuclear pellet was determined by the method of Burton 
1  
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(8). Results are expressed as femtomoles (=H)R 5020 specifically bound 
per mg DNA. 
Competition Assay 
For cytosol progestin receptor competition, the MBH-PQA from 8 
OVX, estrogen-treated guinea pigs were pooled and homogenized in 10 ml 
buffer TEGT using a Polytron Tissue Homogenizer at a setting of 5 for 6 
sec. Homogenate was centrifuged at 48,000 X g for 30 min. 
Two-hundred-fifty yl aliquots of the supernatant (cytosol) were 
incubated with 50 ul buffer TEST containing 1.0% ethanol (final 
concentration) and 0.4 nM ('H)R 5020 +/- increasing concentrations of 
progesterone or RU 38486. Following a 6 h incubation, bound (=H)R 5020 
was separated from free as described above. 
For cytosol estrogen receptor competition, the procedure was 
similar to that for progestin receptor competition. Aliquots of Î1BH-P0A 
cytosol obtained from 8 OVX guinea pigs were incubated with 1,0 nM 
tetralabeled (^H)estradiol (Amersham, Arlington Heights, IL; SA = 114 
Ci/mmole) +/- increasing concentrations of unlabeled estradiol or RU 
38486. Relative binding affinities were calculated as (the 
concentrration of RU 38486 required to displace specific binding of the 
labeled liggand by 507. / the concentration of unlabeled progesterone 
(for progestin receptors) or estradiol (for estrogen receptors) required 
to displace specific binding of the labeled ligand by 507.) X 100. 
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RESULTS 
RU 38486 Inhibition of Progesterone-Facilitated 
Sexual Behavior 
In the first experiment, the efficacy of RU 38486 in blocking 
progesterone facilitation of sexual behavior was tested. OVX guinea 
pigs pretreated with 10 ug EB received either vehicle, 0.5 mg, or 5.0 mg 
RU 38486 one h prior to receiving 0.1 rag progesterone. Animals were 
tested hourly for lordosis "until" they no longer responded. Although the 
lower dose of RU 38486 was ineffective in blocking the response to 
progesterone (Table 1), the higher dose inhibited lordosis in nearly all 
of the animals (91% vs. 11%; p = 0.002). Twenty-four h after the 
progesterone injection, animals were treated with 0.5 mg progesterone 
and tested hourly for lordosis to determine if RU 38486 blocks the 
desensitization effect of progesterone. As has been reported previously 
(1, 2), animals which had received an injection of progesterone 24 h 
earlier failed to respond to the second progesterone injection, 
contrasted with responding by 907. of the control animals that had 
received the oil vehicle 24 h earlier. Both groups of animals receiving 
RU 38486 failed to respond to the second progesterone injection. 
Table 1. RU 38486 inhibition of progesterone-facilitated sexual 
behavior 
Treatment" Test 1 
Percent Heat 
Group -1 h Oh n Responding* Duration 
(h)"* 
I. Veh Po.l 10 907. 7.30 
+/-0.90 
II. RUo.s Po.l 9 100% 8.00 
+/-0.99 
III. RUs Po.l 9 11% 0.56 
+/-0.56 
IV. Veh Veh 10 0% 
"All animals received 10 ug estradiol benzoate at -40 h. Veh = 
vehicle, P = progesterone, RU = RU 38486, subscripts are doses in mg. 
Hourly tests for lordosis began just prior to injection at -1 h, and 
continued until all animals were nonrssponsive (Test 1). At 24 h, all 
animals received 0.5 mg progesterone and were tested hourly (Test 2). 
Values reported are means +/- S.E.M. 
"Includes responding animals only. 
•I vs. Ill: P = 0.002, Fisher's Exact Probability Test. 
••I vs. Ill: P < 0.002, Mann-Whitney U-test. 
, •••III vs. IV; P = 0.002, Fisher's Exact Probability Test. 
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Test 2__. 
Heat Latency to Maximum Lordosis Percent 
Duration" Lordosis" Duration" Responding' 
(h) (h) (sec) 
8.11 
+/-0.42 
4.44 
+/-0.63 
12.33 
+ / -1 .00  
0% 
8.00 
+/-0.99 
4.56 
+/-0.34 
14.89 
+ / - 1 . 6 6  
0% 
5.00 7.00 1 0 . 0 0  11% 
907. 
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Ability of Increased Progesterone to Overcome 
RU 3B486-Induced Inhibition 
Because RU 38486 is also a potent glucocorticoid receptor 
antagonist (14), it is possible that in high doses the drug renders the 
animals incapable of displaying lordosis because of debilitation caused 
by impaired glucocorticoid function. This is unlikely, because no 
debilitating effects of RU 38486 were observed in the previous 
experiment. Nevertheless, to test for this and other nonspecific 
effects of the drug, OVX, EB-injected guinea pigs were treated with 
either 0.1 mg or 5.0 mg progesterone one h after receiving 5.0 mg RU 
38486. If the RU 38486-induced inhibition of progesterone-facilitated 
lordosis is due to a debilitating effect, then it would be expected to 
inhibit lordosis regardless of the dose of progesterone. However, a 
greater percentage of animals responded to the larger dose of 
progesterone than the smaller dose (100% vs. 40%; Table 2). 
Furthermore, animals receiving 5 mg progesterone had longer heat 
durations (9.3 vs. 2.0 h, nonresponding animals included) than animals 
receiving 0.1 mg progesterone. These results suggest that the inhibition 
by RU 30486 is specific to progesterone. 
RU 38486 Interaction with Neural Progestin Receptors 
In the next experiment, the ability of RU 38486 to interact with 
MBH-POA cytosol progestin and estrogen receptors, in vitro, was tested 
in competition studies. RU 38486 has a high affinity for guinea pig 
MBH-POA cytosol progestin receptors (relative binding affinity = 50 
Table 2. Ability of a large dose of progesterone to overcome RU 38486-induced inhibition of 
progesterone-facilitated sexual behavior 
.I[eatment*_ Percent Heat Heat Latency to Maximum Lordosis 
-Ï iï 0 h n Responding" Duration Duration" Lordosis" Duration" 
(h)"" (h) (h) (sec) 
RUa 10 40% 2 . 0 0  
+/-1.19 
5.00 
+/-2.3B 
5.75 
+/-1.75 
5.75 
+/-1.44 
RU. 100% 9.33 
+/-0.77 
9.33 
+/-0.77 
3.67 
+/-0.50 
10.67 
+ / - 1 . 1 2  
*A11 animals received 10 yg estradiol benzoate at -40 h. Abbreviations are the same as 
in Table 1. Subscripts are doses in mg. Values reported are means +/- S.E.M. 
"Includes Responding animals only. 
•P = 0.02, Fisher's Exact Probability Test. 
< 0.02, Mann-Whitney U-test. 
***P < 0.02, Student's t-test. 
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compared with progesterone) but not estrogen receptors (relative binding 
affinity < 0.0001 compared with estradiol, Figure 1). This suggests 
that the inhibitory effects of RU 38486 are due to an interaction with 
progestin receptors and not estrogen receptors. 
To verify that RU 38486 also interacts in vivo with intracellular 
progestin receptors, MBH-POA cytosol and nuclear progestin receptors 
were assayed in OVX, estrogen-treated guinea pigs two h after the 
injection of 5.0 mg RU 38486 or vehicle. Eight OVX guinea pigs were 
treated with 10 yg EB. Forty h later, they received either RU 38486 or 
the oil vehicle. Two h later, animals were decapitated, and MBH-POA 
cytosol and nuclear progestin receptor levels were measured. 
RU 38486 decreased the concentration of available cytosol 
progestin receptors in MBH-POA by 35% compared with vehicle-injected 
controls (15.2 femtomoles/mg protein for drug-treated vs. 23.4 
femtomoles/mg protein for controls; p < 0.0025, Student's t test). 
Although we did not observe a statistically significant difference in 
nuclear receptor levels, recent evidence suggests that receptor-bound RU 
38486 may not exchange with the (=H)progestin used in the nuclear 
progestin receptor assay (17). Further study using radioactively 
labeled RU 38486 is required to determine it the drug causes the 
translocation of progestin receptors to cell nuclei. 
Scatchard Analysis 
In order to determine if the observed decrease in MBH-POA cytosol 
progestin binding was due to a decrease in receptor concentration or to 
a decreased affinity of the receptor for the (='H)progestin, cytoplasmic 
Figure 1. Competition of RU 38486 for HBH-POA cytosol progestin and estrogen receptor binding 
PROGESTIN RECEPTOR ESTROGEN RECEPTOR 
«PROGESTERONE 
o—oRlJ 38486 
-II -10 -9 -8 -7 -6 
o 
o\ 
NO 
• • ESTRADIOL 
0---0RU 38486 
-II -10 -9 -8 -7 -4 -3 -2 
COMPETITOR CONCENTRATION 
(L06|o MOLAR) 
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MBH-POA progestin receptors were assayed and the results analyzed by the 
method of Scatchard (18). EB-treated, OVX guinea pigs were injected 
with 5 mg RU 38486 or vehicle. Two h later, animals were killed, and 
MBH-POA cytosol was obtained as described for the competition assay. 
Cytosol was pooled for each group and passed through an LH-20 column to 
remove potentially competing steroids. Aliquots of filtered cytosol 
were incubated with various concentrations of ('H)R 5020 (0.1 - B nM) 
+/- 250-fold excess of progesterone. Following a 16-20 h incubation, 
bound ('H)R 5020 was separated from free as described. When analyzed by 
this method, RU 38486 resulted in a 44% decrease in the concentration of 
available progestin binding sites (28.3 fmoles/mg protein for the 
vehicle-injected group vs. 15.9 fmoles/mg protein for the RU 
38486-injected group) with no alteration in the binding affinity (Figure 
2 ) .  
Figure 2. Scatchard representation of specific {'H)R 5020 binding in MBH-POA cytosol obtained 
from guinea pigs injected with 10 yg EB and either 5 mg RU 38486 or vehicle 
Two h after the injection of RU 38486 or vehicle, animals were decapitated and 
MBH-POA cytosol progestin receptors were assayed in pooled MBH-POA cytosol. 
VEHICLE 
Kd = .19 nM 
NS= 29 fmoles/mg protein 
RU 38486 \ 
Kd= .16 nM ^ 
NS= 16 fmoles/m(j protein 
40 30 20 
BOUND 
(fmoles/mg protein) 
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DISCUSSION 
These findings support earlier studies on the mechanisms of 
progesterone's effects on sexual behavior in guinea pigs, which 
suggested that interaction of progesterone with intracellular progestin 
receptors is a prerequisite for progesterone to facilitate sexual 
behavior. In the present experiments, the progestin receptor 
antagonist, RU 39486, was found to inhibit progesterone-facilitated 
sexual receptivity, presumably by blocking the ability of progesterone 
to bind to its neural receptors. The RU 38486-induced inhibition of 
progesterone-facilitated lordosis is specific to progesterone, because a 
large dose of progesterone is able to overcome the inhibition. RU 33486 
interacts with neural progestin receptors both in yi,tro and i_n yiyg. 
This interaction, in yiyg, leads to a decreased number of cytosol 
progestin binding sites available and not to an alteration in binding 
affinity. 
The failure of RU 38486 to block progesterone's desensitization 
effect should not be interpreted as evidence that progestin receptors 
are not involved in this effect. Decreasing the availability of 
cytoplasmic progestin receptors at the time of the initial progesterone 
injection by administering RU 38486 does not interfere with 
progesterone's desensitization effect. However, these results do not 
conflict with the interpretation that desensitization by progesterone is 
caused by subsequent down-regulation of cytosol progestin receptors (1, 
2, 4, 5). Since both RU 38486 and progesterone decrease the 
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concentration of cytosol progestin receptors in the MBH-POA, all animals 
except the vehicle-injected animals would be expected to be 
hyposensitive to the second progesterone injection. 
These experiments provide direct evidence that progesterone's 
•facilitation of sexual behavior in female guinea pigs requires 
interaction of the hormone with neural progestin receptors. 
Furthermore, these experiments establish RU 38486 as a useful probe in 
elucidating the mechanisms by which progesterone acts in the brain to 
influence neuroendocrine function. 
5 0  
REFERENCES 
1. Blaustein, J. D. 1982. Alteration of sensitivity to progesterone 
facilitation of lordosis in guinea pigs by modulation of 
hypothalamic progestin receptors. Brain Res. 243:287-300. 
2. Blaustein, J. D. 1932. Progesterone in high doses may overcome 
progesterone's desensitization effect on lordosis by translocation 
of hypothalamic progestin receptors. Norms. Behav. 16:175-190. 
3. Blaustein, J. D., and T. J. Brown. 1983. Mechanisms of 
oestrogen-progestin interactions in the regulation of lordosis in 
female guinea pigs. Pages 18-31 in J. Balthazart, E. Prove, and R. 
Gilles, eds. Hormones and behaviour. Springer-Verlag, Berlin, 
Heidelberg. 
4. Blaustein, J. D., and H. H. Feder. 1979. Cytoplasmic progestin 
receptors in guinea pig brain: characteristics and relationship to 
the induction of sexual behavior. Brain Res. 169:481-497. 
5. Blaustein, J. D., and H. H. Feder. 1980. Nuclear progestin 
receptors in guinea pig brain measured by an in vitro exchange 
assay after hormonal treatments that affect lordosis. 
Endocrinology 106:1061-1069. 
6. Blaustein, J. D., and G. N. Wade. 1978. Progestin binding by 
brain and pituitary cell nuclei and female rat sexual behavior. 
Brain Res. 140:360-367. 
7. Bradford, M. 11. 1976. A rapid and sensitive method for 
quantification of microgram quantities of protein utilizing the 
principle of protein-dye binding. Anal. Biochem. 72:248-254. 
8. Burton, K. 1956. A study of the conditions and mechanism of the 
diphenylamine reaction for the colorimetric estimation of 
deoxyribonucleic acid. Biochem. J, 62:315-323. 
9. Goy, R. W., and W. C. Young. 1957. Strain differences in the 
behavioral responses of female guinea pigs to alpha-estradiol 
benzoate and progesterone. Behavior 10:340-354. 
10. Grody, W. W. , W. T. Schrader, and B. W. O'Malley. 1982. 
Activation, transformation, and subunit structure of steroid 
hormone receptors. Endocrine Rev. 3:141-163. 
11. Herrmann, W., R. Wyss, A. Riondel, D. Philibert, G. Teutsch, E. 
Sakiz, and E. E. Baulieu. 1982. Effet d'un sterol de 
anti-progesterone chez la femme: interruption du cycle menstruel et 
51  
de la grossesse au debut. Comptes Rendues- Acad. Sci. Paris 
294:933-938. 
12. Horwitz, K. B., G. R. Friedenberg, R. L. Sheridan, and P. S. 
Alexander. 1983. Progestins and the antiprogestin RU 38486: 
effects on progesterone receptors and on proliferation of human 
breast cancer cells. 65th Meeting Endocrine Soc. (Abstr. #581). 
13. McEwen, B. S., A. Biegon, P. G. Davis, L. C. Krey, V. N. Luine, M. 
Y. McGinnis, C. M. Paden, B. Parsons, and T. C. Rainbow. 1982. 
Steroid hormones: humoral signals which alter brain cell properties 
and functions. Rec. Prog. Horm. Res., 38:41-92. 
14. lioguilewsky, M., and D. Philibert. 1983. A possible mechanism for 
the potent antiglucocorticoid activity of RU 38486: an inability to 
promote receptor activation. 65th Meeting Endocrine Soc. (Abstr. 
#1015). 
15. Morin, L. P., and H. H. Feder. 1974. Hypothalamic progesterone 
implants and facilitation of lordosis behavior in estrogen-primed 
ovariectomized guinea pigs. Brain Res. 70:81-93. 
16. O'Malley, B. W., and A. R. Means. 1974. Female steroid hormones 
and target cell nuclei. Science 183:610-620. 
17. Philibert, D., R. Deraedt, G. Teutsch, C. Tournemine, and E. Sakiz. 
1982. RU 38486 - a new lead for steroidal anti-hormones. 64th 
Meeting Endocrine Soc. (Abstr. #668). 
18. Scatchard, G. 1949. The attraction of proteins for small 
molecules and ions. Ann. N.Y. Acad. Sci. 51:660-672. 
19. Warembourg, M. 1975. Radioautographic study of the brain and 
pituitary after (^H)progesterone injection into estrogen-primed 
ovariectomized guinea pigs. Neurosci. Lett, 7:1-5. 
20. Young, W.C. 1969. Psychobiology of sexual behavior in the guinea 
pig. Pages 1-110 in D.S, Lehrman, R.A. Hinde, and E. Shaw, eds. 
Advances in the study of behavior, vol II. Academic Press, New 
York. 
21. Young, W. C., E. Dempsey, C. W. Hagquist, and J. L. Boling. 1937. 
The determination of heat in the guinea pig. J. Lab. Clin. Med. 
23:300-302. 
22. Zucker, I. 1966. Facilitation and inhibitory effects of 
progesterone on sexual responses of spayed guinea pigs. J. Comp. 
Physiol. Psychol. 62:376-381. 
52  
SECTION II. l-(o-CHL0R0PHENYL)-l-(B-CHL0R0PHENYL)2,2,2-TRICHL0R0ETHANE 
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HYPOTHALAMUS AND PITUITARY GLAND 
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ABSTRACT 
A recent report suggests that estrogen induction of hypothalamic 
progestin receptors is not a prerequisite for the facilitation by 
progesterone of female sexual behavior in rats. Progesterone was found 
to facilitate sexual behavior despite no apparent induction of progestin 
receptors by g,g'-DDT. To investigate these findings further, 
ovariectomized rats were treated with daily injections of g,g -DDT for 
3 d followed by progesterone on day 4. Daily injections of 400 mg 
o,g'-DDT/kg resulted in the activation of lordosis in 507. of the 
animals; injections of 200 mg/kg were ineffective. Cytoplasmic and 
nuclear progestin receptor levels in the mediobasal 
hypothalamus-preoptic area and pituitary gland were then determined in 
similarly treated animals. Because competition assays revealed that 
g,g -DDT interacts with progestin binding sites in vitro, residual 
g,B -DDT was removed from the cytosol fraction prior to assay. g,g'-DDT 
treatment increased the level of cytoplasmic progestin receptors by 43% 
compared with oil-injected controls. Progesterone administration to 
g,B*-DDT-treated rats resulted in a 1377. increase in the level of 
nuclear progestin receptors relative to levels observed in animals 
receiving no progesterone. These findings contradict a previous report 
using g,g'-DDT, and support the hypothesis that estrogen-induced 
progestin receptors are required for the facilitation of sexual 
receptivity by progesterone. 
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INTRODUCTION 
Sexual behavior during the estrous cycle of several rodent 
species is activated by the sequential presence of estradiol and 
progesterone secreted from the ovaries (13). In ovariectomized, 
estrogen-pretreated animals, administration of progesterone activates a 
similar period of sexual responsiveness (7, 13). 
Several studies indicate that estrogen-induced intracellular 
progestin receptors mediate progesterone-facilitated sexual receptivity 
in female rats and guinea pigs. Estradiol treatment increases the 
concentration of cytoplasmic progestin receptors in several brain 
regions, including the mediobasal hypothalamus and preoptic area (4, 21, 
25, 29, 34). These regions are thought to contain the primary sites for 
the activation- of sexual receptivity by progesterone (22, 26, 30, 33). 
Progesterone administration to estrogen-pretreated animals results in an 
accumulation of these receptors in cell nuclei (2, 3, 5, 6, 24). This 
accumulation and retention of nuclear progestin receptors in the 
hypothalamus correlates closely with the initiation and duration of the 
receptive period (2, 5, 10, 24). In addition, we have recently shown 
that the progestin receptor antagonist RU 486 can block 
progesterone-facilitated lordosis in female guinea pigs (9), providing 
strong evidence that progestin receptors are involved in mediating 
progesterone's facilitory effect on sexual behavior. 
A recent study by Etgen (12) has questioned the role of 
cytoplasmic progestin receptors in the activation of sexual receptivity 
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in female rats by progesterone. It was reported that when rats were 
primed with g,g'-DDT, a polychlorinated pesticide with estrogenic 
properties (14, 15, 27, 32), rather than estradiol, 
progesterone-activated sexual receptivity occurred despite no apparent 
induction of cytoplasmic progestin receptors in the hypothalamus. These 
findings seemingly suggest that estrogen-induced progestin receptors are 
not critical for the activation of sexual receptivity by progesterone. 
Because these findings conflict with a variety of previous studies that 
suggest estrogen induction of intracellular progestin receptors is 
necessary for progesterone's facilitory effects on sexual receptivity, 
we attempted to replicate and extend Etgen's findings. 
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MATERIALS AND METHODS 
Animals 
Female Sprague-Dawley rats (Charles River Breeding Laboratories; 
Wilmington, MA) weighing 175-225 g were ovariectomized (31) 1-2 weeks 
prior to experimental treatment. Animals were housed separately in 17 X 
24 X IB cm wire mesh cages or in groups of 4 in 41 X 24 X 18 cm wire 
mesh cages. Food (Purina Laboratory Chow, St. Louis, MO) and water were 
freely available, and a 14:10 light/dark cycle was maintained with 
lights on from 2300-1300 h. 
Injections 
All injections were administered subcutaneously. Estradiol 
benzoate (EB) was dissolved in sesame oil and injected in a 0.1 ml 
volume. Progesterone was dissolved in peanut oil and injected in a 0.1 
ml volume. o,g -DDT, (1-(g-chlorophenyl)-1-(g-chlorophenyl)2,2,2-
trichloroethane; Aldrich Chemical Co., Milwaukee, WI) was dissolved in a 
1:1 mixture of peanut oil and benzyl benzoate, 250 mg/ml. 
Behavioral Testing 
Tests for lordosis were conducted by placing the experimental 
female in a round plexiglass arena (53 cm diameter X 41 cm high) with 2 
stimulus males until 10 mounts were observed. The quality of each 
lordosis response was rated on a scale of 0-3 (no - full dorsiflexion) 
(17) with the experimenter blind to the assigned treatment group. 
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Results are expressed as mean lordosis quotient (percentage of mounts 
resulting in a lordosis response) and mean lordosis rating (sum of 
quality scores/10). With the exception of the pretest in experiment 1, 
all tests occurred 2-3 h after the onset of darkness. 
Brain Dissection 
Rats were decapitated and their brains and pituitary glands 
rapidly removed. The mediobasal hypothalamus (MBH) and preoptic area 
(POA) were dissected on a chilled block. The wedge-shaped MBH sample 
was bounded rostrally by the caudal edge of the optic chiasm and 
caudally by the caudal edge of the mammillary bodies. Cuts were made 
extending from the lateral hypothalamic fissure to the midpoint of the 
corpus callosum to form the lateral boundaries, and a cut through the 
level of the fornix formed the dorsal boundary. The POA sample extended 
2 mm rostrally from the hypothalamic section and included the anterior 
hypothalamus and preoptic area. A line continuous with the lateral 
ventricles formed the lateral boundaries and the anterior commissure 
formed the dorsal boundary. The MBH and POA were pooled for each 
animal. 
Combined Cytosol and Nuclear Progestin Receptor Assay 
Cytosol and nuclear progestin receptor levels were measured as 
described previously (2, 3). All procedures were conducted at 0-4 °C. 
Tissues were pooled for 2 similarly-treated rats in 1.0 ml buffer AT 
(0.32 M sucrose, 1 mM KHgPO*, 1 mM MgCla, 10% glycerol, 12 mM 
monothioglycerol, pH 7.2) and homogenized in glass tissue grinders with 
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a teflon pestle. The homogenates were transferred to 12 X 75 mm 
polycarbonate tubes and the tissue grinders were rinsed with 250 IJ1 AT. 
Following centrifugation at 1,000 x g for 5 min, the supernatant was 
transferred to polycarbonate tubes and centrifuged at 48,000 x g for 30 
min to obtain the cytosol fraction. 
The pellet from the first centrifugation was washed twice by 
dispersing in 2.0 ml AT and centrifuging at 1,000 x g for 5 rain. 
Following the second wash, the crude nuclear pellet was resuspended in 
300 yl AT, and 1.0 ml buffer B (2.15 M sucrose, 1 mM KH2PO4, 1 mM MgCla, 
107. glycerol, pH 7.2) was added. The tube contents were then 
vortex-mixed. Following centrifugation at 27,500 x g for 20 min, the 
pellicle and supernatant were discarded and the walls of the tube dried. 
The.resulting purified nuclei were resuspended in 285 yl buffer TEGT ilO 
mM Tris-HCl, 1.5 mM Na EDTA, 10% glycerol, 12 mM monothioglycerol, pH 
7.4). Following a 15 rain incubation, 285 yl buffer TESTK-l.O (TEGT + 
1.0 M KCl ) were added and the contents vortex-mixed periodically during 
a 15 min incubation. The nuclei were then centrifuged at 48,000 x g for 
5 min. The supernatant (nuclear extract) was decanted and 250 yl 
samples were incubated at 0-4 °C with 50 yl buffer TEGTK-0.5 (TEGT + 0.5 
M KCl) containing ethanol (1% final concentration) and (=H)R 5020 (SA = 
87 Ci/mmol; New England Nuclear) with or without a 250-fold 
concentration of unlabeled progesterone. A final concentration of 1.5 
nH (^H)R 5020 was used because this concentration saturates the 
progestin receptor pool while minimizing binding to nonspecific binders 
(31). 
Bound (®H)R 5020 was separated from free by gel filtration using 
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4.5 X 68 mm Sephadex LH-20 columns (Pharmacia Fine Chemicals, 
Piscataway, NJ). Aliquots of incubate (250 pi) were loaded onto the 
columns and washed in with 150 ul TEGTK-0.5 (TEGT + 0.5 M KCl). Thirty 
min after sample loading, the macromolecular fraction (containing the 
bound ('H)R 5020) was eluted into scintillation vials with 700 yl 
TEGTK-0.5. Five ml scintillation fluid (0.17 g Bis-MSB + 5.5 g 
PPO/liter scintillation grade toluene containing 337. scintillation 
surfactant (Fisher Scientific) were added and radioactivity counted on a 
Packard Tricarb model 300C spectrophotometer at an efficiency of 41%. 
The DMA concentration of the nuclear pellet was determined by the method 
of Burton (11). Results are expressed as femtomoles (=H)R 5020 
specifically bound/mg DNA. 
To remove potentially competing molecules from the cytosol 
fraction, 300 pi samples of cytosol were loaded onto Sephadex LH-20 
columns (3). The samples were washed in with 100 yl AT and eluted with 
700 yl AT. Aliquots (250 yl) of filtered cytosol were incubated 
overnight with 50 yl AT containing ('H)R 5020 +/- 250-fold concentration 
of progesterone. A 0.4 nM concentration of ('K)R 5020 was used to 
minimize binding to blood contaminants and low-affinity binders (4). 
Following an overnight incubation at 0-4 °C, bound (=H)R 5020 was 
separated from free as described for the nuclear assay except that 
buffer AT was used. Cytosol protein concentration was determined by the 
dye-binding method of Bradford (8) with bovine serum albumin (Sigma 
Chemical Co., St. Louis, MO) used as a standard. Results are expressed 
as femtomoles (=H)R 5020 specifically bound/mg cytosol protein. 
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Cytosol Estrogen Receptor Assay 
Cytoplasmic estrogen receptor levels were measured by a 
modification of the method by Ginsburg et al. (16). Animals were 
decapitated and MBH-POA and pituitary dissected and homogenized as 
described above in 1.0 ml buffer TEGT, Uterine horns were also removed 
from the animal, minced, placed in 12 X 75 mm polycarbonate tubes 
containing 2.0 ml TEGT, and homogenized with a Polytron PT-7 tissue 
homogenizer. MBH-POA and pituitary homogenates were transferred to 12 X 
75 mm polycarbonate tubes and the tissue grinders were rinsed with 
250 ul TEGT. Homogenates were centrifuged at 48,000 x g for 30 min and 
the supernatant (cytosol) was decanted and filtered as described above. 
Aliquots (250 ul) of cytosol were incubated at 0-4 °C with 50 ul TEGT 
containing 17. ethanol and 1.0 nM (®H)estradiol (New England Nuclear, SA 
= 95 Ci/mmol) with or without 100 nM unlabeled estradiol (final 
concentrations in 300 ul). Following an overnight incubation, bound 
CH)estradiol was separated from free as described for the progestin 
receptor assays except that buffer TEGT was used. 
Competition Assays 
For estrogen receptor competition assays, MBH-POA and pituitary 
cytosol obtained from 16 OVX rats was pooled. Aliquots (250 yl) of the 
pooled cytosol were incubated with 50 ul TEGT containing 2% ethanol and 
1.0 nM (3H)estradiol (final concentration in 300 yl) with or without 
increasing concentrations of unlabeled estradiol (0.02 nil - 0.1 uM) or 
g,e'-DDT (0.02 yM - 0.4 mM). Following a 5 h incubation at 0-4 °C, 
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bound (3H)estradiol was separated from free as described. 
For progestin receptor competition, MBH-POA and pituitary cytosoi 
was obtained and pooled from 12 OVX rats treated with 10 yg EB 2 days 
prior to assay. Aliquots (250 vil) of cytosoi were incubated with 50 yl 
TEST containing 27. ethanol and 0.4 nM ('H)R 5020 with or without 
increasing concentrations of progesterone (0.017 nM - 1.0 ytl) or 
OJE'-DDT (1.5 yM - 0.35 mM). 
Relative binding affinities (RBAs) were calculated as (the 
concentration of g,g'-DDT required to displace specific binding of the 
labeled ligand by 507. / the concentration of unlabeled estradiol (for 
estrogen receptors) or progesterone (for progestin receptors) required 
to displace specific binding of the labeled ligand by 507.) X 100. 
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RESULTS 
Experiment 1 
To confirm the finding that g,g'-DDT can substitute for estradiol 
in the activation of progesterone-facilitated sexual receptivity, we 
treated OVX female rats as in the previous study by Etgen (12). In 
addition, we tested the animals prior to progesterone treatment to 
ensure they were actually responding to the progesterone injection. 
Animals were injected daily with 200 mg o,g'-DDT/kg body weight or 1 yg 
EB for 3 days. On the fourth day, animals were tested for sexual 
receptivity (pre-test), injected with 0.5 mg progesterone, and tested 
again 4 h later (post-test). Because cervico-vaginal stimulation has 
been shown to influence subsequent behavior tests (1, 20), vaginal masks 
(31) were used to prevent intromission. 
Animals treated with daily injections of estradiol exhibited a 
low level of sexual receptivity in the absence of progesterone 
(pre-test. Table 1). Following progesterone treatment, these animals 
became highly receptive (post-test). In contrast to the study by Etgen, 
DDT-treated animals did not respond to progesterone, nor were they 
responsive prior to the progesterone injection. 
Experiment 2 
In the study by Etgen (12), a single injection of 500 mg 
g,g'-DDT/kg resulted in maximal depletion of cytoplasmic estrogen 
receptors in the hypothalamus 8 h after injection. Because in 
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Table 1. Failure of 200 mg g,B'-DDT/kg to mimic the action of estradiol 
on lordosis 
Lgrdgsis_Qugtient___ LSCdosi5_Rating 
Group* n Pre-test Post-test Pre-test Post-test 
EB 16 28.75 100* 0.59 2.35" 
+/-8.70 - +/-0.21 +/-0.08 
DDT 16 0.63 0.63 0.01 0.01 
+/-0.63 +/-0.63 +/-0.01 +/-0.01 
•Animals received daily injections of 1 yg estradiol benzoate 
(EB) or 200 mg o,g'-DDT/kg for three days. On day 4, animals were 
tested for lordosis (pre-test), injected with 0.5 mg progesterone, and 
tested for lordosis 4 h later (post-test). Results are expressed as 
means +/- S.E.M. 
•Pre-test vs. Post-test: p < 0.001, Mann-Whitney U-test. 
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Experiment 1 we tailed to replicate the previously reported behavioral 
results obtained by Etgen, we examined the amount of cytoplasmic 
estrogen receptor depletion in our rats under similar conditions. 
A single injection of 500 mg g,g'-DDT resulted in no detectable 
depletion of cytoplasmic estrogen receptors at 8 h in our rats (Figure 
i). Uterine estrogen receptors, however, were decreased by 507. by 
g,g'-DDT injection. 
Experiment 3 
The binding of o,g'-DDT to cytosol uterine estrogen receptors is 
well-established (14, 19, 27, 28). Because we failed to detect 
depletion of MBH-POA and pituitary cytoplasmic estrogen receptors by 
g,B -DDT, we conducted binding competition assays to verify that 
g,e'-DDT can interact with estrogen receptors from these tissues. 
Binding competition assays for progestin receptors were also conducted 
to determine if g,g'-DDT interacts with progestin receptors. 
For estrogen receptor binding competition, MBH-POA and pituitary 
cytosol obtained from OVX rats was incubated with 1.0 nM 
(3H)estradiol in the presence or absence of various concentrations of 
unlabeled estradiol or o,g'-DDT. For progestin receptor binding 
competition, cytosol obtained from estrogen-treated OVX rats was 
incubated with 0.4 nM (=H)R 5020 in the presence or absence of various 
concentrations of unlabeled progesterone or g,g'-DDT. 
As expected, o,e'-DDT competed for both MBH-POA and pituitary 
estrogen binding sites (RBA compared to estradiol = 0.01 and 0.02 
respectively; Figure 2). Surprisingly, in contrast to the previous 
Figure 1. Cytoplasmic estrogen receptor levels 8 h following the injection of 500 mg 
q,e'-DDT/kg (DDT; n=6) or oil vehicle (VEH; n=6) 
Bars represent the group mean + S.E.M. 
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Figure 2. Competition of o,g'-DDT for MBH-POA and pituitary cytosol estrogen binding sites 
Aliquots of cytosol were incubated with 1.0 nM ('H)e5tradiol +/- various 
concentrations of unlabeled estradiol or g,g -DDT. 
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report by Etgen (12), g,g'-DDT was also -found to compete for MBH-POA and 
pituitary progestin binding sites (RBA compared to progesterone = 0.02 
and 0.03 respectively; Figure 3). 
Experiment 4 
Based on the results of Experiment 1 and 2, it is possible that 
our rats may be less sensitive to g,g'-DDT than were those used in the 
study by Etgen. Therefore, we tested the ability of a larger dose of 
g,a'-DDT to substitute for estradiol in the activation of 
progesterone-facilitated sexual receptivity. Animals were injected 
daily with 400 mg g,g -DDT/kg for three days. On the fourth day, 
animals were injected with 0.5 mg progesterone or the oil vehicle, and 
tested 4 h later. 
In the absence of progesterone treatment, none of the animals 
exhibited sexual behavior while 507. of the animals injected with 
progesterone responded (Table 2). 
Experiment 5 
In Experiment 4, we confirmed that g,g'-DDT can substitute for 
estradiol in providing responsiveness to progesterone in the activation 
of sexual receptivity. If intracellular progestin receptors are 
involved in mediating progesterone's effects on lordosis, then 
hypothalamic nuclear progestin receptor levels should be elevated 
following progesterone treatment. To test this as well as to determine 
if g,g'-DDT induces cytoplasmic progestin receptors, both cytoplasmic 
and nuclear progestin receptor levels were measured in animals treated 
Figure 3. Competition of g,g -DDT for HBH-PDA and pituitary cytosol progestin binding sites 
Aliquots of cytosol obtained from estradiol-treated OVX rats were incubated 
with 0.4 nM ('H)R 5020 +/- various concentrations of unlabeled progesterone or 
o,b'-DDT. 
PROGESTERONE 
COMPETITOR CONCENTRATION 
PITUITARY 
DDT 
PROGESTERONE 
-7  -5  -3  
molar) 
Table 2. Ability of 400 mg g,g'-DDT/kg to mimic the action of estradiol 
on lordosis 
Percent Lordosis Lordosis 
Group" n Responding* Quotient** Rating** 
Veh 11 07. 
PROG 12 507. 45.83 
+/-13.40 
1.01 
+/-0.30 
"Animals received daily injections of 400 rag o,g'-DDT/kg for 
three days. On day 4, animals received either 0.5 mg progesterone 
(PROG) or the oil vehicle (Veh), and were tested for lordosis 4 h later. 
An animal with a lordosis quotient of 20 or greater was considered 
responsive. Results are expressed as means +/- S.E.M. 
*p < 0.013, Fisher's Exact Probabilty Test. 
•*p < 0.05, Mann-Whitney U-test. 
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as in Experiment 4. 
Rats received daily injections of 400 mg o,B'-DDT/kg or the oil 
vehicle for three days. On the fourth day, animals received either 0.5 
mg progesterone or the oil vehicle and were killed three hours later for 
determination of MBH-POA and pituitary cytoplasmic and nuclear progestin 
receptor levels. Because g,g'-DDT binds to progestin receptors in vitro 
(Experiment 3), cytosol was filtered through Sephadex LH-20 columns to 
remove any potentially competing g,g'-DDT. 
In contrast to the previous report (12), g,g'-DDT treatment 
increased MBH-POA and pituitary progestin receptors by 43% and 42% 
respectively (p<0.01; Figure 4). Progesterone administration resulted 
in a depletion of pituitary cytoplasmic receptors (p<0.05, 1-tail test); 
however, the decrease seen in the MBH-POA was not statistically 
significant. 
MBH-POA and pituitary nuclear progestin receptors were increased 
by 137% and 172% respectively by progesterone treatment (compared to 
DDT-VEH animals: p<0.01 and p<0,05; Figure 5). DDT-treated rats which 
received the vehicle rather than progesterone exhibited a slight 
elevation in MBH-POA nuclear progestin receptor levels (p<0,05, 1-tail) 
compared to animals treated with only vehicle injections. 
Figure 4. Cytoplasmic progestin receptor levels 
OVX rats were injected daily with 400 mg o,B'-DDT/kg or the oil vehicle (VEH) 
for three days. On the fourth day, rats received 0.5 mg progesterone (PROG) and were 
killed 3 h later to determine progestin receptor levels. Bars represent means + 
S.E.M. (n=6). 
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DISCUSSION 
Confirming a previous report by Etgen (12), o,o'-DDT was found to 
have an estrogenic effect on female sexual behavior. Rats treated with 
daily injections of 400 mg g,g'-DDT/kg became sexually receptive 
following the injection of progesterone. While the previous study 
reported that daily injections of 200 mg/kg are sufficient, this dose 
was without effect in our animals. This is most likely due to a lower 
sensitivity of our animals to g,g'-DDT. In support of this 
interpretation, no depletion of MBH-POA or pituitary cytoplasmic 
estrogen receptor levels was detected in our animals at 3 h following a 
single injection of 500 mg g,B'-DDT/kg. In the previous study, a 50% 
depletion was observed under similar conditions. 
In contrast to the results reported by Etgen (12), g,g'-DDT 
treatment was found to induce cytoplasmic progestin receptors in the 
MBH-POA and pituitary. Furthermore, these receptors appear to be 
functional since progesterone treatment results in accumulation of 
progestin receptors in the cell nucleus. 
One reason for the discrepancy in results between our study and 
Etgen's could be that we used a higher dose of g,g'-DDT. Perhaps at 
lower doses, o,g -DDT does not induce progestin receptors but does 
produce other estrogenic effects which may be involved in lordosis 
activation. However, this argument is unlikely because the dose used in 
the present study was near the threshold dose required to elicit 
lordosis in our animals; only 50% of the animals treated with 400 mg 
80  
0,2 -DDT/kg injections were found to respond to progesterone. In 
addition, one-half the amount of this dose was ineffective in our 
animals. 
A more likely explanation for the difference in results is that 
in the present study, cytosol was filtered prior to assaying progestin 
receptor levels in order to remove residual g,g'-DDT. Based on the 
finding that o,e'-DDT competes for progestin binding sites in vitro 
(Experiment 3), residual g,B'-DDT, if not removed, could compete with 
(®H)R 5020 for progestin receptor binding in the binding assay. It is 
possible that in the previously reported study (12), residual g,g'-DDT 
masked the increase in cytoplasmic progestin receptor levels. 
It should be pointed out that although the same strain of rats 
was used in both studies, the animals were obtained from different 
suppliers. The possibility that the difference in sensitivity to 
g,g'-DDT observed between the previous and present studies is due to 
subtle animal differences cannot be ruled out. It is also possible that 
different preparations of g,g'-DDT used in the two studies contained 
different amounts of the two enantiomers of o,g'-DDT. The levo form has 
been shown to have more estrogenic activity than the dextro form in the 
immature rat uterus (23). 
It is interesting to note that MBH-POA nuclear progestin 
receptors are elevated in g,g'-DDT-treated rats in the absence of 
progesterone. It is conceivable that g,g -DDT not only increases their 
availability, but also binds to progestin receptors in vivo and causes 
their translocation to cell nuclei; however, more evidence is required 
to determine if this is the case. 
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In Experiment 2, depletion of cytosol estrogen receptor levels by 
o,g'-DDT was observed in the uterus but not in the MBH-POA or pituitary. 
The fact that depletion was observed in the uterus indicates that 
g,G'-DDT was capable of interacting with estrogen receptors in the 
present study. However, further conclusions based on this experiment 
are limited because receptor levels were measured at only one time point 
following g,g'-DDT injection. Perhaps estrogen receptor depletion in 
the MBH-POA and pituitary would have been observed if receptor levels 
were measured at an earlier or later time. The time point we chose was 
based on work by Etgen (12) showing that maximal depletion of 
hypothalamic estrogen receptors occurred 8 h after g,g'-DDT injection. 
To our knowledge, Experiment 3 provides the first evidence that 
g,g -DDT interacts with progestin receptors. g,g -DDT was found to 
compete for progestin binding sites with about the same affinity as it 
competes for estrogen binding sites. The level of estrogen receptor 
competition obtained in this study agrees with that reported for uterine 
estrogen receptors (14, 27, 28). An approximately lO^-fold higher 
concentration of g,g'-DDT is required to obtain the same level of 
competition as is observed with unlabeled estradiol. 
In light of recent studies (IB, 35), it may be necessary to 
slightly modify our current concepts of steroid receptor action. 
According to these studies, steroid receptors may reside primarily in 
the cell nucleus. Upon binding to steroid hormone, the receptor protein 
may become tightly associated with nuclear components. Therefore, 
receptors measured in the cytosol fraction by present assaying 
techniques may represent loosely associated, unbound receptors released 
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from the ceil nucleus during tissue homogenization, while those measured 
in the nuclear fraction may represent predominantly tightly-associated 
receptors. In any event, our results demonstrate that g,g'-DDT acts in 
the brain to increase the availability of intracellular progestin 
receptors. 
In summary, in contrast to a previous report (12), we have found 
that a minimal dose of g,g'-DDT that provides neural responsiveness to 
progesterone for facilitation of sexual behavior, does indeed increase 
the concentration of cytoplasmic progestin receptors. Therefore, our 
results provide further support for the hypothesis that estrogen 
induction of intracellular progestin receptors is a prerequisite for 
progesterone to facilitate the expression of female sexual behavior. 
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SECTION III. SUPPLEMENTAL PROGESTERONE DELAYS HEAT TERMINATION AND THE 
LOSS OF PROGESTIN RECEPTORS FROM HYPOTHALAMIC CELL NUCLEI 
IN FEMALE GUINEA PIGS 
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ABSTRACT 
Previous studies indicate that the retention of hypothalamic 
nuclear progestin receptors parallels the expression of sexual 
receptivity in ovariectomized, hormonally-treated guinea pigs. In this 
study, the effect of a supplemental progesterone injection on heat 
termination and retention of nuclear progestin receptors was examined. 
Ovariectomized guinea pigs were injected with 50 yg progesterone 48 h 
after receiving 4 yg estradiol benzoate and were tested hourly for 
lordosis. Eight h after progesterone treatment, animals received either 
500 yg progesterone or the oil vehicle. The supplemental progesterone 
injection delayed the termination of heat by more than 2 h compared to 
oil-injected animals. 
The effect of supplemental progesterone on the retention of 
nuclear progestin receptors was then determined. Animals were killed 8, 
10, or 14 h after the initial injection of progesterone, and cytosol and 
nuclear progestin receptor concentrations in mediobasal 
hypothalamus-preoptic area were determined. Supplemental progesterone 
further increased the level of nuclear progestin receptors measured at 
10 h, and at 14 h these levels were still elevated above baseline. In 
contrast, nuclear progestin receptor levels in animals which received 
only the initial progesterone injection had returned to baseline by 14 
h, a time when similarly-treated animals were no longer receptive. 
These results suggest that the mechanism by which heat termination 
occurs may involve loss of nuclear progestin receptors. 
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INTRODUCTION 
Estradiol and progesterone interact to activate a period of 
sexual behavior in intact, estrous-cycling as well as ovariectomized 
(OVX) guinea pigs (11, 15, 29). This period of sexual behavior (heat), 
which is characterized, in part, by the elicitation of the lordosis 
posture by mating stimulation, has a duration of about 8-10 hours (31). 
While the mechanisms regulating the onset of sexual behavior have been 
well studied, little is known of the mechanisms responsible for its 
termination. 
It has been hypothesized that neural intracellular progestin 
receptors mediate the activation of sexual receptivity by estradiol and 
progesterone (3, 6, S, 16). In OVX guinea pigs, estradiol treatment 
increases the level of cytoplasmic progestin receptors in certain 
regions of the brain, primarily the mediobasal hypothalamus (MBH) and 
preoptic area (POA) (3, 27). These regions are thought to contain the 
principal sites for the facilitation of female sexual receptivity by 
estradiol and progesterone in rodents (20, 22, 24). Administration of 
progesterone to OVX, estrogen-treated guinea pigs results in a transient 
increase of progestin receptors in the hypothalamic cell nuclear 
fraction while concurrently decreasing the level of receptors in the 
cytosol (4). 
This transient accumulation of nuclear progestin receptors 
correlates with the expression of sexual receptivity; nuclear progestin 
receptor levels increase prior to the initiation of sexual receptivity 
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and decline to baseline levels as the receptive period terminates (4). 
This correlation suggests that heat termination may result from the loss 
of progestin receptors from the cell nucleus. Based on this hypothesis, 
hormonal manipulations that delay heat termination should also delay the 
decline in nuclear progestin receptor levels. In support of this 
hypothesis, we recently confirmed previous studies (11, 14) showing that 
a supplemental injection of estradiol at the time of progesterone 
treatment increased the duration of heat (1). Furthermore, we found 
that 12 h after supplemental estradiol treatment, hypothalamic nuclear 
progestin receptor concentrations were 557. greater than in animals which 
received only progesterone. In the present study, we determine the 
effects of a supplemental progesterone injection on heat termination and 
the retention of nuclear progestin receptors. 
In previous studies measuring nuclear progestin receptors by an 
in vitro exchange assay, we used the potent synthetic progestin, R 5020, 
as the labeled ligand (i, 2, 4). R 5020 is preferred over progesterone 
because it binds specifically to progestin receptors with a higher 
affinity than progesterone and dissociates more slowly from the receptor 
(3, 16). However, in order to increase the sensitivity of the assay, 
(=H)progesterone, which is available at a higher specific activity than 
('H)R 5020, was used in this study to detect nuclear progestin receptor 
levels. 
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MATERIALS AND METHODS 
Animals 
Adult, Hartley strain female guinea pigs (Biolab Corp., St. Paul, 
MN) were group-housed in 38 X 48 X 20 cm cages with lights on from 0600 
- 2000 h. Guinea pig chow (Teklad Mills, Madison, WD and water were 
freely available. All animals were OVX as described previously (8) and 
had received estradiol and progesterone treatment in previous 
experiments. A 3 week interval from the last treatment was allowed 
before animals were used in this study. All hormone injections were 
subcutaneous in a 0.1 ml volume. Estradiol benzoate (EB) was dissolved 
in sesame oil, and progesterone was dissolved in sesame oil containing 
157. benzyl benzoate and 57. benzyl alcohol. In experiments validating 
assay procedures, guinea pigs were injected with 1 mg progesterone 48 h 
after receiving 10 yg EB. Animals were killed 2 h after progesterone 
treatment. 
Behavioral Testing 
Guinea pigs were tested hourly for lordosis using manual 
stimulation with the experimenter blind to treatment groups (30). 
Testing began just prior to the initial progesterone injection and 
continued until all animals were nonresponsive. An animal was 
considered responsive if she held the lordosis posture for a minimum of 
I sec during two consecutive hourly tests. Heat was considered 
terminated in a responsive animal when she failed to respond during two 
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consecutive tests. Latency to lordosis, maximum lordosis duration, and 
heat duration were calculated as described previously (5, 13). Latency 
to lordosis is the time interval from progesterone administration to the 
first lordosis response. Heat duration is the time in hours from the 
first lordosis response to the last lordosis response with both the hour 
of first and last lordosis counted. Maximum lordosis duration is the 
maximum amount of time that an animal held the lordosis posture. Time 
of last lordosis is the hour after the initial progesterone injection in 
which the animal last responded. 
Combined Cytosol and Nuclear Progestin Receptor Assay 
Cytosol and nuclear progestin receptor levels were measured as 
described previously (1, 2). Guinea pigs were decapitated and their 
brains rapidly removed. The MBH, PDA (8), and cerebral cortex (CTX) (3) 
were dissected on a chilled block as described previously. The MBH and 
PDA were pooled for each animal. All subsequent procedures were 
at 0-4 ®C. Tissues were placed in glass tissue grinders containing 1.0 
ml Buffer TEGST (10 mM Tris-HCl, 1.5 mM NagEDTA, 0.32 M sucrose, 10% 
glycerol, 12 mM monothioglycerol, pH 7.2) and homogenized with a teflon 
pestle with appropriate clearance for cell nuclear isolation. 
Homogenates were transferred to 12 X 75 mm polycarbonate tubes and the 
tissue grinders were rinsed with 0.5 ml TEGST. The homogenates were 
then centrifuged at 1,000 g for 5 min. Cytosol extract was obtained by 
centrifuging the supernatant at 48,000 g for 30 min. The pellet from 
the first centrifugation was washed twice with 2.0 ml Buffer AT (0.32 M 
sucrose, 1 mM KHaPO*, 1 mM MgClg, 10% glycerol, 12 mM monothioglvcerol, 
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pH 7.2) by centri-fuging at 1,000 g and decanting the supernatant. The 
crude nuclei were then purified by adding 0.3 ml AT + 1.0 ml Buffer B 
(2.15 M sucrose, 1 m M KH2PO4, 1 mM MgCls, 107. glycerol, pH 7.2), 
vortexing, and centrifuging at 25,000 g for 20 min. The pellicle and 
supernatant were removed and the walls of the tube dried leaving the 
purified cell nuclei. 
To remove potentially competing steroids from the cytosol (2), 
400 pi samples of cytosol were applied to 4.5 X 68 mm Sephadex LH-20 
columns (Pharmacia Fine Chemicals, Piscataway, NJ). Immediately after 
running into the column the macromolecular fraction was eluted with 
700 ]J1 TEGST. Two hundred and fifty pi aliquots of filtered cytosol 
were incubated with 50 pi TEGST containing 17. ethanol (final 
concentration) and (®H)R 5020 (New England Nuclear, Boston, MA; Specific 
activity = 87 Ci/mmol) +/- 100-fold excess of unlabeled R 5020. A final 
concentration of 0.4 nM (=H)R 5020 was used because this concentration 
results in binding almost exclusively to the progestin receptor with 
almost no specific binding to blood contaminants or low affinity binders 
(3). 
Following a 12-16 h incubation at 0-4 =C, bound (=H)R 5020 was 
separated from tree by gel filtration with Sephadex LH-20 columns 
equilibrated with TEGST. Two hundred and fifty yl samples of incubate 
were applied to the column and washed in with 150 yl TEGST. Thirty min 
after applying the sample the protein peak was eluted into scintilation 
vials with 700 yl TEGST. Five ml toluene-based scintilation fluid 
containing 337. Triton X-100 were added and radioactivity was counted on 
a Packard Tri-Carb Model 300C spectrophotometer at an efficiency of 417.. 
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Specific binding was calculated by subtracting non-specific binding 
(with unlabeled R 5020) from total binding (without unlabeled R 5020). 
Protein concentration of the filtered cytosol extract was determined by 
the protein dye-binding method of Bradford (7). Receptor concentrations 
are expressed as femtomoles (=H)R 5020 specifically bound per mg 
protein. 
For the nuclear progestin receptor assay, the cell nuclear pellet 
was dispersed in 280 yl Buffer TEBT (10 m M tris-HCl, 1.5 m M NazEDTA, 107. 
glycerol, 12 mM monothioglycerol, pH 7.4). After 15 min, an equal 
volume of Buffer TEGTK 1.0 (TEST + 1.0 M KCl, pH 7.4) was added and the 
tube contents vortexed. Following a 15-30 min incubation, the nuclei 
were centrifuged at 48,000 g for 5 min. Two hundred and fifty pi 
samples of the supernatant (nuclear extract) were incubated with 50 yl 
Buffer TEGTK 0.5 (TEST + 0.5 M KCl) containing 1% ethanol (final 
concentration) and CH)progesterone (New England Nuclear, SA = 165-179 
Ci/mmole) +/- a 100-fold concentration of unlabeled R 5020. A final 
concentration of 5 nM (^H)progesterone was used. Following a 12-16 h 
incubation at 0-4 "C, bound CH)progesterone was separated from free as 
described for the cytosol receptor assay except that Buffer TEGTK 0.5 
was used and the macromolecular fraction was eluted 20 minutes after 
sample application. The DMA content of the nuclear pellet was 
determined by the method of Burton (10). Receptor concentrations are 
expressed as femtomoles CH)progesterone specifically bound per mg DNA. 
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Statistical Analysis 
Results are presented as mean +/- S.E.M. Differences between 
group means were considered statistically significant if p<0.05 as 
determined by Student's t test. Probability levels given are for 
two-tailed comparisons unless stated otherwise. 
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RESULTS-
Saturation Curve and Scatchard Analysis 
A Scatchard analysis (25) of CH)progesterone binding in MBH-POA 
nuclear extract was conducted to verify that binding is to a high 
affinity, saturable binder. Five OVX guinea pigs were injected with 1 
mg progesterone 2 days after receiving 10 ug EB. Two h later, animals 
were killed and MBH-POA nuclear progestin receptors assayed as described 
except that nuclear extract was pooled and incubated with a range of 
CH)progesterone concentrations (0.1-20.0 nM) with or without a 100-fold 
concentration of unlabeled R 5020. 
Scatchard analysis revealed that ('H)progesterone binds with high 
affinity (apparent dissociation constant = 0.33 nM) to a saturable 
binder in MBH-POA nuclear extract (Figure la). Binding to a lower 
affinity binder (apparent dissociation constant = 8.0 nM) was also 
detected. Similar results were obtained in the CTX (data not shown). 
As determined by the saturation curve (Figure lb), a concentration of 5 
nM (®H)progesterone saturates the progestin receptor pool while 
minimizing binding to nonspecific and low-affinity binders. 
Time Course of Binding 
To determine the time course of the binding reaction, 6 OVX 
guinea pigs were treated with EB and progesterone. Two h after the 
injection of progesterone, MBH-POA nuclear extract was obtained, pooled, 
and incubated with (®H)progesterone with or without unlabeled R 5020 for 
\ 
Figure 1. Scatchard Analysis of CH)progesterone binding 
A: Scatchard representation of specific CH)progesterone binding in MBH-POA nuclear 
extract 
Nuclear extract obtained from OVX guinea pigs treated with EB and progesterone 
was incubated with a range of CH)progesterone concentrations (0.1-20.0 nM) +/-
100-fold concentration of R 5020. 
B; Saturation curves of data represented in Scatchard plot 
(•) = total binding (•) = specific binding, (A) = nonspecific binding 
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1, 2, 4, S, or 16 h. Bound (=H)progesterone was separated from free as 
described. 
The in vitro binding reaction is complete by 8 h with no loss of 
specific binding detected by 16 hours of incubation (Figure 2). 
Dissociation of Bound CH)Progesterone 
in Contact with Sephadex LH-20 
The amount of dissociation of specifically bound 
(3H)progesterone and (=H)R 5020 in contact with Sephadex LH-20 was 
determined by applying 250 pi samples of MBH-POA nuclear extract 
incubate to Sephadex LH-20 columns. Immediately after running into the 
column, samples were washed in with 150 yl buffer. Macromolecular 
fractions were eluted with 700 yl buffer 15, 25, and 35 min after sample 
application. 
The ('H)R 5020-progestin receptor complex is relatively stable 
during separation from free ligand (Figure 3). CH)Progesterone-
progestin receptor complexes are less stable with a 157. and 36% decrease 
in specific binding seen at 25 and 35 min respectively. Therefore, to 
minimize loss of binding, columns were eluted 20 min after sample 
application. 
Supplemental Progesterone Delays Heat Termination 
To test if supplemental progesterone can delay heat termination 
in estrogen-treated OVX guinea pigs, animals were treated with 50 yg 
progesterone (0800 h) 48 h after receiving 4 yg EB. Animals were tested 
hourly for lordosis. Eight h after the injection of progesterone, 
Time course of (^H)progesterone binding 
Nuclear extract obtained from OVX guinea pigs treated with EB and progesterone 
was incubated with 5 nM (^H)progesterone +/- 500 nM R 5020 for 1, 2, 4, 8, or 16 h. 
(•) = total binding, <•) = specific binding, (A) = nonspecific binding. 
incubation period, h 
Figure 3. Stability of specifically bound (^H)progesterone and (®H)R 5020 in contact with 
Sephadex LH-20 
Aliquots of nuclear extract incubates were applied to columns of Sephadex 
LH-20. The macromolecular fraction was eluted 15, 25, or 35 min after sample 
application. 1007. = levels detected at 15 min. 
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animals were matched for latency and divided into two groups. Animals 
in one group received an injection of 500 yg progesterone, ten times the 
initial dose, while animals in the other group received the oil vehicle. 
Testing continued until all animals were nonresponsive. 
Heat termination was delayed by 2 h in animals treated with the 
supplemental progesterone injection compared with control animals 
{p<0.05, Table 1). No difference in maximum lordosis duration after the 
supplemental progesterone injection was observed between groups. 
Supplemental Progesterone Delays the Loss 
of Nuclear Progestin Receptors 
To determine if the supplemental progesterone injection delays 
the loss of nuclear progestin receptors, cytoplasmic and nuclear 
progestin receptor levels were determined in OVX guinea pigs treated as 
in the behavioral experiment. A third group which received EB and oil 
injections rather than progesterone was included to establish baseline 
levels of nuclear progestin receptors. Animals were sacrificed and 
MBH-POA and CTX progestin receptor levels were determined at 8, 10, and 
14 h after the initial injection of progesterone (0, 2, and 6 h after 
the second progesterone injection). 
MBH-POA nuclear progestin receptor levels were still elevated 8 h 
after the initial injection of progesterone (p<0.005, compared to 
baseline levels; Figure 4b). The injection of supplemental progesterone 
increased the level of nuclear progestin receptors measured at 10 h 
(p<0.005). At 14 h, a time when 80% of similarly treated animals were 
still in heat (Figure 4a), nuclear progestin receptor levels were still 
Table 1. Supplemental injection of progesterone delays the termination of sexual receptivity 
Ireatment^ Latency to Heat Time of Maximum Lordosis 
Oh B h n Lordosis Duration* Last Lordosis** Duration" 
(h) (h) (h) (h) 
PROG Veh 10 4.4 8.6 12.0 12.1 
+/-0.31 +/-0.78 +/-0.77 +/-3.06 
PROG PROG 10 4.6 10.8 14-4 15.8 
+/-0.50 +/-0.84 +/-0.62 +/-1.91 
'Forty-eight hours prior to receiving the initial injection of progesterone, OVX guinea 
pigs were treated with 4 lig estradiol benzoate. At 0 h, animals were tested for lordosis and 
injected with 50 g progesterone (PROG). Eight h later, animals were matched for latency to 
lordosis, and injected with either 500 yg progesterone or the oil vehicle (Veh). Values 
reported are means +/- S.E.M. 
"After injection at 8 h. 
•p < 0.05, Student's t-test, one-tail. 
""p < 0.05, Student's t-test. 
Figure 4. MBH-POA progestin receptor levels 
A: Percent of guinea pigs responding during tests for 
lordosis (data from Table 1) 
Animals were treated with 50 yg progesterone 48 h 
after receiving 4 yg EB. Eight h later, animals received a 
supplemental injection of 500 yg progesterone or oil (At 14 
h: p=0.02, two-tailed Fisher's Exact Probability Test). 
B: MBH-POA nuclear progestin receptor levels in guinea pigs 
treated as in A 
Animals received 50 ug progesterone or oil 48 h after 
receiving 4 yg EB. .Eight h later, animals were sacrificed or 
received 500 yg progesterone or oil and were sacrificed 10 or 
14 h after the initial progesterone injection (n = 5-9). 
C: MBH-POA cytoplasmic progestin receptor levels measured in 
the animals described in B 
Specifically bound ('H)-R 5020, 
fmol/mg protein 
Specifically bound (^H)-pro-
gesterone, fmol/mg DNA % responding 
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elevated in supplemental progesterone-treated guinea pigs (p<0.025). In 
contrast, receptor levels in animals treated with only the initial 
injection of progesterone have returned to baseline by 14 h, a time when 
80% of similarly treated animals were no longer in heat. 
As expected, supplemental progesterone further decreased the 
level of MBH-POA cytoplasmic progestin receptors (p<0.01; Figure 4c). 
In animals receiving only the initial injection of progesterone, 
cytoplasmic progestin receptors were indistinguishable from baseline 
levels at 10 and 14 h. 
In CTX, supplemental progesterone further decreased the level of 
available cytoplasmic progestin receptors (p<0.01, 10 h; Figure 5). No 
other significant differences were detected in cytosol receptor levels 
after supplemental progesterone injection nor were any differences noted 
in nuclear receptor levels. 
Figure 5. Nuclear (A) and cytoplasmic (B) progestin receptor levels in 
CTX from the same animals described in Figure 4 
Specifically bound (^H)-R 5020, 
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DISCUSSION 
The experiments validating the use of (=H)progesterone in the 
nuclear exchange assay indicate that progesterone binds with 
different affinity to two components in MBH-POA nuclear extract. A 
similar finding has been reported with (=H)R 5020 binding in 
hypothalamic nuclear extract (28); The dissociation constant obtained 
for the high-affinity binding component is similar to that obtained 
using ('H)R 5020 (4, 28). The binding capacity of this component has 
been shown to vary with behaviorally relevant hormonal treatments (4); 
however, the identity and function of the low-affinity component is 
unknown. 
The period of sexual behavior in intact estrous-cycling guinea 
pigs is temporally linked with ovulation. The onset and termination of 
the receptive period parallels the rise and fall of the preovulatory 
surge of progesterone (12). However, in OVX estrogen-treated guinea 
pigs, heat termination occurs despite prolonged elevation of blood 
progesterone levels, indicating that the availability of progesterone is 
not the primary determinant of heat duration (19). We recently found 
that in OVX guinea pigs implanted with Silastic capsules containing 10% 
estradiol and capsules containing various lengths of crystalline 
progesterone, heat termination occurred despite the continued presence 
of estradiol and progesterone (9). 
The results of the present study confirm the work of Morin and 
Feder (19) showing that progesterone can influence the time at which 
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heat termination occurs in OVX guinea pigs. In their study, multiple 
injections of 0.1 mg progesterone administered every 3 h prolonged the 
duration of heat by more than 2 h. We found that a supplemental 
progesterone injection, ten times the dose of the initial injection, 
delayed heat termination by more than 2 hours. In addition, 
supplemental progesterone was found to increase the cell nuclear 
retention of MBH-POA progestin receptors. In animals receiving only the 
initial progesterone injection, nuclear progestin receptor levels 
returned to baseline by 14 h, a time when similarly-treated animals were 
no longer receptive. In contrast, animals which received supplemental 
progesterone were still sexually receptive at 14 h and still had an 
elevated level of nuclear progestin receptors. These findings are 
consistent with the hypothesis that heat termination results from the 
loss of progestin receptors from the cell nucleus. 
Six hours following the supplemental injection of progesterone, 
nuclear progestin receptor levels were only slightly elevated. However, 
if the initial progesterone injection was not given, nuclear progestin 
receptor levels would not be expected to return to baseline until 12-24 
h after injection (4/. This raises the question of what factors 
regulate the retention of progestin receptors in cell nuclei. One such 
factor may be circulating progesterone levels. It seems likely that as 
the circulating level of progesterone decreases, no further nuclear 
accumulation of progestin receptors would occur. Indeed, experiments by 
Blaustein and Feder (4), and McGinnis et §1^ (17), show an apparent 
correlation between blood progesterone levels and nuclear progestin 
receptor retention. However, in our experiments, blood progesterone 
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levels would not be expected to return to baseline until 12-24 h 
following the supplemental injection of progesterone (4). This suggests 
that circulating progesterone is not the only factor which regulates 
nuclear progestin receptor retention. 
Another factor which may regulate nuclear progestin receptor 
retention is the concentration of cytoplasmic progestin receptors. As 
cytoplasmic progestin receptor levels decrease because of translocation 
to cell nuclei and declining estrogen-priming action, the level of 
nuclear progestin receptors decreases (1, 2), We found that the 
supplemental progesterone injection further decreased cytoplasmic 
progestin receptor levels and that as nuclear receptor levels declined, 
the level of cytoplasmic receptors was not replenished (4, 17). It is 
possible that the magnitude of this sustained decrease in cytoplasmic 
progestin receptors prevented further translocation of receptors to cell 
nuclei. This could then have resulted in the decline of nuclear 
progestin receptors even in the presence of elevated circulating 
progesterone levels. This may explain how termination of the receptive 
period can occur despite maintained high levels of progesterone. 
Although no significant differences were noted in nuclear 
accumulation and retention of progestin receptors in CTX following 
supplemental progesterone treatment, the pattern observed is similar to 
that seen in the MBH-POA. Any comparison of the effects of supplemental 
progesterone on estrogen-induced vs. nonestrogen induced receptors would 
require further study. 
While the results of the present study suggest that termination 
of heat may result from the loss of nuclear receptors from neurons 
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involved with activating lordosis, there are other mechanisms by which 
heat termination can occur. Reading and Blaustein (23) recently found 
that mating-induced heat termination in rats is independent of neural 
progestin receptors. Two h of mating stimulation which prematurely 
terminated heat had no apparent effect on the level of either 
cytoplasmic or nuclear progestin receptor concentrations. Heat 
termination occurred despite elevated nuclear progestin receptor levels. 
The mechanism by which mating-induced heat abbreviation occurs, 
therefore, may involve a more direct effect on neurons involved in 
lordosis and may be unrelated to the mechanism by which heat terminates 
in the non-mated animal. 
Sodersten et alj. (26) have demonstrated that vasopressin can 
terminate heat in OVX rats treated with estradiol and progesterone, and 
have suggested that a circadian increase in brain vasopressin may play a 
role in terminating heat in the intact rat. However, if a diurnal 
increase in vasopressin causes termination of receptivity, it follows 
that animals should fail to show or show diminished levels of lordosis 
during the light portion of their light-dark cycle. We have not 
observed such an effect in our animals (Brown and Blaustein, unpublished 
observations, Iowa State University). Therefore, further study is 
necessary to determine if vasopressin plays any role in the termination 
of heat. 
The mechanisms by which a decline in nuclear progestin receptor 
concentration may lead to termination of sexual receptivity are unknown. 
Rainbow et aK (21, 22) have shown that progesterone's effects on 
lordosis are protein-synthesis dependent, suggesting that progesterone 
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may activate sexual receptivity via a genomic mechanism. Perhaps as 
nuclear progestin receptor concentrations decrease, the 
progesterone-induced protein changes dissipate leading ultimately to the 
termination of the receptive period. 
The results of this study suggest that in intact, non-mated 
guinea pigs, heat termination may result from a decline in nuclear 
progestin receptor concentration. This decline in nuclear progestin 
receptors may result from either a decline in circulating progesterone 
levels, a decrease in cytoplasmic progestin receptor concentration in 
target neurons, or both. Further studies are planned to investigate 
progestin receptor dynamics and how they relate to heat termination in 
the intact animal. 
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SECTION IV. LOSS OF HYPOTHALAMIC NUCLEAR-BOUND PROGESTIN RECEPTORS; 
FACTORS INVOLVED AND THE RELATIONSHIP TO HEAT TERMINATION 
IN FEMALE GUINEA PIGS 
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ABSTRACT 
The hypothesis that the termination of sexual receptivity (heat) 
in female guinea pigs results from loss of progestin receptors from 
hypothalamic cell nuclei was tested. First, we attempted to find an 
optimal dose of progesterone that would result in a prolonged period of 
sexual receptivity. Ovariectomized guinea pigs were implanted with 10% 
estradiol capsules. Forty h later, each received one of several sized 
progesterone capsules before being tested hourly for lordosis. 
Surprisingly, none of the progesterone doses resulted in delayed heat 
termination. In order to determine whether elevated levels of estradiol 
and progesterone maintain elevated levels of nuclear progestin receptors 
despite the lack of effect on heat duration, animals were treated as 
described above except that only one size progesterone capsule (3.0 cm) 
or an empty capsule was implanted. Despite elevated serum progesterone 
concentrations, nuclear progestin receptor levels decreased gradually 
and approached control levels at about the same time as heat termination 
had occurred in similarly-treated animals. Cytosol progestin receptor 
levels decreased following progesterone treatment and remained lowered 
at all times measured. In order to further investigate the relationship 
between blood progesterone concentrations and retention of nuclear 
progestin receptors we decreased blood progesterone concentrations by 
removing progesterone capsules 2 h following insertion. Nuclear 
progestin receptor levels declined gradually concurrent with a decline 
in serum progesterone levels in animals exposed to progesterone capsules 
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for only 2 h. In animals exposed to capsules continuously, nuclear 
progestin receptor levels again decreased but at a slightly slower rate. 
In order to test the effect of progesterone capsule removal on female 
sexual behavior, ovariectomized guinea pigs were treated as desribed and 
tested hourly for lordosis. Fewer animals in the group exposed to 
progesterone capsules for 2 h became sexually receptive as compared to 
animals continuously-exposed to progesterone capsules. Of those animals 
that did respond, heat termination had occurred by the same time that 
nuclear progestin receptor levels had returned to control levels in 
similarly-treated animals. These experiments support the hypothesis 
that heat termination results from the loss of progestin receptors from 
hypothalamic cell nuclei. In addition, they demonstrate that 
circulating progesterone levels play a role in regulating nuclear 
progestin receptor retention. 
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INTRODUCTION 
Substantial experimental evidence exists suggesting that the 
hormonal activation of female sexual behavior in several rodent species 
is mediated by hypothalamic intracellular progestin receptors. 
Estradiol treatment in ovariectomized (OVX) rats and guinea pigs 
increases the concentration of progestin receptors in cytosols obtained 
from several brain regions, including the mediobasal hypothalamus (MBH) 
and preoptic area (POfi) (16, 17, 20, 22, 26). These regions have been 
shown to contain the primary site for the hormonal induction of female 
sexual behavior by estradiol and progesterone (17, 21, 23-25). 
Administration of progesterone to estrogen-pretreated animals results in 
a transient elevation of progestin receptor levels measured in 
hypothalamic cell nuclei, and a sustained decrease in receptor levels 
measured in cytosol (6, 19). This sustained decrease in cytosol 
progestin receptor levels appears to cause refractoriness to further 
stimulation by progesterone (2, 3, 5). 
The transient elevation of nuclear progestin receptors following 
progesterone injection has been shown to correlate with the expression 
of sexual receptivity in guinea pigs; nuclear progestin receptor levels 
increase prior to the initiation of sexual receptivity and return to 
baseline as the receptive period ends. This correlation has led to the 
hypothesis that the termination of sexual receptivity (heat) results 
from the loss of progestin receptors from hypothalamic cell nuclei (6, 
9). Perhaps as the concentration of progesterone-progestin receptor 
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complexes in cell nuclei decreases, the cellular effects of progesterone 
diminish, resulting in the loss of sexual responsiveness. 
Based on this hypothesis, hormonal manipulations that affect the 
duration of the period of sexual receptivity should also affect the 
retention of progestin receptors in hypothalamic cell nuclei. In 
support of this hypothesis, we have recently reported that a 
supplemental injection of progesterone, administered to 
hormonal 1y-treated OVX guinea pigs, not only delays the termination of 
heat, but also delays the loss of progestin receptors from cell nuclei 
(9). Furthermore, we have shown that a similar delay results from 
supplemental injection of estradiol (2). 
In some circumstances, estradiol and progesterone administered in 
a continuous fashion, can activate extended periods of sexual behavior 
in female hamsters (15). Lisk (15) infused progesterone at three 
different rates into OVX hamsters treated with chronically-placed 
estrogen pellets. Infusion of progesterone at the slow rate failed to 
activate sexual behavior, while infusion at the high rate activated 
periods of sexual behavior of normal duration. Infusion at the moderate 
rate, however, resulted in animals remaining sexually receptive for an 
extended period of time. Based on our hypothesis that heat duration is 
linked to the retention of nuclear progestin receptors, a possible 
explanation for these results is that at the optimum level of 
progesterone, nuclear progestin receptor levels may remain elevated for 
an extended period of time. This could occur by a balance being 
attained between receptor induction (by estradiol), receptor 
transformation (by progesterone), and receptor inactivation. As long as 
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such a balance is maintained, nuclear progestin receptor levels might 
remain elevated, and the period of sexual receptivity may be extended 
Because this phenomenon provides a unique test of the hypothesis that 
heat termination results from the loss of progestin receptors from 
hypothalamic cell nuclei, we attempted to study it in OVX guinea pigs 
treated with estradiol and progesterone administered in a continuous 
fashion. 
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METHODS 
Animals 
Adult, Hartley strain female guinea pigs obtained from Biolab 
Corp. (St. Paul, MN; Experiment 1 and 2) or from Camm Research Inst. 
(Wayne, NJ; Experiment 3) were group housed in 51 X 56 X 23 cm cages 
with lights on from 0600 - 2000 h. Guinea pig chow (Experiment 1: 
Teklad, Madison,WI; Experiment 2 and 3: Ralston Purina, St. Louis, MO) 
and water were freely available. All animals were bilaterally 
ovariectomized 2-3 weeks prior to use under conditions described 
previously (8). 
Hormones 
Five mm capsules containing 107. crystalline estradioI-176 were 
constructed from Silastic Medical Grade tubing (id; 1.47 ram, od: 1.96 
mm; Dow Corning, Midland, MI) as described previously (4). Capsules 
containing crystalline progesterone or progesterone mixed with 
cholesterol were constructed in a similar manner (id: 3.35 mm; od: 4.70 
mm; length: 0.5, 1.0, 1.5, or 3.0 cm). To stabilize the diffusion of 
steroid, capsules were incubated in host female guinea pigs for 24 h 
just prior to their insertion into experimental animals. At the time of 
capsule insertion, animals were lightly anesthetized with methoxyflurane 
(Metofane; Pitman-Moore, Washington Crossing, NJ) and capsules were 
placed subcutaneously in the nape of the neck (estradiol) or in the 
axillary region (progesterone). 
1 2 8  
Estradiol benzoate was dissolved in sesame oil and was injected 
subcutaneausly in a 0.1 ml volume. 
Behavioral Testing 
Guinea pigs were tested hourly for lordosis by manually 
stimulating the flanks and perineal area and measuring the length of 
time the lordosis posture was held (28). Testing began just prior to 
the insertion of progesterone capsules and continued until all animals 
were unresponsive. All tests were conducted with the experimenter blind 
to the assigned treatment group. An animal was considered responsive if 
the lordosis posture was held for at least 1 sec during two consecutive 
tests. Heat was considered terminated in a responsive animal when no 
response was noted during two consecutive tests. Latency to lordosis, 
maximum lordosis duration, heat duration, and time of last lordosis were 
calculated as described previously (9, 13). 
Combined Cytosol and Nuclear 
Progestin Receptor Assay 
Guinea pigs were decapitated and their brains rapidly removed. 
The mediobasal hypothalamus (MBH) and preoptic area (POft) were dissected 
on a chilled block and pooled for each animal (B). Cytosol and nuclear 
progestin receptor levels were measured as described previously with 
minor modifications (2, 3). All procedures were conducted at 0-4 "C. 
Tissues were placed in a glass tissue grinder containing 1.0 ml buffer 
At  ( 0 . 32  M sucrose, 1  mM KH2PO4, 1  mM MgCls, 1 0 %  glycerol, 12  mM 
monothioglycerol, pH 7.2) and were homogenized with a Teflon pestle with 
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appropriate clearance for cell nuclear isolation (18). Homogenates were 
transferred to 12 X 75 mm polycarbonate tubes and the tissue grinders 
were rinsed with 0.5 ml At. The homogenates were centrifuged at 1000 
X g for 5 rain. Cytosol extract was obtained by centrifuging the 
resulting supernatant at 48,000 X g for 30 min. The pellet from the 
first centrifugation was washed twice by adding 2 ml AT and centrifuging 
at 1000 X g for 5 min. The crude nuclear pellet was then purified by 
dispersing in 0.3 ml AT + 1.0 ml buffer B (2.15 M sucrose, 1 mM KHzPO*, 
1 mil MgClz, 107. glycerol, pH 7.2) and centrifuging at 25,000 X g for 20 
min. The pellicle and supernatant were removed and the walls of the 
tube were dried. 
For the cytosol assay, 300 yl samples of cytosol were applied to 
4.5 X 68 mm columns of Sephadex LH-20 (equilibrated with buffer AT) to 
remove potentially competing steroids (3). Immediately after running 
into the column, the sample was washed in with 100 yl AT and the 
macromolecular fraction was eluted with 700 yl AT. Aliquots of 250 yl 
filtered cytosol were incubated with 50 yl AT containing IX ethanol 
(final concentration) and ( 17ci-methyl-=H)R 5020 (New England Nuclear, 
Boston, MA; spec. act. = 87 Ci/mmol) +/- 250-fold concentration of 
unlabeled progesterone. A final concentation (in 300 yl) of 0.4 nM 
(=H)R 5020 was used because this concentration results in binding almost 
exclusively to the progestin receptor with almost no specific binding to 
blood contaminants or low affinity binders (5, 16). 
Fallowing an overnight incubation at 0-4 °C, bound (=H)R 5020 was 
separated from free by gel filtration on Sephadex LH-20 columns 
(Pharmacia Fine Chemicals, Piscataway, NJ), Samples of incubate 
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(250 ul) were applied to the column and washed in with 150 pi of buffer 
AT. Thirty min after applying the sample, the macromolecular fraction 
was eluted into scintillation vials with 700 pi of At. Five mi of 
scintillation fluid (0.17 g Bis MSB + 5.5 g PRO / liter scintillation 
grade toluene (Fisher Scientific) containing 33% Triton X-100) were 
added and radioactivity was counted on a Packard Tri-Carb Model 300C 
spectrophotometer at an efficiency of 40%. Specific binding was 
calculated by subtracting nonspecific binding (with unlabeled 
progesterone) from total binding (without unlabeled progesterone). 
Protein concentration was determined by the dye-binding method of 
Bradford (7), using bovine serum albumin as the standard. Results are 
expressed as femtomoles ('H)R 5020 specifically bound per mg cytosol 
protein. 
For the nuclear receptor assay, the purified nuclear pellet was 
dispersed with 285 pi buffer TEST (10 mM Tris-HCl, 1.5 mM NagEDTA, 10% 
glycerol, 12 mM monothioglycerol, pH 7.4). After 15 min, an equal 
volume of buffer TEGT-Ki.o (TEST + I M KCl, pH 7.4) was added. The tube 
contents were vortex-mixed and incubated for 15 min. The nuclei were 
then centrifuged at 48,000 X g for 5 min. Samples (250 pi) of the 
supernatant (nuclear extract) were incubated with 50 pi buffer 
TEGT-Ko.s (TEST + 0.5 M KCl, pH 7.4) containing 1% ethanol (final 
concentration) and ('H)R 5020 +/- 250-fold concentration of unlabeled 
progesterone. A final concentration of 3.0 nM ('H)R 5020 was used (6). 
Following an overnight incubation at 0-4 =C, bound (=H)R 5020 was 
separated from free as described above except that buffer TEGT-Ko.s was 
used. The DNA content of the nuclear pellet was determined by the 
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method of Burton (11). Results are expressed as femtomoles ('H)R 5020 
specifically bound per rag DNA. 
Serum Progesterone Levels 
At the time of decapitation, trunk blood was collected in 13 X 
100 mm culture tubes and kept at 0-4*C overnight. Serum was obtained by 
centrifuging the blood at 1,000 X g for 20 min, and was stored at -20=C 
until time of assay. Serum progesterone was measured by a modification 
of the technique by Abraham et al. (1). 
Extraction 
Samples (200 ul) of serum were placed into 13 X 100 mm culture 
tubes immediately after thawing. Fifty #1 of assay buffer (0.1% 
gelatin-phosphate buffered saline) were added to each tube. To a 
duplicate set of samples, 50 ul buffer containing 2,000 cpm 
(®H)progesterone (New England Nuclear, Boston, MA; spec. act. = 115 
Ci/mmol) were added to determine extraction efficiencies. Each sample 
was extracted twice with 1.5 ml cyclohexane (Fisher Scientific) by 
vortex-mixing each tube for 30 sec and centrifuging at 1500 X g for 5 
rain. The organic phases were collected in 12 X 75 mm culture tubes and 
the cyclohexane was dried off under vacuum. 
Radioimmunoassay 
The dried residue was redissolved in 2.0 ml assay buffer. 
Triplicate 500 pi aliquots were taken from the duplicate tubes to 
calculate extraction efficiency. Triplicate 500 ul aliquots from the 
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remaining tubes were transferred to 12 X 75 mm tubes for 
radioimmunoassay. One-hundred yl of antiserum (no. 337, provided by G. 
Niswender; formed against progesterone-ll-bovine serum albumin) at a 
dilution of 1:400 in assay buffer were added. Thirty min later, 50 yl 
buffer containing 30,000 cpm (®H)progesterone were added to each tube. 
A standard curve was constructed with 0, 25, 50, 100, 200, 400, 800, 
1600, 3200, and 6400 pg progesterone per 2 ml buffer. Triplicate 500 pi 
aliquots were taken from the standard curve tubes and treated as 
described above. 
Following an overnight incubation at 0-4 =C, bound 
(=H)progesterone was separated from free by gel filtration on 4.5 X 68 
mm Sephadex LH-20 columns. Three-hundred yl samples from each tube were 
loaded onto the columns. Immediately after running into the column bed, 
the samples were washed in with 100 yl buffer. Thirty min after sample 
application, the bound fraction of ('H)progesterone was eluted into 
scintillation vials with 700 yl buffer. Five ml of scintillation fluid 
were added and radioactivity was determined. Results are expressed as 
nanograms of progesterone per ml serum. 
SBgcificitx 
The antiserum used has less than 17. crossreactivity with other 
steroids except: 1IB-hydroxyprogesterone (139%), 5a-pregnans-3,20-dione 
(44%), 17a-hydroxyprogesterone (2.9%), corticosterone (2.2%), 
20a-bydroxypregn-4-en-3-one (1.77.), pregnenolone (1.12), and 
deoxycorticosterone (1.0%) (12). 
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Sensitivity 
The sensitivity of the assay was approximately 50 pg progesterone 
(0.25 ng/ml). 
Extraction Efficiency 
The mean efficiency of extraction was 85. 97. +/- 0.7 (mean +/-
S.E.M.). No differences in extraction efficiencies between treatment 
groups were noted. 
Accuracy 
The accuracy of the assay was assessed by adding 100, 1000, or 
5000 pg progesterone to serum obtained from OVX guinea pigs. The mean 
recoveries were 96.4, 1124.9, and 5262.5 pg. The percent deviations 
were -3.6%, +12.5%, and +5.37. respectively. 
Precision 
Because progesterone levels were determined in more than one 
assay, the precision within and between assays (intraassay and 
interassay variability) was evaluated by measuring progesterone levels 
in the some samples twice. The within assay coefficient of variation 
(C.V.I as computed by Snedecor's formula (1) for the 17 duplicates 
considered was 14.16% and the between assay C.V. for the 10 duplicates 
considered was 10.92%. 
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RESULTS 
Experiment 1 
In an attempt to find the optimal dose of progesterone that would 
result in greatly extended heat durations, Silastic capsules containing 
107. estradiol were implanted into DVX guinea pigs. Forty hours later, 
animals received one of the following progesterone capsule treatments: 
one 5% 0.5 cm capsule, one 10% 0.5 cm capsule, one 257. 0.5 cm capsule, 
one 507. 0.5 cm capsule, one 1007. 0.5 cm capsule, one 1.5 cm capsule, one 
3.0 cm capsule, one 1.5 and one 3.0 cm capsule (4.5 cm), or two 3.0 cm 
capsules (6.0 cm). Animals were tested hourly for lordosis until all 
animals were unresponsive. 
The percentage of animals in each treatment group that became 
sexually receptive is presented in Table 1. Treatment with 57. or 107. 
0.5 cm progesterone capsules resulted in less than 207. of the animals 
becoming sexually receptive; therefore, these treatments were considered 
subthreshold and were not included in the data analysis. 
The time at which heat termination occurred did not differ among 
treatment groups (time of last lordosis; Figure Ic; F(4,iio)= 1.222, 
p>0.25); heat termination occurred at about the same time regardless of 
progesterone dose and despite the continued administration of estradiol 
and progesterone. While some differences between groups were noted in 
heat duration (F<6,iio)= 2.896, p<0.025; Figure lb), these differences 
can be attributed to differences in latency to lordosis (F(<,,iio> = 
3.838, p<0.005; Figure la). 
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Table 1: Percentage of animals that became sexually receptive in each 
treatment group 
TREATMENT 
Progesterone Capsule Percent 
Content Length n Responding 
5 % 0.5 cm 12 17 
10 0.5 11 10 
25 0.5 11 82 
50 0.5 18 83 
100 0.5 18 83 
100 1.5 18 89 
100 3.0 33 88 
100 4.5 13 92 
100 6.0 27 78 
Figure 1. Effect of estradiol and various doses of progesterone, administered via capsules, on 
sexual behavior in female guinea pigs 
DVX guinea pigs were implanted with an estradiol capsule. Forty h later, 
animals received a progesterone capsule, one of several lengths and concentrations. 
Animals were tested hourly for lordosis until heat terminated. Bars represent group 
means + 3.E.M. Groups with different letters are significantly different from one 
another as determined by a protected Duncan's Multiple Range Test (alpha = 0.05). 
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Experiment 2 
The finding that heat termination occurs despite continued 
administration of estradiol and progesterone introduced the possibility 
of a dissociation between nuclear progestin receptor retention and heat 
duration. Perhaps elevated blood levels of these hormones maintained 
elevated nuclear progestin receptor levels, even though they did not 
prolong the duration of the period of sexual receptivity. Such a 
dissociation might suggest that some process other than loss of 
nuclear-bound progestin receptors is responsible for heat termination. 
Therefore, we measured the retention of hypothalamic nuclear progestin 
receptors following progesterone capsule insertion. 
Guinea pigs were treated as in the previous experiment except 
that only one size progesterone capsule (3.0 cm) or an empty capsule was 
implanted. Animals were killed 4, 14, 18, or 20 h after capsule 
insertion, and progestin receptor levels in the cytosol and nuclear 
fractions of the MBH-POA were measured. Because this experiment was 
conducted at a site different from the first, a group of 8 OVX guinea 
pigs were treated as described and tested hourly for lordosis. 
Progestin receptor levels were compared to the level of sexual 
responsiveness in these animals. 
By 4 h after capsule insertion, the concentration of nuclear 
progestin receptors was increased by approximately 2007. (t<io)= 8.861, 
p<0.001; Figure 2a) and the concentration of cytosol progestin receptors 
was decreased by 507. (t<to>= 8.768, p<0.001; Figure 2b) as compared to 
control levels. The level of cytosol progestin receptors remained 
Figure 2. Progestin receptor levels following 3.0 cm progesterone capsule insertion 
ft: Nuclear progestin receptor levels measured in MBH-POA 
QVX guinea pigs were treated with a Silastic capsule containing 10% estradiol 
40 h prior to receiving either a 3.0 cm progesterone capsule or an empty capsule. 
Receptor levels were measured 4, 14, 18, and 20 h after progesterone capsule 
insertion (n = 6 except at IB h, n = 3). 
B: Cytosol progestin receptor levels measured in the same animals described in A 
C: Percent of guinea pigs, treated as described in A (progesterone-treated) that 
responded during hourly tests for lordosis (n = 7) 
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decreased in the progesterone-treated group for the duration of the 
experiment, and the level of nuclear progestin receptors declined at a 
steady rate. By 20 h after capsule insertion, a time when 
similarly-treated animals were no longer receptive (Figure 2c), the 
level of nuclear progestin receptors had declined to a level near 
control values (t(io>= 1.568, p>0.10). 
To confirm that the decline in nuclear progestin receptor levels 
was not secondary to a decline in blood progesterone levels, serum 
progesterone levels were determined in the animals used for receptor 
assays. Serum progesterone levels were increased to 19.4 ng/ml by 4 h 
after insertion and remained elevated for the duration of the experiment 
(Figure 3). These results demonstrate that hypothalamic nuclear 
progestin receptor levels decline despite the continued presence of 
circulating estradiol and progesterone. 
Experiment 3 
In the previous experiment, we demonstrated that hypothalamic 
nuclear progestin receptor levels decline even in the presence of 
elevated blood progesterone levels. In order to further investigate the 
relationship between circulating progesterone levels and nuclear 
progestin receptor retention, we attempted to decrease blood 
progesterone concentrations by removing progesterone capsules 2 h 
following their insertion. QVX guinea pigs were injected with 10 yg 
estradiol benroate (EB). Forty h later, animals received a 1.0 cm 
progesterone capsule or an empty capsule. Two h after capsule 
insertion, capsules were removed from one-half of the animals and 
Figure 3. Levels of progesterone measured in serum obtained from animals treated as described 
in figure 2 
Progesterone levels measured in animals treated with empty capsules did not 
vary with time, therefore, these values were pooled, n = 3-6. 
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sham-removed from the others (animals were anesthesized and the wound 
clip was changed). Animals were killed 3, 6, 10, or IB h after capsule 
insertion (i, 4, 8, or 16 h after capsule removal), and MBH-POA 
progestin receptor levels and serum progesterone levels were measured. 
Removal of the progesterone source should result in rapid loss of 
circulating progesterone. If nuclear retention of progestin receptors 
is dependent upon circulating progesterone levels, then the loss of 
progestin receptors from cell nuclei should parallel the decline in 
blood progesterone levels. Furthermore, the loss of nuclear progestin 
receptors should occur at a faster rate in animals in which the 
progesterone capsule is removed. 
In the group continuously-exposed to progesterone cap.sules, serum 
progesterone concentrations were elevated by 3 h after capsule insertion 
(t<B>= 11.644, p<0.001; Figure 4), and remained elevated for the 
duration of the time period studied. In the group exposed to capsules 
for 2 h, serum progesterone levels gradually declined toward control 
levels following capsule removal. At 1, 4, and 8 h after capsule 
removal (3, 6, and 10 h after capsule insertion), serum progesterone 
levels were slightly elevated above control levels (t(a>= 5.463, 
p<0.001; t<a>= 6.090, p<0.001; and t<Q>= 4.059, p<0.005). By 16 h after 
capsule removal, levels had declined to control levels (t<B>= 0.615, 
p>0.50). 
By 3 h after capsule insertion, cytosol progestin receptor levels 
were decreased in both progesterone-treated groups as compared to 
control levels (t<7)= 2.867 and 2.715, p<0.05; Figure 5b). The 
concentration of cytosol progestin receptors remained at this level in 
Figure 4. Levels of progesterone measured in serum obtained from QVX guinea pigs exposed to 
progesterone capsules for 2 h or for the duration of the experiment (in situ) 
Animals were injected with 10 pg estradiol benzoate, and 40 h later, they 
received a 1.0 cm capsule containing progesterone or an empty capsule. Two h after 
capsule insertion, progesterone capsules were removed from one-half of the animals (n 
= 5). 
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Figure 5. Progestin receptor levels following progesterone capsule removal 
A: Nuclear progestin receptor levels (mean +/- S.E.H.) measured in MBH-POA of 
guinea pigs described in figure 4 
In animals treated with empty capsules, nuclear receptors were assayed only 
at 3 and 18 h and cytosol receptors only at 18 h (n = 5-12). 
B: Cytosol progestin receptors measured in same animals as in A 
C: Percent of similarly-treated guinea pigs that responded during hourly tests for 
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the group exposed to progesterone capsules for only 2 h, but continued 
to decrease in the group continuously exposed to progesterone (2 hour 
vs. in situ: t<I3>= 6.651, p<0.001 at 10 h; t<io)= 7.999, p<0.001 at 18 
h) . 
As was seen in the previous experiment, the concentration of 
nuclear progestin receptors declined even in animals exposed 
continuously to progesterone. In the group exposed to progesterone 
capsules for only 2 h, nuclear progestin receptors declined more rapidly 
at a rate parallel to the decline in circulating progesterone levels. 
At 6 and 10 h after capsule insertion, nuclear progestin receptor levels 
in animals exposed to progesterone capsules for 2 h were elevated above 
control levels, but were lower than levels measured in animals 
continuously-exposed to progesterone (t<i3)= 3.273, p<0.01 and t<2i)= 
4.312, p<0.001). By IB h, nuclear receptor levels had declined to 
control levels in both groups. 
In order to test the effect of progesterone capsule removal on 
female sexual behavior, OVX guinea pigs were treated as described above 
and tested for lordosis. Bullock <10) has reported that exposure to 
progesterone capsules for as little as 30 minutes activates sexual 
receptivity in 1007. of all guinea pigs tested. If the presence of 
sexual behavior is determined by the concentration of nuclear progestin 
receptors, then based on the results of our receptor assays, we would 
predict that fewer animals exposed to progesterone capsules for 2 h 
would have responded with sexual receptivity as compared to animals 
continuously-exposed. In addition, because the concentration of nuclear 
progestin receptors had returned to baseline fay 18 h in both groups, we 
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would predict that heat termination would have occurred in all animals 
by that time. 
Heat termination occurred at about the same time in both groups; 
however, fewer animals became sexually receptive in the group exposed to 
progesterone capsules for only 2 h (Table 2). As seen previously, a 
relationship appears to exist between nuclear progestin receptor 
concentration and the number of animals displaying lordosis (Figure 5a & 
c). At 10 h after capsule insertion, fewer animals were sexually 
receptive in the group exposed to progesterone capsules for only 2 h. 
In similarly-treated animals, nuclear progestin receptor levels were 
lower than those measured in animals continuously-exposed to 
progesterone capsules. By 18 h after capsule insertion, a time when 
hypothalamic nuclear progestin receptor levels had returned to control 
levels in similarly-treated animals, heat termination had occurred in 
all animals tested. 
Table 2. Effect of progesterone capsule removal on lordosis 
Percent Latency to Heat Heat Last Maximum Lordosis 
Group* Responding* Lordosis'* Duration'' Duration Lordosis'* Duration" 
n (h) (h) (h) (h) (sec) 
In Situ 24 637. 6.00 8.40 5.25 13.40 11.63 
+/-0.44 +/-0.88 +/-0.98 +/-0.47 +/-1.40 
2 Hour 26 42% 6.18 8.18 3.46 13.36 12.45 
+/-0.85 +/-0.88 +/-0.54 +/-1.74 
"DVX guinea pigs were injected with 10 vg estradiol benzoate. Forty hours later, a 1.0 
cm progesterone capsule was inserted for either 2 h or for the duration of the experiment (in 
situ). Hourly tests for lordosis began prior to capsule insertion and continued until heat had 
terminated. Values represent means +/- S.E.M. 
"Based on responding animals only. 
"X^ = 3.93, p < 0.05. 
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DISCUSSION • 
The purpose of these experiments was to test the hypothesis that 
heat termination results from the loss of progestin receptors from 
hypothalamic cell nuclei. From this hypothesis, it follows that 
hormonal manipulations that maintain elevated levels of nuclear 
progestin receptors should maintain the period of sexual receptivity. 
In Experiment 1, guinea pigs were treated with estradiol and various 
doses of progesterone, administered in a continuous fashion, in an 
attempt to delay heat termination. However, despite the continuous 
administration of both hormones, and regardless of the progesterone dose 
tested, heat termination occurred at about the same time in all groups. 
The dose of progesterone used did affect latency to lordosis, but the 
mechanisms by which this effect occurred is not known. 
The fact that heat termination occurred despite the continued 
administration of estradiol and progesterone introduced the possibility 
of a dissociation between elevated nuclear progestin receptor levels and 
sexual receptivity. Perhaps elevated blood levels of these hormones 
succeeded in maintaining elevated nuclear progestin receptor levels even 
though they did not prolong the duration of the period of sexual 
receptivity. Such a dissociation would negate our hypothesis and would 
indicate that some process other than the loss of nuclear progestin 
receptors is responsible for the termination of heat. The results from 
Experiment 2 demonstrate that nuclear progestin receptor levels do, in 
fact, decline in the presence of continued administration of estradiol 
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and progesterone. Nuclear progestin receptor levels declined gradually 
and approached control levels at about the same time that heat had 
terminated in similarly-treated animals. Thus, these data support the 
hypothesis that heat termination may result from the loss of 
hypothalamic nuclear progestin receptors. 
One possible explanation for our failure to find an optimal dose 
of progesterone that maintains sexual receptivity in guinea pigs for a 
prolonged period may be that a species difference in progestin receptor 
dynamics exists between hamsters and guinea pigs. As discussed earlier, 
Lisk (15) has demonstrated in hamsters that progesterone, when infused 
at an optimal rate, can activate a period of sexual receptivity of 
prolonged duration. It is possible that in hamsters progestin receptor 
processing occurs at a different rate than in guinea pigs. It is also 
possible that an optimal dose of progesterone exists in guinea pigs but 
that this dose was not included in the present study. The wide range of 
doses tested, however, makes this possibility unlikely. 
The results obtained in this study raise the question of what 
factors are responsible for the loss of nuclear-bound progestin 
receptors. Experiment 3 was designed, in part, to test what effect 
decreasing blood progesterone levels has on nuclear retention of 
progestin receptors. It was found that upon removal of the progesterone 
source, blood progesterone levels and nuclear progestin receptor levels 
decreased at parallel rates. A similar finding has been reported in 
guinea pigs following the subcutaneous injection of progesterone (6), 
and in rats following an intravenous injection of progesterone (18). 
These studies demonstrate that under certain conditions, circulating 
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levels of progesterone influence the retention of nuclear progestin 
receptors. As blood levels of progesterone decrease, less progesterone 
is available to interact with progestin receptors, resulting in a 
decreased level of nuclear progestin receptors. 
Although blood progesterone levels may be one source of 
regulation of nuclear progestin receptor retention, the results from 
Experiments 2 and 3 indicate that other factors also may be involved. 
One such factor may be the level of progestin receptors available for 
binding to progesterone (cytosol receptors). As the level of available 
progestin receptors decreases, fewer receptors are available to interact 
with progesterone. The result is a decreased level of nuclear-bound 
progestin receptors. It is possible that this is the mechanism fay which 
nuclear progestin receptors are lost in the presence of high levels of 
circulating progesterone. Following progesterone capsule insertion, 
cytosol progestin receptor levels decreased (Experiment 2) and remained 
lowered even after nuclear progestin receptors had declined to baseline. 
This is particularly interesting since these animals should have 
elevated blood estradiol levels and would be expected to have on-going 
progestin receptor induction. This raises the possibility that 
progesterone may act to inhibit progestin receptor induction by 
estradiol or that prolonged progesterone exposure increases the rate of 
receptor degradation. 
The loss of nuclear progestin receptors could also be due to 
mechanisms involved in the processing of progestin receptors. It is 
possible that there is a substance, perhaps regulated by progesterone 
action, that inactivates nuclear progestin receptors directly. It is 
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also possible that the loss of nuclear progestin receptors is a 
consequence of inactivation following the uncoupling of progesterone 
from its receptor. Because of the apparent link between nuclear 
progestin receptor retention and heat duration, studying the mechanisms 
underlying the loss of nuclear progestin receptors may yield important 
new information about the regulation of heat duration. 
In Experiment 3, progesterone capsule removal resulted in lower 
concentrations of nuclear progestin receptors as compared to 
concentrations measured in animals continuously-exposed to capsules. As 
predicted from these receptor levels, fewer animals exposed to 
progesterone capsules for only 2 h became sexually receptive. At 10 h 
after capsule insertion, only 427, of the 2 h-exposed animals were 
sexually receptive compared to 637. of the continuously-exposed animals. 
At 18 h after capsule insertion, a time when nuclear progestin receptor 
levels had returned to control levels in both groups, none of the 
animals tested displayed sexual behavior. 
These results are in partial contrast to those reported by 
Bullock (10). In.that study. Bullock reported that exposure of 
estrogen-treated guinea pigs to Silastic capsules-containing 
progesterone for 0.5 h, 2 h, or for the duration of the study, resulted 
in sexual behavior in 1007. of the animals tested. In addition, he 
reported that the mean heat duration was the same in all treatment 
groups. These data were interpreted to indicate that heat duration was 
determined by the initial exposure to progesterone (within 30 rain of 
capsule insertion). Bullock's conclusions, however, were based on the 
assumption that removal of the progesterone capsule was equivalent to 
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the removal of progesterone from the circulation. Our data indicate 
that this assumption may be false. Upon removal of the progesterone 
source, circulating progesterone levels did not plummet; instead, they 
and consequently nuclear progestin receptor levels, declined gradually 
toward baseline levels over a period of 8-16 hours. 
The results from this study support the hypothesis that heat 
termination results from the loss of hypothalamic nuclear progestin 
receptors. A tight correlation was found to exist between the 
concentration of nuclear progestin receptors and the percentage of 
animals that are sexually receptive. As the concentration of nuclear 
progestin receptors decreased, so did the number of guinea pigs 
displaying lordosis. Based on the nature of this correlation, one would 
predict that the cellular events relevant to lordosis that are induced 
by progesterone action in the cell nucleus are short-lived. In 
contrast, the correlation between elevated nuclear progestin receptors 
and sexual receptivity in rats appears to be rather loose. In OVX 
female rats treated with estradiol and progesterone, hypothalamic 
nuclear progestin receptor levels decrease to control levels .8-12 h 
before heat terminates in similarly-treated animals (Ahdieh, Brown, 
Wade, and Blaustein, unpublished observations). Therefore, one would 
predict that in rats the cellular effects of progesterone action 
relevant to lordosis are longer-lived. Research is currently underway 
in this laboratory to investigate these predictions. 
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SECTION V. ABBREVIATION OF THE PERIOD OF SEXUAL BEHAVIOR IN FEMALE 
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ABSTRACT 
In previous studies we have tested the hypothesis that the 
termination of the period of female sexual behavior results from the 
loss of progestin receptors from hypothalamic cell nuclei. We have 
shown that hormonal manipulations that delay heat termination also delay 
loss of hypothalamic nuclear progestin receptors. In order to determine 
if accelerated nuclear receptor loss results in attenuation of the 
period of sexual behavor, we tested the effect of RU 486, a progesterone 
antagonist, on heat termination. Ovariectomized guinea pigs were 
treated with 10 yg estradiol benzoate. Forty h later, animals received 
100 yg progesterone followed 4 h later by an injection of RU 486 or 
vehicle. RU 486 injected 4 h after progesterone caused heat termination 
to occur earlier than in vehicle-injected animals. We have found that 
RU 486 administration to estradiol-treated guinea pigs causes 
accumulation of progestin receptors in cell nuclear extract. Because 
this accumulation can be detected only when assay conditions are used 
that promote exchange of RU 486 progestin receptor complexes (15 °C 
incubation rather than 0 °C) , our routine assay conditions (at 0 °C) can 
be used to measure primarily receptors that are occupied by 
progesterone. In order to confirm that RU 486 decreased 
progesterone-occupied nuclear progestin receptor levels when injected 4 
h after progesterone, animals treated as in the behavioral experiment 
were killed 6 or 10 h after progesterone injection (2 or 6 h after RU 
486), and nuclear progestin receptor levels were measured. RU 486 
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treatment resulted in lowered nuclear concentrations of hypothalamic 
progestin receptors at both times. These results support our hypothesis 
that the termination of the period of sexual receptivity in female 
guinea pigs is the result of loss of progestin receptors from 
hypothalamic cell nuclei. 
1 6 4  
INTRODUCTION 
The sequential secretion of estradiol and progesterone during the 
estrous cycle of many rodent species, including guinea pigs, has been 
shown to activate a period of female sexual behavior of limited duration 
(13, 25, 50). Substantial experimental evidence exists suggesting that 
intracellular progestin receptors in mediobasal hypothalamus (MBH) 
neurons are involved in this activation. Hormonal implant studies of 
the brain have identified the MBH as the primary site for both estradiol 
and progesterone's actions on sexual receptivity (14, 31, 36, 43, 44). 
Estradiol administered to OVX rats or guinea pigs increases the 
concentration of progestin receptors in MBH cytosol (5, 30, 35, 37, 48), 
while subsequent progesterone treatment results in a transient increase 
in the concentration of these receptors in the cell nuclear fraction (6, 
33). Concurrent with this increase in nuclear progestin receptors, the 
concentration of receptors in the cytosol decreases; however, cytosol 
receptor levels are not replenished as nuclear receptor levels decrease 
(6, 10). As a result of the transient increase in nuclear binding, the 
progesterone-receptor complex is thought to influence protein synthesis, 
resulting in activation of sexual behavior (15, 39, 40). 
We have previously hypothesized that the termination of the 
period of sexual receptivity (heat) results from the loss of progestin 
receptors from hypothalamic cell nuclei (9, 10). It seems possible that 
as the concentration of progesterone-progestin receptor complexes in 
cell nuclei decreases, the cellular effects of progesterone diminish, 
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thereby resulting in the loss of sexual responsiveness. In support of 
this hypothesis, it has been shown that the increase and subsequent 
decrease in nuclear progestin receptor levels parallels the onset and 
decline of sexual receptivity (6, 10). Furthermore, hormonal 
manipulations that result in delayed heat termination also cause delayed 
loss of nuclear progestin receptors, ft supplemental injection of 
progesterone, administered to hormonal 1y-treated OVX guinea pigs, or a 
supplemental injection of estradiol have both been shown to result in 
increased heat duration and prolonged retention of elevated levels of 
hypothalamic nuclear progestin receptors (3, 9). 
In the present study, we further tested this hypothesis by 
determining if accelerated nuclear progestin receptor loss results in 
abbreviation of the period of sexual receptivity. With the development 
of the antiprogestin, RU 486, such an attempted manipulation has been 
made possible. We have previously shown that RU 486 prevents the 
initiation of sexual behavior when administered one hour prior to 
progesterone, presumably by decreasing the concentration of available 
progestin receptors in hypothalamic cytosol (8). If RU 486 treatment 
leads to decreased levels of progesterone-bound MBH nuclear progestin 
receptors, then based on our hypothesis, RU 486 should abbreviate heat 
duration when administered following progesterone injection. 
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METHODS 
Animals 
Adult Hartley strain female guinea pigs weighing 300 - 350 g were 
obtained from Charles River Breeding Laboratories (Wilmington, MA) and 
were group-housed in 51 X 56 X 23 cm metal cages. A 14 / 10 h light -
dark cycle was maintained with lights on from 0600 h to 2000 h. Food 
(Purina guinea pig chow) and water were freely available. Two to four 
weeks after arrival, animals were bilaterally ovariectomized under 
conditions reported previously (8). A 2 - 3 week recovery period was 
allowed before animals were used in this study. 
Hormones 
173-Estradiol benzoate (EB) was dissolved in sesame oil; 
progesterone, hydrocortisone (Cortisol), and RU 486 (176-hydroxy-
110-(4-dimethyiaminophenyl)-17a-(1-propyl)-estra-4,9 
diene-3-one, Roussel-Uclaf, Romainville, France) were dissolved in 
sesame oil containing 157. benzyl benzoate and 5% benzyl alcohol. 
Injection volumes were 0.1 ml for EB, progesterone, and Cortisol, and 
0.4 ml for RU 486. All injections were administered subcutaneously in 
the axillary region. In all experiments, EB injection occurred at 1700 
h. 
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Behavioral Testing 
Animals were tested hourly for lordosis by manually stimulating 
the flanks and perineal area and measuring the length of time the 
lordosis posture was held (51). All tests were conducted with the 
experimenter blind to the assigned treatment group. An animal was 
considered sexually responsive if the lordosis posture was held for at 
least 1 sec during two consecutive tests. Testing continued until all 
animals were unresponsive, or for a minimum of 14 h. The period of 
sexual receptivity was considered terminated when lordosis could not be 
elicited during two consecutive tests. Latency to lordosis, maximum 
lordosis duration, heat duration, and time of last lordosis were 
calculated as described previously (9, 16). 
Combined Cytosol and Nuclear Progestin Receptor Assay 
Guinea pigs were decapitated and their brains rapidly removed. 
The mediobasal hypothalamus (MBH) or the mediobasal hypothalamus-
preoptic area (MBH-POA) was dissected on a chilled block as described 
previously (3). 
Cytosol and nuclear progestin receptor levels were measured as 
described previously with minor modifications (3, 4, 6). All procedures 
were conducted at 0-4 °C unless otherwise noted. Tissues were placed in 
glass tissue grinding vessels containing 1.0 ml buffer A (0.32 M 
sucrose, 1 mM KHgPO*, 1 mM MgCla, 10% glycerol, 12 mM monothioglycerol, 
pH 7.2), and were homogenized with a Teflon pestle with appropriate 
clearance for cell nuclear isolation (32). Homogenates were transferred 
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to 12 X 75 mm polycarbonate tubes and the grinding vessels were rinsed 
with 0.5 ml ft. The homogenates were centrifuged at 1000 X g for 5 min. 
Cytosol extract was obtained by centrifuging the resulting supernatant 
at 48,000 X g for 30 min. The pellet from the first centrifugation was 
washed twice by adding 2 ml buffer A and centrifuging at 1000 X g for 5 
min. The crude nuclear pellet was then purified by dispersing in 0.3 ml 
buffer A and 1.0 ml buffer B (2.15 M sucrose, 1 mli KHzPO*, 1 m M MgClz, 
10% glycerol, pH 7.2), and centrifuging at 25,000 X g for 20 min. The 
pellicle and supernatant were removed and the walls of the tube were 
dried. 
For the cytosol assay, 300 yl samples of cytosol extract were 
applied to 4.5 X 68 mm columns of Sephadex LH-20 (Pharmacia Fine 
Chemicals, Piscataway, NJ) to remove residual, potentially competing 
steroids (4). Immediately after running into the columns, samples were 
washed in with 100 yl buffer A and the macromolecular fraction was 
eluted with 700 yl A. Aliquots of 250 yl filtered cytosol were 
incubated with 50 yl buffer A containing 1% ethanol (final 
concentration) and (17a-methyl-=H)R 5020 (New England Nuclear, Boston, 
MA; spec. act. = 87 Ci/mmol) +/- 250-fold concentration of unlabeled 
progesterone. A final concentation (in 300 yl) of 0.4 nM (®H)R 5020 was 
used because this concentration results in binding almost exclusively to 
the progestin receptor with almost no specific binding to blood 
contaminants or low affinity binders (5). 
Following an overnight incubation at 0-4 "C, bound ('H)R 5020 was 
separated from free by gel filtration on Sephadex LH-20 columns. 
Samples of incubate (250 yl) were applied to the column and washed in 
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with 150 yl of buffer A. Thirty min after applying the sample, the 
macromolecular fraction was eluted into scintillation vials with 700 yl 
of A. Five ml of scintillation counting fluid (0.17 g Bis MSB + 5.5 g 
PPO / liter scintillation grade toluene (Fisher Scientific) containing 
337. Fisher's surfactant) were added and radioactivity was counted on a 
Packard Tri-Carb Model 300C spectrophotometer at an efficiency of 407.. 
Specific binding was calculated by subtracting nonspecific binding (with 
unlabeled progesterone) from total binding (without unlabeled 
progesterone). Protein concentration was determined by the dye-binding 
method of Bradford (7), using BSA as the standard. Results are 
expressed as femtomoles (®H)R 5020 specifically bound per mg cytosol 
protein. 
For the nuclear receptor assay, the purified nuclear pellet was 
dispersed with 285 yl buffer TEST (10 mM Tris-HCl, 1,5 mM NagEDTA, 10% 
glycerol, 12 mM monothioglycerol, pH 7.4). After 15 min, an equal 
volume of buffer TEGT-Ki.o (TEST + 1 M KCl, pH 7.4) was added. The tube 
contents were vortex-mixed and incubated for 15 min. The nuclei were 
then centrifuged at 48,000 X g for 5 min. Samples (250 yl) of the 
supernatant (nuclear extract) were incubated with 50 yl buffer 
TEGT-Ko.3 (TEST + 0.5 M KCl, pH 7.4) containing 1% ethanol (final 
concentration) and (='H)R 5020 +/- 250-fold concentration of unlabeled 
progesterone. A final concentration of 3.0 nM (®H)R 5020 was used (6). 
Following an overnight incubation at 0-4 °C, bound (=H)R 5020 was 
separated from free as described above, except that buffer TEGT-Ko.s was 
used. The DNA content of the nuclear pellet was determined by the 
method of Burton (11) with calf thymus DNA used as the standard. 
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Results are expressed as femtomoles ('H)R 5020 specifically bound per mg 
DNft. 
Cytosol Exchange Assay 
To assay progestin receptors in MBH-POA cytosol, tissues were 
homogenized in 3 ml TEST (1 MBH-POA / ml) with a Polytron tissue grinder 
(Brinkmann Instruments, Westbury, NY). Following centrifugation at 
48,000 X g, the supernatant (cytosol extract) was filtered through 
Sephadex LH-20 columns as described above to remove any residual steroid 
hormone. The filtered cytosol was pooled for each treatment group and 
750 yl aliquots were incubated with 150 yl TEST containing 0.4 nM ('H)R 
5020 +/- 0.1 vH unlabeled progesterone (in a total volume of 900 pi) at 
0 or 15 °C. After a 2, 4, or 8 h incubation, a 250 ul sample of 
incubate was applied to Sephadex LH-20 columns to separate bound (=H)R 
5020 from free as described above. 
Statististical Analysis 
Differences in the percentage of animals responding to various 
hormone treatments were analyzed by Fisher's Exact Probability Test. 
Other differences, both in behavioral parameters and in receptor 
concentrations, were analyzed by Student's t-test. Levels of 
significance given are based on two-tailed comparisons unless otherwise 
stated. 
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RESULTS 
Experiment 1 
In addition to its antiprogestin properties, RU 486 has been 
shown to be a potent glucocorticoid antagonist (2, 12, 26, 34, 38). We 
demonstrated in earlier work that the inhibitory effect of RU 486 on 
sexual receptivity could be overcome with a large dose of progesterone, 
indicating that the inhibition was not the result of debilitation caused 
by impaired glucocorticoid activity (8). However, because progesterone 
in high doses can act as a partial glucocorticoid agonist (41,45), it 
remained possible that the high dose of progesterone used to overcome 
the inhibition was acting to restore impaired glucocorticoid actvitity, 
thereby allowing the animals to become sexually receptive. Therefore, 
in this experiment the ability of Cortisol to overcome RU 486-induced 
inhibition of sexual behavior was tested. If RU 486 inhibited sexual 
receptivity in cortisol-treated animals, then it would serve as further 
evidence that RU 486 was not influencing sexual behavior through its 
actions on the glucocorticoid system. 
Forty h after receiving 10 wg EB, OVX guinea pigs were divided 
into  f o u r  g r o u p s  a n d  a d m i n i s t e r e d  t h e  f o l l o w i n g  t r e a t m e n t s :  g r o u p  1 = 5  
mg RU 486 and 100 ug progesterone; group 2 = oil vehicle and 100 yg 
p r o g e s t e r o n e ;  g r o u p  3  =  5  m g  R U  4 8 6  a n d  5  m g  p r o g e s t e r o n e ;  g r o u p  4 = 5  
mg RU 486, 100 yg progesterone, and 5 mg Cortisol. Beginning just prior 
to progesterone injection, all animals were tested hourly for the 
presence of lordosis. 
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Confirming our earlier work, RU 486 inhibited the display of 
female sexual behavior (207. vs. 1007., 2=0.048; Table 1). This 
inhibition was overcome by the administration of a larger dose of 
progesterone (100% vs. 20%, g=0. 048) but not of Cortisol (0% vs. 207.). 
These results, therefore, support our earlier conclusions that RU 
486-induced inhibition of sexual receptivity is the result of actions 
upon the progestin system rather than of actions on the glucocorticoid 
system. 
Experiment 2 
Previously, we reported that the concentration of hypothalamic 
cytosol progestin receptors decreased following administration of RU 486 
to estrogen-pretreated OVX guinea pigs (8). Interestingly, no 
concurrent increase in nuclear progestin receptor levels was noted. One 
possibility for this is that RU 486-bound receptors may be present in 
the cytosol extract, but under our current assay conditions (at 0 °C) RU 
486 does not exchange with the radiolabeled ligand, (3H)R 5020, and 
therefore, the receptors are not detected. It is also possible that RU 
486-bound progestin receptors may be present in the KCl-nuclear extract 
but are not detected for the same reason. Alternatively, it is possible 
that by binding RU 486, progestin receptors may be rapidly degraded or 
lose their ability to bind ligand. 
In order to determine if RU 486-bound receptors are present in 
the cytosol fraction, MBH-POA progestin receptors were assayed at a 
slightly elevated incubation temperature of 15 °C. Incubation at 
elevated temperatures has been shown to facilitate nuclear estrogen 
Table 1. Failure of Cortisol to overcome RU 486-induced inhibition of lordosis 
Treatment" 
n 
Percent 
Respond!ng 
Latency to 
Lordosis" 
(h) 
Heat 
Duration* 
(h) 
Heat 
Duration 
(h) 
Last 
Lordosis* 
(h) 
Maximum Lordosis 
Duration* 
(sec) 
Veh + Po.i 5 100% 4.60 
+/-1.03 
7.40 
+/-1.63 
7.40 
+/-1.63 
11.00 
+/-1.18 
9.60 
+/-2.60 
RUa + Po.1 5 20% 4.00 10.00 2.00 
+/-2.00 
13.00 9.00 
RUa + Po 5 100% 5.4.0 
+/-0.75 
8.80 
+/-0.58 
8.80 
+/-0.58 
13.20 
+/-0.37 
11.20 
+/-2.18 
RUa + Po. 1 
+ Corts 
5 0% 
•"OVX guinea p i g s  were treated w i t h  10 pg EB. Forty h l a t e r ,  a n i m a l s  were d i v i d e d  i n t o  4 
groups, and were administered one of t h e  4 treatments l i s t e d .  Values g i v e n  r e p r e s e n t  group 
means +/- S.E.M. (Veh = vehicle, P = progesterone, RU = RU 486, Cort = Cortisol; subscripts are 
doses in mg). 
^Based on responding animals only. 
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receptor ligand exchange (42), and we have found that incubation of 
hypothalamic cytosol at up to 15 °C for 8 h does not result in loss of 
progestin binding (see Appendix A). Six OVX guinea pigs were treated 
with 10 ug EB forty h before receiving an injection of 5 mg RU 486 or 
oil vehicle. Three hours later, animals were killed and cytosol 
progestin receptors were measured. As described in Methods, cytosol was 
incubated with ('H)R 5020 at both 0 °C and 15 °C for 2, 4, or 8 h. If 
RU 486-bound progestin receptors are present in the cytosol, and RU 486 
exchanges with (=H)R 5020 at elevated temperatures, then the level of 
receptors measured in MBH-POA from RU 486-treated animals at 15 °C 
should approach the level measured in vehicle-injected animals. 
In a separate experiment, the possibility that RU 486-bound 
progestin receptors are present in 0.5 M KCl-nuclear extract was 
investigated. Twelve OVX guinea pigs were treated with 5 mg RU 486 or 
the oil vehicle 40 h after receiving 10 pg EB. Three h after RU 486 
injection, animals were killed and MBH-POA, KCl-nuclear extracts were 
obtained. Aliquots of extract were incubated with ('H)R 5020 at 0 or 15 
°C for 8 hours. We have found that incubation of nuclear extract at up 
to 15 "C for 8 h does not result in loss of progestin binding (see 
Appendix B). If RU 486-bound progestin receptors are present in the 
nuclear extract, and RU 486 exchanges with (=H)R 5020 at 15 °C, then the 
level of nuclear progestin receptors measured at 15 "C should be greater 
in RU 486-injected animals than in vehicle-injected animals. 
Confirming our previous study, RU 486 injection decreased cytosol 
progestin receptor levels by about 50%. While incubation of cytosol at 
15 °C resulted in slightly greater measured progestin receptor levels in 
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both groups, the percent decrease in receptor concentration caused by RU 
486 was not altered by the elevated incubation temperature (Figure 1). 
In contrast, incubation of MBH-POA nuclear extract from RU 486-injected 
animals at 15 °C revealed a 100% increase in progestin receptor 
concentration over levels measured in vehicle-injected animals 
(t<io>=4.68, B<0.001; Figure 2). These data suggest that RU 486-bound 
progestin receptors are located primarily in the nuclear extract and not 
in the cytosol. 
Experiment 3 
In order to determine if RU 486 treatment decreases 
progesterone-occupied nuclear progestin receptor concentrations when 
injected 4 h after progesterone, MBH progestin receptor levels were 
measured in OVX guinea pigs treated with 100 jjg progesterone 40 h after 
receiving 10 fjg EB. Four h after progesterone injection, animals 
received 5 mg RU 486 or the oil vehicle. Animals were killed 2 or 6 h 
later (6 or 10 h after progesterone injection), and progestin receptor 
concentrations were measured in MBH cytosol and KCl-nuclear extract. A 
third group of estradiol treated animals which received only vehicle 
injections was included as a control group. Because we found in 
Experiment 2 that only a very slight amount of RU 486-bound nuclear 
progestin receptors was detected with our routine assay procedure (at 0 
°C), the level of nuclear progestin receptors measured in RU 486 treated 
animals in this experiment represents primarily receptors that were 
occupied by progesterone. 
Progesterone treatment resulted in decreased cytosol progestin 
receptor concentrations and increased nuclear receptor concentrations at 
Figure 1- Failure to detect RU 486-bound progestin receptors in MBH-POA cytosol 
QVX guinea pigs were treated with 5 mg RU 486 or oil vehicle 40 h after 
receiving 10 yg EB. Two h later, animals were killed and MBH-POA cytosol was 
obtained and pooled from similarly-treated animals. Aliquots of cytosol were 
incubated with (=H)R 5020 +/- unlabeled progesterone at 0 "C or 15 =C for 2, 4, or B 
h. Results are expressed as a percent ratio of ('H)R 5020 specifically bound / (®H)R 
5020 specifically bound in cytosol incubated at 15 °C (for 8 h) from vehicle-injected 
animals. 
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Figure 2. RU 486 causes the accumulation of progestin receptors in 
MBH-POA cell nuclear fraction 
OVX guinea pigs were treated with 5 mg RU 486 or oil 
vehicle 40 h after receiving 10 ug EB. Nuclear extract was 
obtained and aliquots were incubated with (=H)R 5020 +/-
unlabeled progesterone at 0 =C or 15 °C for 8 h. Results are 
expressed as a percent ratio of ('H)R 5020 specifically bound 
/ (=H)R 5020 specifically bound in nuclear extract incubated 
at 15 =C (for 8 h) from vehicle-injected animals (n = 6 per 
group). 
1 7 9  
VEHICLE RU 486 VEHICLE RU 486 
CC O'C I5*C 15 "C 
1 8 0  
both 6 and 10 h after progesterone injection (Figure 3; cytosol: 
t(2o»=2.67, g<0.02 at 6 h, and t<i7>=4.10, b<0.001 at 10 h; nuclear: 
t(20)=3.77, B<0.01 at 6 h and t<2s>=5.57, g<0.001 at 10 h). Cytosol 
progestin receptor concentration was further decreased by 2 h after RU 
486 injection (6 h after progesterone; t<2i>=4.63, e1<0.001), and was 
still decreased 4 h later (t(i7)=3.16, B<0.01). RU 466 decreased the 
level of progesterone-occupied nuclear progestin receptors as measured 
at both 6 (t<2o>=2.10, g<0.05) and 10 h (t (2*) =1.75, g,<0.05, I-tailed 
comparison) after progesterone injection. 
Experiment 4 
In order to determine if the observed decrease in nuclear 
progestin receptors was due to a decrease in receptor concentration or 
to a decrease in binding affinity of receptors for (=H)R 5020, MBH 
nuclear extract obtained from animals treated as in experiment 3 were 
assayed with a range of (=H)R 5020 concentrations, and the results were 
analyzed by the method of Scatchard (46). Twenty-two OVX guinea pigs 
were treated with 100 yg progesterone 40 h after receiving 10 yg EB. 
Four h later, animals received either 5 mg RU 486 or the oil vehicle. 
Two h later (6 h after progesterone injection), animals were killed and 
MBH nuclear extract was obtained as described. Extracts were pooled for 
each group and 250 yl aliquots were incubated with a range of ('H)R 5020 
concentrations (0.04 - 11 nil) in the presence or absence of a 250-fold 
excess of unlabeled progesterone. Following an overnight incubation, 
bound ('H)R 5020 was separated from free as described. 
The binding isotherms obtained were analyzed with the Lundon-1 
Figure 3. Effect of RU 486, administered 4 hours after progesterone, on 
progestin receptor levels 
A: Progestin receptor levels measured in MBH nuclear 
fraction 
OVX guinea pigs were treated with 100 pg progesterone 
or oil vehicle 40 h after receiving 10 yg EB. Four h later, 
animals received 5 mg RU 486 or oil vehicle. Animals were 
killed 6 or 10 h after progesterone injection, and progestin 
receptor levels were determined in the cytosol and nuclear 
fractions of the MBH. Values given represent mean +/- S.E.M. 
with levels measured in vehicle-injected animals (63.0 fmoles 
/ mg DNA at 6 h, and 35.0 fmol es / mg DNA at 10 h) 
subtracted, n = 11 to 14 per group. 
B: Progestin receptor levels measured in MBH cytosol 
Values given represent fmoles (^HiR 5020 specifically 
bound / mg cytosol protein (mean +/- S.E.M.). n = 9 to 11 
per group. 
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program for ligand binding analysis (Lundon Software, Cleveland, OH). 
When analyzed using the Lundon one site model (29), which was the model 
that best fit the data, RU 486 treatment caused a 23% decrease in the 
concentration of nuclear KCl-extractable progestin binding sites and had 
little effect on binding affinity (Figure 4). 
Experiment 5 
To further test our hypothesis that heat termination results from 
loss of hypothalamic nuclear progestin receptors, the effect of RU 486 
on heat termination was tested. Our hypothesis predicts that RU 486 
administered after progesterone should, by decreasing nuclear progestin 
receptor levels, cause heat abbreviation. OVX guinea pigs were treated 
with 10 yg EB. Forty h later, animals received 100 pg progesterone 
followed 4 h later by an injection of 5 mg RU 486 or oil vehicle. A 
third group which was treated with RU 486 at- the time of progesterone 
treatment, was included for comparison. 
As expected, RU 486 treatment at the time of progesterone 
inhibited the activation of sexual receptivity (317. vs. 927., as compared 
to vehicle-injected controls, g=0.005; Table 2). -RU 486 treatment at 4 
h did not affect the latency to lordosis, but, as predicted, caused heat 
termination to occur at an earlier time than in vehicle-injected animals 
(t(i8)= 2.27, b<0,05). By 13 h after progesterone injection, heat had 
terminated in animals treated with RU 486 at 4 h, whereas in 
vehicle-treated animals heat termination occurred by 16 h (Figure 5). 
No effect of RU 486 on maximum lordosis duration of the responding 
animals was noted. 
Figure 4. Scatchard representation of (=H)R 5020 binding to HBH nuclear extract 
OVX guinea pigs were treated with 100 yg progesterone 40 h after receiving 
10 yg EE. Four h later, animals received 5 mg RU 486 or oil vehicle, and were killed 
2 h later (6 h after progesterone injection). Aliquots of HBH nuclear extract 
obtained were incubated with a range of (®H)R 5020 (0.04 - 11 nH) +/- unlabeled 
progesterone. Following an overnight incubation, bound (^H)R 5020 was separated from 
free 
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Table 2. RU 486 abbreviates the period of sexual receptivity 
Percent Latency to Heat Heat Last Maximum Lordosis 
Treatment" Responding Lordosis'* Duration'' Duration Lordosis'" Duration" 
n (h) (h) (h) (h) (sec) 
Veh 12 927. 4.91 
4/-0.41 
7.55 
+/-0.96 
6.92 
+/ -1 .08  
11.36 
+/-0.72 
11.64 
+ / - 1 . 6 8  
RU - Oh 13 31% 5.25 
+/-1.38 
5.00 
+/-0.71 
1.54 
+/-0.69 
9.25 
+/-1.11 
9.25 
+/-2.29 
RU - 4h 13 697. 4.67 
+/-0.41 
5.22 
+ / -1 .06  
3.62 
+ / - 1 . 0 0  
8.89 
+/-0.82 
12.33 
+/-2.07 
*OVX guinea pigs were treated with 100 pg progesterone 40 h after receiving 10 pg EB. 
Animals were divided into 3 groups and administered one of the three treatments listed 
at the time of progesterone injection or 4 h later (Veh = vehicle, RU = RU 486). 
•"Based on responding animals only. 
Figure 5. Percent of animals exhibiting lordosis during hourly tests 
for lordosis 
OVX guinea pigs were treated with 100 yg progesterone 
40 h after receiving 10 yg EB, and were divided into three 
groups. Two groups received 5 mg RU 486 administered at the 
time of progesterone, or 4 h later. The third group received 
the oil vehicle 4 h after progesterone injection. All 
animals were tested hourly for lordosis beginning just prior 
to progesterone injection. 
1 8 8  
/ 
n 
li 
/ 
' A  
--VEHICLE 
I— RU 486 at 0 h 
RU 486 at 4 h 
L.. 
12 16 
TIME AFTER PROGESTERONE (hours) 
1 8 9  
DISCUSSION 
RU 486 has been shown to act as a potent antiprogestin and 
antiglucocorticoid both in vivo and in vitro (1, 2, 8, 12, 17, 19-22, 
26, 34, 38, 47). These actions are thought to be the result of a direct 
interaction of the synthetic steroid with the intracellular progestin or 
glucocorticoid receptor (1, 8, 17, 22, 26, 34, 38). Previously, we 
reported that RU 486 prevented the onset of progesterone-facilitated 
female sexual behavior in OVX hormonally-treated guinea pigs. This 
inhibition could be overcome by the administration of a larger dose of 
progesterone, suggesting that the inhibition was the result of the 
antiprogestin action of RU 486 rather than of a debilitating effect 
caused by impaired glucocorticoid action (8). However, because 
progesterone, under certain conditions, has been shown to act as a 
suboptimal glucocorticoid agonist (41, 45), the possibility still 
remained that the large dose of progesterone used was acting to restore 
impaired glucocorticoid activity, thereby allowing animals to exhibit 
lordosis. In the first experiment of this study,we found that an 
injection of Cortisol at the time of RU 486 injection could not prevent 
RU 486-induced inhibition of progesterone-facilitated sexual 
receptivity. Therefore, it is highly unlikely that the large dose of 
progesterone overcame the inhibition by acting to restore glucocorticoid 
activity. Thus, this experiment confirms the interpretation that RU 486 
inhibits sexual behavior through its actions on the progestin system. 
In previous studies, we have provided evidence to support the 
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hypothesis that heat termination results from the loss of progestin 
receptors from hypothalamic cell nuclei. We have shown that hormone 
treatments that result in delayed heat termination also result in a 
delayed loss of hypothalamic nuclear progestin receptors (3, 9). In 
addition, we recently reported that, in the presence of continued 
administration of both estradiol and progesterone, sexual receptivity 
decreased parallel to a decrease in hypothalamic nuclear progestin 
receptor levels (10). In the present study, we provided further support 
for this hypothesis by demonstrating that a treatment that accelerated 
the loss of MBH nuclear progestin receptors also accelerated heat 
termination. 
Administration of RU 486 four hours after progesterone injection 
decreased progestin binding in MBH-nuclear extract within 2 hours. This 
decrease in binding was a result of a decrease in the concentration of 
progesterone-bound receptors rather than a decrease in receptor affinity 
as demonstrated by Scatchard analysis. It is not known why the 
concentration of progestin receptor levels measured by Scatchard 
analysis in this assay were higher than those we normally measure. 
However, the relative decrease in nuclear progestin receptor 
concentration caused by RU 486 was the same as what was found with the 
one-point assay (23 - 28%). This decrease represents approximately 
one-half of the progesterone-dependent nuclear progestin receptor 
concentration. 
In similarly-treated animals, RU 486 administered four hours 
after progesterone injection abbreviated the period of sexual 
receptivity. Two hours after RU 486 injection, the percentage of 
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sexually receptive animals began to decline. By 9 hours after RU 486 
injection (13 hours after progesterone injection), heat had terminated 
in all animals treated with RU 486, whereas heat termination in 
vehicle-injected animals did not occur until 2 to 3 hours later. This 
suggests that accelerated loss of hypothalamic nuclear progestin 
receptors results in accelerated heat termination. 
In addition to decreasing the concentration of progesterone-bound 
nuclear progestin receptor levels, RU 486 injection also further 
decreased the level of cytosol progestin receptors. It is not known if 
the decrease in nuclear receptor concentration occurred secondarily to 
this decrease in cytosol concentration, or if RU 486 acted directly to 
displace progesterone from the nuclear-bound receptor. Surprisingly, 
nuclear progestin receptor levels did not appear to decrease further 
between 2 and 6 hours after RU 486 injection. It is possible that if 
receptor levels were measured at a later time point, a further decrease 
would have been observed. Nevertheless, it seems that nuclear progestin 
receptor levels were decreased to a level below that required to 
continue induction of progesterone's lordosis-relevant cellular events. 
The finding that RU 486 administered to OVX estradiol-pretreated 
animals results in accumulation of nuclear progestin receptors suggests 
that RU 486 binds to progestin receptors in vivo, and is capable of 
allowing them to be transformed, a process thought to be necessary for 
nuclear binding (18). A similar finding has been reported after RU 486 
treatment in human endometrial cells (17). Similarly, Jung and Baulieu 
(26) have reported that exposure of cultured mouse fibroblast cells to 
RU 486 resulted in nuclear accumulation of glucocorticoid receptors; 
1 9 2  
however, Moguilewsky and Philibert (34) have reported that 
glucocorticoid receptors bound to RU 486 are not transformed in vitro. 
The characteristics of the RU 486-accumulatBd nuclear progestin 
receptor complex that determine why RU 486 acts as an antagonist on 
progesterone-facilitated sexual behavior are not yet known. We have 
found no difference between the salt extractability of RU 
486-accumulated nuclear progestin receptors and progesterone-accumulated 
progestin receptors (see Appendix C), suggesting that both types of 
receptor-ligand complexes interact with nuclear binding components with 
similar affinities (27). However, it is possible that RU 436-progestin 
receptor complexes interact with different nuclear binding components or 
at different sites, or that they do not undergo receptor processing, 
proposed as a necessary step for nuclear estrogen receptor action (23, 
24). 
In a recent study by Gravanis et al. (17) it was found that RU 
486 acted as a partial progestin agonist with regard to progesterone's 
effects on estradiol-dehydrogenase activity, DMA polymerase activity, 
and secretory cell transformation in the postmenopausal human uterus. 
In the presence of progesterone, however, RU 486 acted to inhibit 
progesterone's effect. In addition, Horwitz (22) has reported that in 
T47D cells, RU 486 acts as a progestin agonist to inhibit cell 
proliferation. These findings raise the possibility that RU 486 may act 
as a progestin antagonist by acting as a suboptimal progestin receptor 
agonist. However, because RU 486 administered in combination with 
progesterone resulted in no progestin activity attributable to either 
steroid in the human uterus (17), it is unlikely that all of RU 486's 
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inhibitory effects can be ascribed to its acting as a suboptimal 
agonist. In addition, RU 486 has been shown to act as a pure progestin 
antagonist in the rat and rabbit uterus (38). Further study of any 
possible agonistic actions of RU 486, and of the characteristics of RU 
486-bound progestin receptors is required to determine the mechanism of 
RU 486 inhibition of progesterone action. 
It should be noted that recent studies suggest that steroid 
hormone receptors, both occupied and unoccupied, reside primarily in the 
cell nucleus (23, 49). According to the proposed model of steroid 
hormone action resulting from these studies, steroid hormone receptors 
are in loose association with nuclear components in the absence of bound 
ligand. Upon binding steroid hormone, the receptor complex becomes 
tightly associated with specific nuclear components. Receptors measured 
in the cytosol fraction by routine techniques such as those used in the 
present study, therefore, may represent loosely associated, unoccupied 
receptors released from cell nuclei during tissue homogenization, 
whereas receptors in the nuclear fraction may represent tightly 
associated, occupied receptors. In any event, our results indicate that 
RU 486 administration caused a reduction in the concentration of 
hypothalamic nuclear-bound, progesterone-occupied progestin receptors. 
In summary, as predicted based on our hypothesis that heat 
termination results from the loss of progestin receptors from 
hypothalamic cell nuclei, injection of RU 486 four h after progesterone 
administration resulted in abbreviation of heat duration. These data 
support our hypothesis that heat termination results from the loss of 
progestin receptors from hypothalamic cell nuclei. Maintenance of 
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progesterone action on sexual receptivity may require elevation of 
nuclear progestin receptor levels. However, as receptor levels decline, 
progesterone action diminishes, resulting in the decline of sexual 
behavior and termination of the receptive period. 
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DISCUSSION AND SUMMARY 
Three major hypotheses were tested and are supported by the 
experiments presented in this dissertation. These are: 
1) Intracellular hypothalamic progestin receptors are involved 
in the facilitation of sexual receptivity by progesterone; 
2) Estradiol induction of intracellular progestin receptors may 
be necessary for the activation of sexual behavior by progesterone; and 
3) The mechanism responsible for heat termination may include 
the loss of progestin receptors from hypothalamic cell nuclei. 
Although all of the studies included in this dissertation provide 
support for the involvement of intracellular progestin receptors in the 
facilitation of sexual receptivity, the best evidence is provided by 
experiments in the first and fifth studies, in which the antiprogestin, 
RU 486, was used. RU 486 administered one hour before, or at the same 
time as progesterone, inhibited the facilitation of sexual receptivity 
by progesterone. This inhibition could be overcome by administration of 
a higher dose of progesterone, but not Cortisol, indicating that the 
inhibition was the result of RU 486 acting on the progestin-sensitive 
system and not on the glucocorticoid-sensitive system. RU 486 was shown 
to compete for progestin binding sites in vitro, and to decrease the 
availability of hypothalamic cytosol progestin receptors in vivo. In 
addition, RU 486 decreased the concentration of nuclear progestin 
receptors when injected four hours after progesterone. These findings 
strongly suggest that RU 486 inhibits progesterone facilitation of 
sexual behavior by blocking the interaction of progesterone with its 
intracellular receptor. 
These data, however, do not exclude the possibility that 
progesterone's effects on sexual behavior are mediated by membrane-bound 
receptors. It is possible that RU 486 interacts with membrane-bound 
progestin receptors to prevent progesterone action. Investigation of 
the binding characteristics of the membrane-bound progestin receptors, 
described by Towle and Sze (169), should help in determining if RU 486 
could be acting in this manner. Nevertheless, the data presented in 
this dissertation provide strong evidence to support further the 
hypothesis that intracellular progestin receptors are involved in the 
activation of progesterone-facilitated sexual behavior. 
The hypothesis that estradiol induction of intracellular 
progestin receptors may be necessary for the activation of sexual 
behavior by progesterone is supported by experiments presented in the 
second study. Etgen (56) had previously reported that the 
polychlorinated pesticide, o,g'-DDT, could substitute for estradiol in 
priming OVX female rats to respond to subsequently administered 
progesterone. However, g,B'-DDT did not appear to increase the 
concentration of hypothalamic intracellular progestin receptors. These 
results were interpreted as evidence that intracellular progestin 
receptor induction during the estrogen priming period is not essential 
for the facilitation of sexual receptivity by progesterone. Therefore, 
it was concluded that a sufficient concentration of estrogen-independent 
progestin receptors is available to mediate progesterone's effects on 
sexual behavior. 
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In contrast to the above study ( 5 6 ) ,  it was found in the second 
study of this dissertation that, under experimental conditions similar 
to those of Etgen (56), o,b'-DDT treatment increased the concentration 
of hypothalamic intracellular progestin receptors. Although the dose 
used in this study was higher than that used by Etgen, it was found to 
be a threshold dose for behavioral responsiveness in the animals used in 
this study. The most likely reason for the discrepency between the 
results obtained in these two studies is that in the present study, 
hypothalamic cytosol was filtered prior to assaying progestin receptors 
in order to remove any residual g,g'-DDT. g,Q'-DDT was shown to compete 
for cytosol progestin binding sites in vitro; therefore, failure to 
remove residual amounts of o,g'-DDT in the cytosol prior to assaying 
progestin receptors may have resulted in Etgen's failure to detect an 
increase in receptor concentration. The results presented in this 
dissertation suggest that the estrogen priming action of d , b ' " D D T  
includes the induction of hypothalamic intracellular progestin 
receptors. Therefore, these results are consistent with, and provide 
further support for, the hypothesis that induction of intracellular 
progestin receptors by estrogen action is a prerequisite for 
progesterone facilitation of sexual receptivity to occur. 
In addition to mediating the onset of the period of sexual 
receptivity, progesterone interaction with intracellular progestin 
receptors may also lead to the termination of the receptive period. We 
have hypothesized that the mechanism responsible for heat termination 
may involve the loss of progestin receptors from hypothalamic cell 
nuclei (58), This hypothesis was originally based on the observation 
that a temporal correlation exists between the transient elevation of 
hypothalamic nuclear progestin receptor levels and the expression of 
sexual receptivity. Nuclear progestin receptor levels have been shown 
to increase prior to the onset of sexual receptivity and to decrease to 
baseline levels as the period of receptivity terminates (20). It seems 
possible that as nuclear progestin receptor levels decrease, the 
cellular effects of progesterone action diminish, resulting in the loss 
of receptivity. This hypothesis has been tested by investigating how 
various hormonal treatments affect both heat duration and the retention 
of progestin receptors in hypothalamic cell nuclei. Based on this 
hypothesis, hormonal manipulations that delay heat termination should 
also delay the decline in nuclear progestin receptor levels. Blaustein 
(13) has shown that administration of supplemental estradiol, at the 
time of progesterone administration to estradiol-pretreated OVX guinea 
pigs, delayed the loss of progestin receptors from hypothalamic cell 
nuclei. This treatment also resulted in delayed heat termination (13, 
38, 82), indicating that estradiol may increase heat duration by 
increasing the concentration of intracellular progestin receptors, 
thereby delaying the loss of nuclear progestin receptors. 
The studies on heat termination included in this dissertation 
were conducted to determine the effect of progesterone on heat 
termination and on the retention of nuclear progestin receptor levels. 
Several studies have indicated that progesterone can influence heat 
duration. Morin and Feder (115), have reported that injections of 
progesterone administered every three hours to estradiol-pretreated OVX 
guinea pigs increased heat duration by more than 2 hours. Similarly, 
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Hansen and Sodersten (74) found that heat duration in the rat is 
dependent upon the dose of progesterone as well as the dose of 
estradiol. In addition, Lisk (93) has shown that the dose of 
progesterone regulates heat duration in female hamsters. In the third 
study of this dissertation, evidence was provided demonstrating that a 
supplemental injection of progesterone, administered 8 hours after an 
initial progesterone injection, delayed heat termination by more than 
two hours. This treatment was also shown to result in a delayed loss of 
hypothalamic nuclear progestin receptors in similarly-treated animals. 
In a further test of the hypothesis that heat termination results 
from the loss of progestin receptors from hypothalamic cell nuclei, an 
attempt was made to find an optimum dose of progesterone that would 
result in greatly prolonged heat durations. In experiments described in 
the fourth study, estradiol and various doses of progesterone were 
administered in a continuous fashion to OVX guinea pigs. It was 
reasoned that at an optimal level of progesterone, and with the 
continued administration of estradiol, nuclear progestin receptor levels 
might remain elevated for a greatly extended period of time. This could 
occur by a balance being attained between cytosol progestin receptor 
induction by estradiol action and nuclear accumulation of receptors by 
progesterone binding. Based on our hypothesis, such an extended 
retention of nuclear progestin receptors should result in delayed heat 
termination. However, heat termination occurred at about the same time 
in all animals regardless of the dose of progesterone, and despite the 
continued administration of estradiol and progesterone. 
This finding raised the possibility of a dissociation between 
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nuclear progestin receptor levels and the termination of sexual 
behavior. It was possible that continued administration of estradiol 
and progesterone maintained high levels of nuclear progestin receptors, 
but failed to maintain sexual responsiveness. Such a dissociation would 
negate our hypothesis and indicate that some process other than the loss 
of nuclear progestin receptors is responsible for heat termination. 
However, it was found that nuclear progestin receptors levels did, in 
fact, decrease despite the continued administration of both estradiol 
and progesterone. 
These findings raised the question of what factors regulate the 
retention of progestin receptors in cell nuclei. One such factor is 
circulating levels of progesterone. Blaustein and Feder (20) and 
McGinnis et al. (106) have reported that the transient increase in 
nuclear progestin receptor levels following the injection of 
progesterone parallels the rise and fall of blood progesterone levels. 
To investigate this relationship further, progesterone capsules were 
removed from OVX estradiol-pretreated guinea pigs two hours after their 
insertion, and the effect on hypothalamic nuclear progestin receptor 
levels was monitored. Following capsule removal,nuclear progestin 
receptor levels gradually decreased in parallel with the decline in 
blood progesterone concentration. By 18 hours after capsule insertion, 
nuclear progestin receptor levels as well as serum progesterone 
concentrations had returned to baseline levels. In animals that were 
continuously exposed to progesterone, serum progesterone concentrations 
remained elevated throughout the course of the experiment; however, 
nuclear progestin receptor levels also decreased gradually to near 
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baseline levels by 18 hours after capsule insertion. These results 
demonstrate that under certain conditions, circulating progesterone 
levels influence the nuclear retention of progestin receptors; however, 
because nuclear receptor levels decrease despite elevated circulating 
progesterone levels, other factors must be involved. 
One factor that may be involved in regulating retention of 
nuclear progestin receptors is the level of available cytosol receptors. 
As the level of progestin receptors in the cytosol decreases due to 
progesterone binding or to degradation, fewer receptors are available to 
accumulate in the cell nucleus; thus nuclear progestin receptor levels 
decline. This is most likely the mechanism by which nuclear progestin 
receptor levels decline in the presence of high levels of circulating 
progesterone. Following progesterone capsule insertion, cytosol 
progestin receptor levels decreased, and remained lowered even as 
nuclear progestin receptor levels declined to baseline. 
This interpretation suggests that heat termination may be the 
result of the same cellular events that lead to sequential inhibition. 
As discussed in the General Introduction, evidence exists which suggests 
that sequential inhibition may be a period of hyposensitivity to 
progesterone (13, 14, 22, 77). This hyposensitivity is thought to 
result from a diminished level of cytosol progestin receptors due to 
prior progesterone exposure (19, 112). Because fewer cytosol progestin 
receptors are available to interact with progesterone, an insufficient 
level of nuclear progestin receptor accumulation for activation of 
sexual behavior occurs (13, 14, 101). This same mechanism appears to be 
responsible for heat termination; in fact, the hyposensitivity to 
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progesterone can be thought of as an extension of heat termination. 
This idea is further supported by the finding that supplemental 
progesterone injection delays heat termination. In the absence of the 
initial injection of progesterone, the second dose of progesterone would 
be expected to activate a receptive period that would not terminate 
until 12 to 16 hours after injection. Instead, in the presence of the 
initial progesterone, heat termination occurred 4 to 0 hours after the 
second injection of progesterone. 
It is probable that in intact estrous-cycling guinea pigs, both a 
decrease in circulating progesterone levels and a decrease in 
hypothalamic progestin receptor concentrations are responsible for the 
decline in. nuclear progestin receptors, and therefore, heat termination. 
During the estrous cycle, the appearance of sexual behavior parallels 
the transient preovulatory increase in circulating progesterone levels 
(64). As progesterone levels decrease, the period of sexual behavior 
terminates, indicating that availability of progesterone influences heat 
duration, and possibly nuclear retention of hypothalamic progestin 
receptors. Soy et al. (71) have demonstrated that in intact female 
guinea pigs, estradiol and progesterone administered near the end of the 
receptive period or during the luteal phase of the estrous cycle, was 
unable to stimulate sexual receptivity. Based on the findings discussed 
above, it is likely that this refractoriness is due to decreased cytosol 
progestin receptor availability. Therefore, it seems likely that in the 
intact animal, availability of cytosol progestin receptors may play a 
role in regulating nuclear retention of progestin receptors, and 
therefore, heat duration. 
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In the fourth study of this dissertation, exposure of guinea pigs 
to progesterone capsules for 2 hours resulted in fewer animals becoming 
sexually receptive as compared to the number of animals continuously 
exposed to progesterone. Of those animals that did become sexually 
receptive, heat termination occurred at about the same time regardless 
of treatment group. However, a tight correlation was found to exist 
between the percentage of animals sexually receptive at a given time 
following progesterone exposure, and the level of hypothalamic nuclear 
progestin receptors. As the concentration of nuclear progestin 
receptors decreased, so did the number of guinea pigs displaying 
lordosis. In contrast, the correlation between elevated nuclear 
progestin receptors and sexual receptivity in rats indicates a time lag 
may exist between nuclear progestin receptor loss and heat termination 
(1). In OVX female rats treated with estradiol and progesterone, 
hypothalamic nuclear progestin receptor levels decreased to baseline 
levels 8 to 12 hours before heat terminated in similarly-treated 
animals. 
Rainbow and coworkers (144, 145) have shown that 
progesterone-facilitated sexual receptivity is protein synthesis 
dependent. Based on the results of the studies presented here, one 
would predict that in guinea pigs, the proteins that may be induced by 
progesterone action have a short half-life, whereas in the rat, the 
induced protein, or perhaps induced RNA, has a longer half-life. This 
prediction could be tested by inhibiting RNA or protein synthesis at 
various times after progesterone injection. If the putative induced 
proteins are short-lived, then inhibition of protein synthesis toward 
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the end of the receptive period should result in premature heat 
termination. Alternatively, if the induced proteins are longer-lived, 
then administration of protein synthesis inhibitors toward the end of 
the receptive period would be without effect. By comparing the effect 
of protein synthesis inhibition with the effect of RNA inhibition, it 
may be possible to determine if the maintenance of sexual receptivity in 
rats in the absence of nuclear-bound progesterone is the result of 
induction of proteins with a long half-life, or of induction of mRNAs 
with a long half-life. 
In the fifth study of this dissertation, the effect of 
accelerating the loss of hypothalamic nuclear progestin receptors on 
heat termination was examined. RU 486 administered four hours after 
progesterone injection was found to accelerate the loss of 
progesterone-occupied progestin receptors from hypothalamic cell nuclei. 
This treatment also accelerated the termination of sexual receptivity, 
providing strong support for the involvement of hypothalamic nuclear 
progestin receptor loss in heat termination. 
In addition to the mechanism for heat termination examined in 
these studies, other mechanisms for heat termination have been proposed. 
Hansen et al. (76, 77) and Sodersten et al. (167) have proposed that a 
circadian factor is responsible for heat termination. This hypothesis 
originated in the finding that injection of progesterone early on the 
day of behavioral estrus advanced the onset of sexual receptivity in 
female rats, but did not affect when the receptive period ended (165). 
Hansen et al. (76, 77) have reported a circadian rhythm in the display 
of lordosis in estrogen-treated OVX rats, with high levels of 
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receptivity being exhibited during the dark phase of the light / dark 
cycle. This circadian cyclicity was abolished by lesions of the 
suprachiasmatic nucleus (SCN) (76). In a recent study, Sodersten et al. 
(167) reported that the circadian signal responsible for inhibition of 
lordosis during the photoperiod, and perhaps for heat termination, is 
arginine vasopressin. Vasopressin is produced by the SCN and has been 
shown to be present in cat cerebral spinal fluid in a diurnal pattern 
(150). Sodersten et al. (167) have found that arginine vasopressin 
administered intraventricularly 3 hours after progesterone injection 
inhibited sexual behavior in a dose-dependent manner. This effect of 
vasopressin was independent of any systemic effect on blood pressure, 
and could be blocked by intraventricular administration of antisera to 
arginine vasopressin. While it is possible that a circadian signal 
plays a role in heat termination, some rearchers have reported an 
absence of a circadian rhythm in the display of sexual behavior in 
estrogen-treated OVX rats (32, 53). In addition, sequential estradiol 
and progesterone treatment is capable of activating lordosis during the 
light phase of the light / dark cycle (unpublished observations), when 
cerebral spinal levels of vasopressin would be expected to be elevated. 
Further study is required to determine if a circadian factor is involved 
in heat termination. It is conceivable that several independent 
mechanisms are involved in heat termination in the estrous-cycling 
female. Such redundancy could serve to ensure that the animal would not 
remain receptive beyond the onset of light, when the danger of prédation 
could be increased. 
Erskine (51) has suggested that heat termination in 
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estrous-cycling female rats is the result of 5a-reduction of 
testosterone that is secreted in significant amounts just prior to the 
onset of sexual behavior (59). To test this, Erskine (51) has 
administered So^reductase inhibitors or the androgen receptor 
antagonist, flutamide, to estrous-cycling female rats. These treatments 
did not affect the onset of sexual receptivity but did delay heat 
termination. However, flutamide was injected daily for 8 days prior to 
testing, and the 5 -reductase inhibitors were administered 4 days prior 
to testing. It is not apparent why such prolonged drug treatments were 
used. Although no effect of these treatments were noted on serum 
estradiol concentrations or on the duration of the estrous cycle, it 
seems possible that these extreme treatments may have altered heat 
termination in a manner not directly related to their effects on the 
androgen system, 
Rubin and Barfield (157) have proposed that progesterone 
activates two systems within the brain. One system is activated in the 
mediobasal hypothalamus and is responsible for the facilitation of 
sexual behavior, the other system is activated in the midbrain and is 
responsible for the inhibition of sexual behavior; The facilitory 
system, they further suggest, may react to progesterone with a short 
latency, while the inhibitory system is activated with a longer latency. 
In this way, progesterone action first facilitates and then terminates 
the period of sexual receptivity. This dual site / dual function 
explanation for progesterone's actions has been suggested by other 
researchers as well (52, 114). However, as dicussed in the General 
introduction, both of progesterone's effects on sexual behavior can be 
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ascribed to the same neural site. Interestingly, Rubin and Barfield's 
data demonstrate this fact most clearly. Progesterone implants placed 
in the VMM both facilitated sexual receptivity and prevented a 
subsequent progesterone injection from activating a second period of 
receptivity (157). A possible test of this hypothesis would be to 
implant RU 486 in the midbrain and determine if this treatment prolongs 
the period of receptivity induced by a systemic injection of 
progesterone. Based on the finding that RU 486 administered 4 hours 
after progesterone attenuated heat duration, it seems unlikely that such 
a manipulation would extend the receptive period. 
The mechanism by which loss of nuclear progestin receptors from 
hypothalamic cell nuclei results in heat termination is not known. This 
is due primarily to the uncertainty of the mechanism by which 
progesterone action activates sexual receptivity. Several studies have 
implicated the serotonergic system in the regulation of sexual 
receptivity. Pharmacological agents that increase serotonin levels or 
activate serotonin receptors, inhibit the display of lordosis in 
estradiol-progesterone treated rats and guinea pigs (54, 108, 110, 127, 
161). In addition, agents that decrease serotonin levels or inactivate 
serotonin receptors, facilitate lordosis in estradiol-pretreated animals 
(10, 58, 67, 151). The inhibitory effect of serotonin on lordosis 
appears to be specific for the progestin system. Serotonergic agents 
fail to inhibit lordosis that is activated by estrogen treatment alone 
(110), indicating that serotonin does not interfere directly with 
estrogen action. From these findings, it has been suggested that 
progesterone may facilitate sexual receptivity by inhibiting 
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serotonergic activity (54, 108). It seems possible, therefore, that 
heat termination could result from an increase in serotonergic activity 
as progesterone'5 cellular effects diminish. Erskine and Baum (52) have 
tested this possibility and have found no changes in hypothalamic 
serotonin or 5-hydroxyindoleacetic acid levels near the time of heat 
termination. However, in their study, heat termination was induced by 
coital stimulation which may cause heat termination through a mechanism 
different from the one involved in the nonmated animal (149). The 
possibility remains, therefore, that heat termination in non-mated 
animals may involve an increase in serotonergic activity, or possibly an 
increase in serotonergic receptors. 
In addition to serotonin and vasopressin, several other hormones, 
neurotransmitters, and neuropeptides have been shown to affect rodent 
sexual behavior. These include LHRH (123, 135, 152, 158), prolactin 
(46, 166), endogenous opioids (2, 179), oxytocin (31), catacholamines 
(40, 64, 148), melatonin (44), and corticotropic releasing factor (162). 
How, and if, these systems are integrated to regulate sexual behavior is 
completely unknown and will be a major area for research in future 
years. It is probable that until this question is answered, we will not 
fully understand the process by which heat termination occurs. 
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APPENDIX A. EFFECT OF INCUBATION TIME AND TEMPERATURE ON CYTOSOL 
PROGESTIN RECEPTOR MEASUREMENT 
Figure A-i. The effect of incubation time a n d  temperature on hypothalamic progestin receptors 
measurement 
Hypothalamic cytosol extract was obtained from eatradiol-treated OVX guinea 
pigs, and incubated with (='H)R 5020 +/- unlabeled progesterone, at 0, 15, or 20*C 
for 2, 4, 6, 8, or 22 hours. Results are expressed as a percentage of specifically 
bound (=H)R 5020 measured at 15°C for 6 hours. 
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APPENDIX B. EFFECT OF INCUBATION TIME AND TEMPERATURE ON NUCLEAR 
PROGESTIN RECEPTOR MEASUREMENT 
I 
Figure B-1. The effect of incubation time and temperature on nuclear progestin receptor 
measurement 
Hypothalamic cell nuclear extract was obtained from OVX guinea pigs treated 
with estradiol benzoate and progesterone. Progestin receptors were measured by 
incubating the extract with (®H)R 5020 +/- unlabeled progesterone at 0, 10, 15, 20, 
or 25°C for 2, 4, 8, or 22 h. Results are expressed as a percentage of 
specifically bound ('H)R 5020 measured at 15°C for 4 h. 
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APPENDIX C. COMPARISON OF SALT EXTRACTABILITY OF RU 486- AND 
PROGESTERONE-ACCUMULATED NUCLEAR PROGESTIN RECEPTORS 
In order to determine if RU 486-accumulated nuclear progestin 
receptors are as tightly-bound to cell nuclear components as 
progesterone-accumulated receptors, nuclear-bound receptors were 
extracted with a range of salt concentrations. Fourteen DVX guinea pigs 
were injected with 5 mg progesterone or RU 486, 40 h after receiving 
10 ug EB. Three h later, animals were killed and MBH-POA were 
dissected. Following cell nuclear isolation, nuclear pellets were 
suspended in buffer TEST. Suspensions from similarly-treated animals 
were pooled, and aliquoted into polycarbonate tubes. Receptors were 
extracted by adding an equal volume of TEGT containing 0, 0.2, 0.3, 0.4, 
or 1.0 M KCl. Receptors were then measured as described with an 
incubation period of 8 h at 15°C. The results are shown on the facing 
page, and are expressed as a percent of binding measured in the 0.5 M 
KCl extract. 
Because a slight difference in extractability of the receptors 
was noted with 0.2 M KCl (Figure C-1), this finding was reexamined. 
Following RU 486 or progesterone injection, nuclear progestin receptors 
were extracted.with 0.5 M or 0.2 M KCl. No difference was found between 
the extractability of the RU 486- and the progesterone-accumulated 
receptor (80.97. +/- 4.47. and 79.37. +/- 5.97. respectively, n = 6 per 
group). 
Figure C-1. Salt extractability of RU 486- and progesterone-accumulated 
progestin receptors 
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